Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",A1BG,Alpha-1B-glycoprotein,3631,89,0.80 [0.24-2.58],0.7031918763836618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AAMDC,Mth938 domain-containing protein,3520,84,0.90 [0.60-1.35],0.5975771317945875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,4161,121,0.72 [0.54-0.97],0.0279305656518355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,3499,84,3.45 [2.46-4.84],5.951772669236575e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABHD14B,Protein ABHD14B,4131,120,1.11 [0.83-1.48],0.4787890421899591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,4161,121,1.42 [1.14-1.76],0.0016490150522173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABO,Histo-blood group ABO system transferase,3632,90,0.92 [0.80-1.05],0.2234215507683716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,3499,84,0.99 [0.72-1.38],0.9677371731462812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",4058,119,1.18 [0.99-1.40],0.0664713311064798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",3566,88,1.15 [0.88-1.51],0.3026773800929067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",3615,89,0.79 [0.62-1.00],0.0527366141064858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAN,Aggrecan core protein,4134,119,3.15 [1.81-5.48],5.068021337175012e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE,Angiotensin-converting enzyme,3632,90,3.27 [1.63-6.58],0.0008725304729063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE2,Angiotensin-converting enzyme 2,4107,122,0.98 [0.77-1.25],0.8595304407802037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACHE,Acetylcholinesterase,3556,85,1.27 [0.74-2.18],0.3900554351525274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,3602,89,0.93 [0.78-1.11],0.4031526936618664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,4181,121,1.10 [0.81-1.49],0.5536375152248794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,3506,87,0.52 [0.31-0.88],0.0149661090145811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,4205,123,2.93 [1.92-4.48],6.390317113499507e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,4207,123,2.23 [1.63-3.03],4.024597527784931e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRBP,Acrosin-binding protein,3607,90,0.90 [0.53-1.52],0.6976737745137189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRV1,Acrosomal protein SP-10,3506,87,1.42 [1.18-1.73],0.0003156022909594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,3499,84,1.19 [0.69-2.06],0.5310068629730913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",4107,122,2.52 [2.14-2.96],3.3809275512939656e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN2,Alpha-actinin-2,3499,84,1.47 [1.11-1.93],0.0063332722422205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN4,Alpha-actinin-4,4080,118,1.65 [1.22-2.23],0.0010886655539306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,4138,120,12.68 [9.20-17.49],3.587382345143674e-54
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY1,Aminoacylase-1,4181,121,0.71 [0.57-0.90],0.0037265909393213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,3499,84,1.80 [1.33-2.43],0.0001475951052505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACYP1,Acylphosphatase-1,3547,84,0.84 [0.61-1.16],0.288831483814371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA,Adenosine deaminase,4228,121,1.31 [0.86-2.00],0.2141829912235374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA2,Adenosine deaminase 2,4162,122,2.93 [2.22-3.85],1.8524378128743835e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,3506,87,3.93 [2.91-5.33],7.8084787770226455e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,4107,122,2.17 [1.33-3.57],0.0020671669285155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,4145,120,7.73 [5.22-11.44],1.9828546062090573e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,4228,121,10.74 [6.32-18.25],1.6111056917942553e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,4206,121,3.84 [2.59-5.70],2.487660167061316e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,3602,89,7.07 [5.11-9.77],2.776834196379162e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,3506,87,3.39 [2.04-5.66],2.7457550385481885e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,4232,123,0.61 [0.34-1.11],0.1088225175586469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,4161,121,3.10 [2.34-4.12],5.812903745478369e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,4107,122,1.98 [1.46-2.67],9.98727378564324e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,3506,87,2.78 [1.85-4.19],9.500394467360408e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,4185,121,1.18 [0.84-1.67],0.3363151503282185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,3629,87,2.02 [1.30-3.14],0.0017161757064993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,3520,84,1.31 [0.56-3.07],0.5367203821234101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,3615,89,1.90 [1.26-2.86],0.0022093243261352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,4058,119,0.77 [0.44-1.37],0.3764535707425805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADD1,Alpha-adducin,3556,85,0.70 [0.52-0.94],0.0178545183621638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,4138,120,4.70 [3.58-6.17],6.957040399941588e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,3556,85,2.37 [1.55-3.63],7.434017829513908e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,3602,89,2.25 [1.67-3.03],9.745192359190417e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,4198,120,7.15 [4.51-11.35],6.509931269785811e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,4215,123,5.01 [3.59-6.98],2.0431587302578387e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,3615,89,2.15 [1.01-4.58],0.0461147852073799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,4161,121,1.28 [1.12-1.46],0.0002535200806484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,4181,121,0.37 [0.21-0.64],0.0003985724451508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,3493,84,0.95 [0.69-1.31],0.7691071749726569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,3556,85,0.77 [0.60-0.99],0.0433914363599829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,4107,122,0.74 [0.61-0.88],0.000938964358001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADIPOQ,Adiponectin,3631,89,1.32 [1.01-1.71],0.0391631345019193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADM,Pro-adrenomedullin,4215,123,22.79 [13.30-39.05],5.674091484099073e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,3499,84,0.85 [0.59-1.21],0.3695167619983165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFAP1,Actin filament-associated protein 1,3556,85,1.10 [0.86-1.42],0.4337089796255456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFM,Afamin,3631,89,0.16 [0.08-0.32],2.752277665477228e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFP,Alpha-fetoprotein,4131,120,0.49 [0.38-0.64],1.3789953087708753e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,3493,84,1.00 [0.81-1.24],0.973936137631706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,4172,120,3.43 [2.47-4.76],1.872624749384916e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,4027,115,1.73 [1.50-1.99],1.7091062305629546e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR3,Anterior gradient protein 3,4051,119,1.49 [1.15-1.94],0.0028282031012365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRN,Agrin,4198,120,4.77 [3.75-6.07],3.6403457267375394e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRP,Agouti-related protein,4228,121,2.84 [2.10-3.85],1.4622587800045306e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGT,Angiotensinogen,3632,90,1.97 [0.96-4.04],0.0634888083139126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGXT,Serine--pyruvate aminotransferase,4181,121,1.06 [0.88-1.28],0.5513036410575138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHCY,Adenosylhomocysteinase,4181,121,0.94 [0.74-1.20],0.6346509329585791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,3520,84,3.07 [1.88-5.02],7.982605464613502e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK2,Protein AHNAK2,3520,84,2.83 [1.92-4.18],1.6823747701358332e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,3607,90,0.78 [0.54-1.13],0.1846175086060606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,3632,90,0.62 [0.33-1.18],0.1471092906257344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,4186,121,0.79 [0.66-0.95],0.0137366397550397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",3532,86,0.94 [0.72-1.22],0.6318045531285008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1,Allograft inflammatory factor 1,4058,119,1.22 [0.90-1.65],0.1997553256822897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,3520,84,1.64 [1.28-2.10],8.984573033791683e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",4156,121,1.09 [0.94-1.27],0.2533804850623108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK1,Adenylate kinase isoenzyme 1,4181,121,0.72 [0.56-0.93],0.0129953554772339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",3602,87,0.94 [0.77-1.15],0.5585442941032295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKAP12,A-kinase anchor protein 12,3556,85,2.57 [1.25-5.28],0.0105197099304941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,4058,119,0.91 [0.73-1.14],0.4050784633814921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,3532,86,1.10 [0.87-1.39],0.4351137422018922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,4107,122,1.61 [1.33-1.95],9.48777926984531e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,3506,87,1.14 [0.88-1.48],0.3214728080645632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,4054,117,0.83 [0.65-1.06],0.1322222570574884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,3616,90,0.92 [0.78-1.08],0.2886487171336586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,4035,119,1.06 [0.80-1.41],0.679320979389771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALCAM,CD166 antigen,4232,123,9.31 [4.90-17.69],9.941646232326812e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,4195,121,0.58 [0.44-0.77],0.0001203334678612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",3607,90,1.01 [0.70-1.46],0.95853774029139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",4165,119,0.96 [0.79-1.16],0.6457852223724355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",3616,90,1.38 [0.93-2.05],0.105175691378162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALMS1,Alstrom syndrome protein 1,3566,88,1.29 [0.85-1.94],0.231797294496051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,3506,87,1.17 [1.00-1.37],0.0460071676022144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPP,"Alkaline phosphatase, placental type",4161,121,1.11 [0.95-1.28],0.1841229009223254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBN,Ameloblastin,4080,118,1.16 [0.70-1.93],0.5552757363686436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBP,Protein AMBP,4211,123,33.66 [20.12-56.29],6.127565429750837e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,3629,87,0.87 [0.39-1.95],0.7405428611418126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,4054,117,1.32 [1.04-1.67],0.0215870483268511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO1,Amphoterin-induced protein 1,3532,86,0.74 [0.45-1.21],0.2295340391612698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO2,Amphoterin-induced protein 2,4161,121,2.01 [1.05-3.84],0.0357663591494774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMN,Protein amnionless,4080,118,1.60 [1.17-2.19],0.0035788259539329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOT,Angiomotin,3556,85,0.91 [0.55-1.51],0.7201551869058788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOTL2,Angiomotin-like protein 2,3593,88,1.37 [0.98-1.92],0.0676736786786622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMPD3,AMP deaminase 3,3602,87,0.81 [0.61-1.08],0.1464530157268857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,3403,83,1.05 [0.71-1.56],0.7895066219173104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2A,Pancreatic alpha-amylase,4017,118,1.44 [1.07-1.95],0.0173710612268984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2B,Alpha-amylase 2B,3894,114,1.44 [1.07-1.95],0.0175750347308164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANG,Angiogenin,4182,122,3.66 [2.55-5.25],1.973043054688563e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT1,Angiopoietin-1,4163,119,0.99 [0.82-1.19],0.8866851739153596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT2,Angiopoietin-2,4215,123,3.54 [2.52-4.97],2.5680448431568083e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,4112,118,3.64 [2.19-6.05],6.632348189216641e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,4184,120,1.29 [0.88-1.88],0.1933803617725051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,4192,122,1.86 [1.24-2.80],0.0027040995477394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,4192,120,4.19 [3.01-5.81],1.3524223463760249e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,4215,123,2.53 [1.80-3.56],1.0632615682013944e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANK2,Ankyrin-2,3499,84,0.94 [0.69-1.29],0.7213754503680505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,3506,87,0.99 [0.76-1.27],0.9070982307031236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,3482,86,1.11 [0.78-1.58],0.5660516982816226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,4058,119,1.01 [0.78-1.31],0.954498142588464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,3520,84,0.55 [0.27-1.13],0.1040518475512488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANPEP,Aminopeptidase N,4189,122,1.51 [0.90-2.54],0.1198575979353895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA1,Annexin A1,3540,85,1.06 [0.70-1.62],0.7703136856836497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA10,Annexin A10,4054,117,1.27 [1.08-1.50],0.004692029887662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA11,Annexin A11,4169,120,0.83 [0.66-1.05],0.1185213553521209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA2,Annexin A2,3473,83,1.10 [0.82-1.48],0.5115618273286088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA3,Annexin A3,4206,121,0.97 [0.77-1.22],0.7857304983938463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA4,Annexin A4,4161,120,0.84 [0.66-1.05],0.1284247473672222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA5,Annexin A5,4042,116,3.08 [2.34-4.04],5.950949298946917e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],4080,118,0.91 [0.66-1.24],0.552373149026207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC3,Membrane primary amine oxidase,4197,122,8.43 [5.40-13.16],7.357652651818137e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,3607,90,1.07 [0.83-1.37],0.6012689439024881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP2B1,AP-2 complex subunit beta,3532,86,0.83 [0.52-1.30],0.410784803198193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3B1,AP-3 complex subunit beta-1,3602,89,1.16 [0.89-1.51],0.2747226674213191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,3602,87,1.36 [0.91-2.01],0.1300043847716384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,4161,121,1.47 [1.10-1.97],0.0097023592498639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APCS,Serum amyloid P-component,3591,89,0.50 [0.28-0.89],0.0187331625397426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,4202,123,0.92 [0.70-1.21],0.559497334576295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APLP1,Amyloid-like protein 1,4181,121,0.89 [0.65-1.21],0.4580733699667273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA1,Apolipoprotein A-I,3631,89,0.33 [0.17-0.66],0.0015057038648436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA2,Apolipoprotein A-II,3632,90,3.04 [2.12-4.34],1.110997354224723e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA4,Apolipoprotein A-IV,3631,89,4.40 [3.15-6.16],4.925174158272326e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOB,Apolipoprotein B-100,3632,90,0.91 [0.38-2.18],0.8378820797666604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOBR,Apolipoprotein B receptor,3520,84,1.21 [0.72-2.02],0.4771976301015078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOC1,Apolipoprotein C-I,3622,89,0.31 [0.19-0.52],6.19674302772861e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOD,Apolipoprotein D,3481,84,0.71 [0.39-1.28],0.2543864817603684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOE,Apolipoprotein E,3631,89,0.85 [0.58-1.23],0.3843030257646198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOF,Apolipoprotein F,3632,90,1.31 [0.75-2.30],0.337967690080714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOH,Beta-2-glycoprotein 1,4195,121,1.67 [1.16-2.41],0.0060121310581725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOL1,Apolipoprotein L1,3632,90,0.69 [0.47-1.01],0.0558877227175937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOM,Apolipoprotein M,4196,122,0.51 [0.30-0.86],0.0113760888172002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APP,Amyloid-beta precursor protein,4191,121,1.04 [0.82-1.33],0.727135829123292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APPL2,DCC-interacting protein 13-beta,3556,85,0.90 [0.74-1.08],0.2397510588325451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APRT,Adenine phosphoribosyltransferase,4142,120,1.04 [0.73-1.47],0.8303324714526719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,3566,88,1.07 [0.80-1.44],0.6295921351486873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AREG,Amphiregulin,4161,121,3.58 [2.81-4.56],3.4708091484715063e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARF6,ADP-ribosylation factor 6,3602,89,0.93 [0.77-1.13],0.4765740213188626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARFIP1,Arfaptin-1,3616,90,0.95 [0.71-1.28],0.7329880653907253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG1,Arginase-1,4145,122,0.59 [0.44-0.79],0.000411134436087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG2,"Arginase-2, mitochondrial",3607,90,0.82 [0.48-1.39],0.4506041414515068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,4058,119,0.74 [0.52-1.06],0.1050332287560607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,4058,119,1.09 [0.83-1.42],0.5458209547303938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,3566,88,1.12 [0.67-1.88],0.6574751313894656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,3556,85,0.87 [0.67-1.12],0.2735470789788677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,3482,86,1.03 [0.79-1.34],0.8247937767081506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,3602,87,0.97 [0.77-1.23],0.7932971367296183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,3616,90,1.05 [0.85-1.29],0.6720256445723656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,4174,120,0.99 [0.85-1.16],0.8928085654728353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,3493,84,1.42 [1.14-1.77],0.0017394755586607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,3493,84,1.48 [0.89-2.44],0.1309193719452547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,4054,117,0.76 [0.48-1.19],0.2238996162733836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,3499,84,1.08 [0.81-1.44],0.5975334209470189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,3499,84,0.85 [0.50-1.46],0.557368872362741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,3493,84,1.06 [0.75-1.51],0.7425695014699526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,4080,118,1.36 [0.98-1.90],0.0672568808072172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,3499,84,1.03 [0.70-1.53],0.8793153392404003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSA,Arylsulfatase A,4195,121,0.86 [0.61-1.22],0.4048308399508666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSB,Arylsulfatase B,4161,121,0.95 [0.71-1.26],0.7020370609297557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,4197,122,7.31 [5.48-9.76],1.4966691144088848e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,3493,84,1.25 [0.97-1.61],0.0851068973104876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARTN,Artemin,4080,118,0.87 [0.57-1.33],0.5254766284190606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH1,Acid ceramidase,3607,87,1.25 [0.84-1.86],0.2709813302078667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH2,Neutral ceramidase,4145,120,0.84 [0.64-1.11],0.2296216323988036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,4145,120,6.52 [4.73-8.98],1.725915292781874e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,3632,90,11.22 [6.88-18.30],3.7002944612595313e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPN,Asporin,3615,89,1.76 [0.96-3.21],0.0656151744785129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,3616,90,0.86 [0.63-1.18],0.3505002778724013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,3520,84,0.88 [0.71-1.08],0.2239823458626091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASS1,Argininosuccinate synthase,3499,84,0.93 [0.73-1.19],0.570382070220117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,4054,117,1.06 [0.84-1.33],0.6228888039362748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,3482,86,0.56 [0.28-1.09],0.0856721430443068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG16L1,Autophagy-related protein 16-1,3602,89,1.03 [0.81-1.30],0.8236638922978607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG4A,Cysteine protease ATG4A,4058,119,0.80 [0.60-1.05],0.1093516955255886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATOX1,Copper transport protein ATOX1,4185,121,1.25 [0.99-1.59],0.0641243471437984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,3499,84,1.36 [0.95-1.95],0.0879630633227047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,3499,84,0.95 [0.51-1.76],0.875484327803252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,3499,84,1.32 [0.82-2.12],0.2531476081923783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B4,Protein ATP1B4,3482,86,0.96 [0.58-1.59],0.8641096815092021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,3499,84,0.91 [0.62-1.33],0.6164084101222527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",3499,84,1.24 [0.86-1.78],0.2454040594667031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",4198,120,1.03 [0.89-1.19],0.6958602993451802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",4054,117,1.02 [0.71-1.48],0.8980128555780942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6AP2,Renin receptor,4058,119,1.94 [1.46-2.59],4.941367574464956e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,4161,121,1.32 [0.78-2.24],0.3009831304373703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,4046,117,0.81 [0.62-1.05],0.103859946090251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,3520,84,0.87 [0.64-1.17],0.3420004392089796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,3499,84,0.94 [0.74-1.20],0.64465042798595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,3602,89,6.06 [4.56-8.06],2.4105511802761584e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRN,"Attractin, Isoform 2",3631,89,0.47 [0.15-1.49],0.200951546735316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN10,Ataxin-10,4054,117,0.92 [0.74-1.14],0.4318202496794568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2,Ataxin-2,3493,84,0.95 [0.78-1.16],0.6186260334832755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2L,Ataxin-2-like protein,3616,90,0.95 [0.62-1.43],0.7910356263375109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN3,Ataxin-3,3602,87,0.74 [0.53-1.04],0.0801409354277477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXIN1,Axin-1,4174,120,0.98 [0.83-1.16],0.8493891878852773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,4197,122,6.59 [4.16-10.47],1.1812629598689748e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZI2,5-azacytidine-induced protein 2,3616,90,1.14 [0.81-1.62],0.4561168011672319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZU1,Azurocidin,4070,120,1.01 [0.83-1.23],0.9231322557554904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B2M,Beta-2-microglobulin,3631,89,7.28 [5.14-10.31],4.5279099299509364e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,3499,84,0.76 [0.26-2.25],0.620302590817273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",3520,84,4.46 [2.58-7.71],8.97444658136254e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",4198,120,13.61 [9.43-19.64],3.286102955964928e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",4195,121,5.48 [2.85-10.54],3.3895690645399564e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,3506,87,0.63 [0.28-1.45],0.2806586912784709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BACH1,Transcription regulator protein BACH1,4174,120,0.92 [0.73-1.15],0.4659917001319377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,4138,120,2.20 [1.51-3.20],4.419591644099196e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,3506,87,1.45 [1.02-2.07],0.0381366821826217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG6,Large proline-rich protein BAG6,4107,122,1.15 [0.75-1.77],0.5123098636177035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,4058,119,1.33 [1.08-1.64],0.0070292657843251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,4058,119,4.00 [3.12-5.14],1.7044858430378578e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,4174,120,0.93 [0.80-1.08],0.3459105613332333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAP18,Chromatin complexes subunit BAP18,3602,87,1.09 [0.83-1.43],0.52395869558408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,3532,86,0.97 [0.74-1.26],0.7927122525792976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAX,Apoptosis regulator BAX,4047,116,1.06 [0.89-1.28],0.501863354344805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAM,Basal cell adhesion molecule,4195,121,3.23 [1.75-5.99],0.0001893348180238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAN,Brevican core protein,4145,120,0.75 [0.48-1.17],0.2045177287783909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",3615,89,1.17 [0.64-2.13],0.6165949363687688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",3493,84,0.65 [0.39-1.11],0.1126023369120737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCHE,Cholinesterase,3569,89,0.65 [0.35-1.20],0.1673388805492603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2,Apoptosis regulator Bcl-2,3602,89,1.70 [1.37-2.12],2.175546202553488e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L1,Bcl-2-like protein 1,3602,87,0.87 [0.70-1.07],0.1823861097170477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",4174,120,3.01 [1.90-4.76],2.536575213095426e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L15,Bcl-2-like protein 15,3506,87,1.52 [1.19-1.93],0.0006347365940902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,3482,86,0.99 [0.72-1.38],0.962604631220004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,3607,90,0.82 [0.49-1.39],0.4648564410181734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCR,Breakpoint cluster region protein,4174,120,0.95 [0.79-1.13],0.5472027573711098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BDNF,Brain-derived neurotrophic factor,3629,87,0.99 [0.77-1.26],0.9108265205420324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BECN1,Beclin-1,3520,84,0.99 [0.69-1.41],0.9527995264609844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BEX3,Protein BEX3,3482,86,0.93 [0.57-1.52],0.7781350707876187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGLAP,Osteocalcin,3629,87,1.06 [0.86-1.30],0.6110001500601951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGN,Biglycan,4054,119,0.95 [0.83-1.09],0.4596173269839517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,3493,84,0.87 [0.63-1.20],0.3976866364448721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,3499,84,1.26 [0.54-2.95],0.5981735938474652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BID,BH3-interacting domain death agonist,4174,120,0.92 [0.72-1.17],0.5006183273494381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIN2,Bridging integrator 2,4195,121,0.95 [0.80-1.14],0.6112604554638995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,4058,119,1.10 [0.85-1.42],0.4790586193390913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLMH,Bleomycin hydrolase,4232,123,0.78 [0.49-1.24],0.2973407912140095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLNK,B-cell linker protein,3506,87,1.22 [0.78-1.91],0.3833114354481933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,3493,84,0.94 [0.71-1.26],0.6929502170638582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,3602,87,0.92 [0.55-1.53],0.7358455421733872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLVRB,Flavin reductase,4195,121,0.73 [0.56-0.94],0.0138153014068489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP10,Bone morphogenetic protein 10,3556,85,3.89 [2.58-5.87],1.0324180114385428e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP4,Bone morphogenetic protein 4,4138,120,1.58 [1.19-2.09],0.0013854720752288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP6,Bone morphogenetic protein 6,4103,122,1.48 [0.99-2.21],0.0557495637770144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,3556,85,7.79 [4.91-12.36],3.0861274859679122e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,3615,89,0.63 [0.33-1.21],0.1690499868886264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,3506,87,1.94 [1.34-2.82],0.000451467475652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOC,Brother of CDO,4107,122,8.87 [5.00-15.74],8.587866531744799e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA1,BolA-like protein 1,3493,84,1.39 [1.06-1.83],0.0162123024857171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,3520,84,0.65 [0.45-0.95],0.0256810477295913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFA2,BPI fold-containing family A member 2,3413,81,0.99 [0.82-1.19],0.9235025527942629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB1,BPI fold-containing family B member 1,4167,120,0.94 [0.74-1.20],0.6206785067453928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB2,BPI fold-containing family B member 2,3610,89,0.96 [0.74-1.26],0.7787969565626482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRAP,BRCA1-associated protein,3562,88,0.98 [0.81-1.19],0.8589570677659439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD1,Bromodomain-containing protein 1,3566,88,0.88 [0.43-1.77],0.7176015494214503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD2,Bromodomain-containing protein 2,3493,84,0.68 [0.33-1.38],0.2876831724851527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD3,Bromodomain-containing protein 3,3499,84,0.85 [0.52-1.40],0.5214683464251926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRDT,Bromodomain testis-specific protein,3499,84,0.81 [0.45-1.46],0.4897644763287679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRK1,Protein BRICK1,4054,117,1.76 [1.26-2.47],0.0009551073988237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,3493,84,0.68 [0.37-1.25],0.2160698157041378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,3616,90,1.28 [0.77-2.14],0.3389060250686068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSG,Basigin,4220,121,22.46 [14.69-34.33],8.678396313506076e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSND,Barttin,3482,86,1.21 [0.70-2.10],0.4969723652982624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,4212,121,1.00 [0.71-1.41],0.9935511605646418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST2,Bone marrow stromal antigen 2,4212,121,1.51 [1.20-1.91],0.000494733570023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTC,Probetacellulin,4058,119,1.09 [0.88-1.36],0.4243904093850956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTD,Biotinidase,3631,89,0.63 [0.25-1.57],0.3164797717933829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTLA,B- and T-lymphocyte attenuator,3482,86,1.08 [0.90-1.31],0.4047290385498255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,3601,90,1.11 [0.69-1.79],0.6766207419806302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,4198,120,10.44 [7.94-13.74],4.3212883763357527e-63
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,4174,120,5.71 [4.25-7.66],6.383674327595325e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTNL10,Butyrophilin-like protein 10,3482,86,1.14 [0.70-1.87],0.5983077656971258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C19orf12,Protein C19orf12,4054,117,0.73 [0.58-0.93],0.009152403522072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,3499,84,1.18 [0.67-2.10],0.5623723189789586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,4206,121,6.71 [4.00-11.25],5.922380481119143e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",3616,90,0.95 [0.70-1.30],0.7499869523331776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QL2,Complement C1q-like protein 2,3506,87,0.93 [0.58-1.49],0.7615462349545346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,4197,122,1.84 [1.45-2.35],8.619650532438876e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,3556,85,1.74 [1.00-3.03],0.0510292312694987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,3616,90,1.42 [0.84-2.42],0.1932661393147225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,3550,84,1.97 [1.23-3.16],0.0050538589050584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1R,Complement C1r subcomponent,3631,89,0.37 [0.12-1.16],0.0872874231121736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1RL,Complement C1r subcomponent-like protein,3622,89,1.15 [0.43-3.10],0.7778127484228358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1S,Complement C1s subcomponent,3631,89,0.79 [0.32-1.97],0.6141756795459818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2,Complement C2,4196,122,4.81 [2.17-10.67],0.0001131575004125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,4046,117,1.83 [1.36-2.47],7.433482951078898e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2orf69,UPF0565 protein C2orf69,3532,86,1.00 [0.69-1.46],0.9800462198453822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C3,Complement C3,3440,87,1.03 [0.65-1.64],0.8886053108772224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C4BPB,C4b-binding protein beta chain,4185,121,1.71 [1.17-2.48],0.0051046813431403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C5,Complement C5,3631,89,1.35 [0.37-4.87],0.647324926692124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7,Complement component C7,3537,89,3.48 [2.09-5.82],1.8557949619073528e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7orf50,Uncharacterized protein C7orf50,3602,87,0.50 [0.15-1.64],0.2546011041047271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C8B,Complement component C8 beta chain,3631,89,0.61 [0.32-1.16],0.1321253769094379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9,Complement component C9,3632,90,1.12 [0.81-1.55],0.5044529488930906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9orf40,Uncharacterized protein C9orf40,3602,89,0.69 [0.53-0.89],0.0047609917134534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA1,Carbonic anhydrase 1,4116,121,0.71 [0.54-0.93],0.0115283832919688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA11,Carbonic anhydrase-related protein 11,4058,119,1.29 [0.91-1.83],0.1540996294933234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA12,Carbonic anhydrase 12,4161,121,4.92 [3.98-6.09],5.7704282544426994e-49
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA13,Carbonic anhydrase 13,4140,118,0.92 [0.79-1.08],0.3175353986248285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA14,Carbonic anhydrase 14,4215,123,4.73 [3.52-6.35],4.328741066707251e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA2,Carbonic anhydrase 2,4182,121,0.68 [0.54-0.86],0.0013975245950707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA3,Carbonic anhydrase 3,4228,123,1.52 [1.20-1.91],0.000421425241921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA4,Carbonic anhydrase 4,4232,123,8.81 [5.26-14.76],1.350616715109864e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",4107,122,1.30 [1.13-1.50],0.0003018909633663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA6,Carbonic anhydrase 6,4180,119,0.77 [0.60-1.00],0.0459576697069413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA7,Carbonic anhydrase 7,3566,88,0.99 [0.54-1.83],0.977243004351265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA8,Carbonic anhydrase-related protein,3506,87,0.87 [0.36-2.11],0.7603222645472216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA9,Carbonic anhydrase 9,4215,123,2.39 [1.91-3.00],2.0353739547597023e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CABP2,Calcium-binding protein 2,3532,86,0.91 [0.64-1.29],0.5846078507092441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,3493,84,1.01 [0.52-1.98],0.9660681294943604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,3499,84,1.12 [0.82-1.53],0.4615199359378745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,3493,84,0.96 [0.67-1.37],0.8139259238798516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,3616,90,0.99 [0.79-1.26],0.95715633332165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACYBP,Calcyclin-binding protein,3551,84,0.94 [0.76-1.15],0.5334743043311219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CADPS,Calcium-dependent secretion activator 1,3532,86,0.96 [0.59-1.58],0.8813143796115112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB1,Calbindin,4161,121,3.36 [2.58-4.38],4.0156629340045016e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB2,Calretinin,4054,117,4.58 [3.29-6.37],2.203038860381204e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCA,Calcitonin,4137,120,1.95 [1.66-2.30],1.1995642586972709e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,3602,87,2.20 [1.79-2.69],3.3366774363589993e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,4199,123,0.98 [0.84-1.15],0.8490556829060918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,3520,84,0.95 [0.72-1.26],0.7231878465503883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,3499,84,0.81 [0.43-1.52],0.5055566529031044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,4058,119,1.24 [0.87-1.77],0.2266880378480169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,3532,86,1.14 [0.79-1.65],0.4957678000314446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,3616,90,1.08 [0.89-1.31],0.4179991946054324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,4166,120,11.31 [5.59-22.89],1.500526834251319e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPG,Macrophage-capping protein,4149,122,2.01 [1.63-2.48],4.7268371002553777e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPN3,Calpain-3,3607,90,0.89 [0.50-1.58],0.6918931055729496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPS,Calcyphosin,3602,87,1.21 [1.04-1.40],0.0123110703580876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,4054,117,0.78 [0.56-1.09],0.1452000810157884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASC3,Protein CASC3,3532,86,1.01 [0.63-1.63],0.9714412051968616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP1,Caspase-1,4054,117,1.01 [0.81-1.26],0.9426424960222224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP10,Caspase-10,4054,117,1.01 [0.81-1.27],0.9112747900826792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP2,Caspase-2,4174,120,0.89 [0.70-1.13],0.3308078081849312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP3,Caspase-3,4232,123,0.93 [0.77-1.11],0.4297827573575572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP4,Caspase-4,3566,88,0.92 [0.81-1.06],0.2453172048649094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP7,Caspase-7,3602,87,0.93 [0.72-1.19],0.550020068197322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP8,Caspase-8,4203,123,0.98 [0.77-1.27],0.9037356059318528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP9,Caspase-9,3506,87,0.77 [0.53-1.10],0.1502233110139299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASQ2,Calsequestrin-2,3499,84,1.02 [0.62-1.66],0.951241211745166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAT,Catalase,3574,89,0.51 [0.35-0.76],0.0010160005197747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,4181,121,1.65 [1.38-1.97],2.6797210273122765e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN1,Cerebellin-1,3493,84,0.98 [0.77-1.26],0.9003874963209934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN4,Cerebellin-4,4215,123,0.51 [0.33-0.80],0.0030523959219663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBS,Cystathionine beta-synthase,3520,84,0.88 [0.61-1.28],0.5072960816405601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBX2,Chromobox protein homolog 2,3499,84,0.93 [0.52-1.67],0.8107112624794339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,4145,120,1.07 [0.86-1.33],0.5535396405885833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,3602,87,1.04 [0.72-1.49],0.8384256539623562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,3607,90,1.27 [0.85-1.91],0.24873292613386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,3532,86,0.83 [0.42-1.66],0.6048955057465686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,3616,90,1.09 [0.85-1.40],0.4731599037377686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,4181,121,4.23 [3.29-5.45],4.8607534324966797e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,3520,84,1.84 [1.45-2.32],4.478809246565349e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL11,Eotaxin,4228,121,3.69 [2.53-5.38],1.3855480418165451e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL13,C-C motif chemokine 13,4221,121,1.09 [0.87-1.38],0.4495236536136526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL14,C-C motif chemokine 14,4182,122,3.48 [2.68-4.51],9.167706348335206e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL15,C-C motif chemokine 15,4232,123,3.79 [2.94-4.88],7.136294349275773e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL16,C-C motif chemokine 16,4232,123,2.22 [1.68-2.94],2.172229539052504e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL17,C-C motif chemokine 17,4175,120,1.17 [0.98-1.38],0.0747885516016582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL18,C-C motif chemokine 18,4141,121,1.13 [0.92-1.39],0.2505704693370431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL19,C-C motif chemokine 19,4212,121,1.07 [0.96-1.20],0.2016160342744807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL2,C-C motif chemokine 2,4138,120,1.55 [1.16-2.08],0.0029597220020149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL20,C-C motif chemokine 20,4228,121,1.39 [1.22-1.58],6.829072003649934e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL21,C-C motif chemokine 21,4198,120,1.68 [1.36-2.06],1.0457738977009872e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL22,C-C motif chemokine 22,4145,120,1.41 [1.06-1.88],0.0193997448094703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL23,C-C motif chemokine 23,4198,120,2.73 [1.94-3.83],6.794382257345705e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL24,C-C motif chemokine 24,4192,120,1.25 [1.03-1.51],0.0223710819019889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL25,C-C motif chemokine 25,4228,121,3.26 [2.40-4.41],2.5244546037418532e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL26,C-C motif chemokine 26,4174,120,0.99 [0.84-1.18],0.923732782660039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL27,C-C motif chemokine 27,4181,121,1.83 [1.41-2.38],5.469813586239223e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL28,C-C motif chemokine 28,4160,119,1.17 [0.91-1.51],0.2269374175600318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL3,C-C motif chemokine 3,4174,120,1.32 [1.16-1.51],4.090649277324958e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL4,C-C motif chemokine 4,4188,120,1.12 [0.91-1.39],0.2932691054622667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL5,C-C motif chemokine 5,4197,122,0.96 [0.82-1.13],0.6398944420672672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL7,C-C motif chemokine 7,4174,120,1.54 [1.21-1.96],0.00049166715992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL8,C-C motif chemokine 8,4211,123,1.41 [1.08-1.85],0.0115504065849172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN1,CCN family member 1,4157,121,1.36 [1.07-1.73],0.0108009476421141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN2,CCN family member 2,4179,120,1.41 [1.06-1.86],0.0177899704596749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN3,CCN family member 3,4218,123,6.32 [4.88-8.20],4.28640779072516e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN4,CCN family member 4,4215,123,5.54 [4.18-7.35],1.5718084779494358e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN5,CCN family member 5,4195,121,5.74 [4.18-7.88],3.3183507083744105e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCND2,G1/S-specific cyclin-D2,3566,88,1.48 [0.84-2.60],0.1724969371419211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCNE1,G1/S-specific cyclin-E1,3506,87,0.95 [0.72-1.26],0.7253036277178597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCS,Copper chaperone for superoxide dismutase,4145,120,0.48 [0.34-0.69],5.775720065391634e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,4058,119,0.75 [0.50-1.11],0.1445040412473612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD101,Immunoglobulin superfamily member 2,3602,89,1.10 [0.69-1.76],0.6827831826420883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD109,CD109 antigen,4195,121,3.42 [2.19-5.33],5.6639310800994544e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,4120,121,4.55 [3.44-6.01],1.4622939506845083e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD160,CD160 antigen,4228,121,4.58 [3.66-5.74],7.170127123233902e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,4197,122,1.93 [1.38-2.68],9.903976101262196e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164,Sialomucin core protein 24,4195,121,1.95 [1.62-2.35],2.032989246202365e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,3532,86,1.06 [0.62-1.82],0.8316652482049594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD177,CD177 antigen,4184,121,1.09 [0.96-1.24],0.1951029368547562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,4185,121,0.64 [0.36-1.11],0.1100824627586027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2,T-cell surface antigen CD2,3499,84,1.37 [0.95-1.98],0.0886683048456179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200,OX-2 membrane glycoprotein,4174,120,4.20 [3.08-5.73],1.1130969279139095e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,4161,120,1.63 [1.04-2.55],0.0334401078690088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD207,C-type lectin domain family 4 member K,4091,118,4.97 [3.51-7.03],1.3145106869224193e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD209,CD209 antigen,4194,122,2.21 [1.45-3.38],0.0002477181002756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD22,B-cell receptor CD22,4228,121,0.99 [0.69-1.42],0.9544133064055812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD226,CD226 antigen,3506,87,1.52 [0.95-2.44],0.0802217761341887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD244,Natural killer cell receptor 2B4,4228,121,3.19 [1.99-5.11],1.4394399708930608e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD248,Endosialin,3629,87,2.96 [1.87-4.67],3.4947473030961665e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD27,CD27 antigen,4185,121,6.44 [5.18-8.01],3.861347388151008e-63
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,4145,120,3.39 [2.63-4.39],8.626598289926527e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD276,CD276 antigen,4176,120,6.75 [4.87-9.35],1.5598963727347588e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,4058,119,3.07 [2.26-4.17],7.74142233039923e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2AP,CD2-associated protein,4181,121,0.96 [0.75-1.23],0.7377174316186359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300A,CMRF35-like molecule 8,3556,85,14.29 [8.74-23.39],3.3302855553291514e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300C,CMRF35-like molecule 6,4212,121,9.99 [7.00-14.25],5.7115727510180845e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300E,CMRF35-like molecule 2,4202,123,5.64 [4.35-7.30],3.5204243856242405e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LF,CMRF35-like molecule 1,4215,123,3.04 [2.34-3.97],1.520390480546075e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LG,CMRF35-like molecule 9,4195,121,7.31 [5.39-9.94],3.771341857139342e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD302,CD302 antigen,4161,121,8.82 [6.73-11.56],4.553623650516952e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD33,Myeloid cell surface antigen CD33,4185,121,1.14 [0.92-1.42],0.2212246017108108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,4202,121,3.80 [2.05-7.05],2.265882883622923e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD36,Platelet glycoprotein 4,3506,87,1.41 [0.92-2.15],0.1103933337995747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4161,121,7.07 [5.20-9.60],6.754520469591438e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,3493,84,1.18 [0.62-2.26],0.6077435181663846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,3566,88,0.47 [0.23-0.97],0.0403230895662256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,3506,87,1.02 [0.82-1.27],0.8621506698296573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,4169,120,3.88 [2.95-5.10],2.279341969397594e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,4182,120,2.03 [1.59-2.59],1.243721855045122e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40LG,CD40 ligand,4228,121,0.99 [0.81-1.21],0.9041634084840858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD46,Membrane cofactor protein,4166,122,10.60 [7.08-15.87],1.9103421610064647e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD48,CD48 antigen,4192,120,8.22 [5.38-12.56],1.850629629352902e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,4211,123,3.97 [3.17-4.98],5.1335762903473386e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD55,Complement decay-accelerating factor,4033,114,6.58 [4.89-8.86],2.3289435594985336e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD58,Lymphocyte function-associated antigen 3,4168,120,6.32 [2.52-15.84],8.285552909583779e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD59,CD59 glycoprotein,4023,119,11.93 [8.68-16.41],1.61794122737483e-52
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5L,CD5 antigen-like,3612,89,1.53 [1.02-2.30],0.0387680885739319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD6,T-cell differentiation antigen CD6,4220,121,0.98 [0.72-1.34],0.9195847465703904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD63,CD63 antigen,4138,120,0.92 [0.66-1.28],0.6124721974128238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD69,Early activation antigen CD69,4162,121,0.91 [0.75-1.09],0.2984823099924601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD7,T-cell antigen CD7,3496,87,3.58 [2.73-4.70],3.403431385933858e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD70,CD70 antigen,4174,120,2.55 [1.87-3.46],2.456151038679738e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD72,B-cell differentiation antigen CD72,3556,85,3.21 [2.29-4.49],1.1197349854203991e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,4212,121,9.69 [6.95-13.51],6.446414490206752e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,4228,121,4.96 [4.07-6.04],3.0787366567415773e-57
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,3615,89,3.08 [1.94-4.87],1.7215386780295126e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD82,CD82 antigen,3566,88,1.16 [0.79-1.68],0.4485005008747551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD83,CD83 antigen,4174,120,5.79 [4.19-8.00],1.973017040511262e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD84,SLAM family member 5,4174,120,1.12 [0.67-1.85],0.6651317230973985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD86,T-lymphocyte activation antigen CD86,3602,89,1.42 [0.75-2.70],0.2790807386532746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,4212,121,1.59 [1.21-2.10],0.000959822402832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD93,Complement component C1q receptor,4048,117,8.26 [5.93-11.50],8.409348114828247e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99,CD99 antigen,4195,121,36.15 [21.06-62.03],9.29310819013948e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,4195,121,12.54 [7.41-21.22],4.639028377115525e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDA,Cytidine deaminase,3611,89,1.38 [0.97-1.96],0.0708507767020508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDAN1,Codanin-1,3602,87,0.33 [0.12-0.92],0.0335265889041827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC123,Cell division cycle protein 123 homolog,3482,86,0.88 [0.62-1.24],0.4572033076171236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC25A,M-phase inducer phosphatase 1,3482,86,0.74 [0.41-1.35],0.329945795621733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,3596,88,1.15 [0.85-1.55],0.3545851879392527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC27,Cell division cycle protein 27 homolog,4058,119,1.08 [0.83-1.40],0.5844217039635002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,4185,121,0.98 [0.81-1.19],0.8278600120473114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,3602,89,1.04 [0.86-1.27],0.678319332662949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDCP1,CUB domain-containing protein 1,4145,120,1.30 [1.00-1.70],0.0479462380076467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH1,Cadherin-1,4035,117,2.97 [2.47-3.58],1.495780344408154e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH15,Cadherin-15,4204,121,1.40 [1.18-1.67],0.0001556039638464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH17,Cadherin-17,4181,121,1.84 [1.52-2.22],3.1482544446227006e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH2,Cadherin-2,4181,121,1.72 [1.19-2.47],0.0036074695143001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH22,Cadherin-22,3566,88,1.07 [0.52-2.21],0.8618213092363667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH23,Cadherin-23,3602,87,1.19 [0.53-2.66],0.6682551894955499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH3,Cadherin-3,4212,121,6.22 [4.70-8.24],2.1744355921273364e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH4,Cadherin-4,3493,84,0.92 [0.58-1.45],0.7127941256670953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH5,Cadherin-5,4232,123,3.17 [1.98-5.06],1.425698213643794e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH6,Cadherin-6,4181,121,2.77 [1.96-3.92],8.051944645794852e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR1,Cadherin-related family member 1,4054,117,1.23 [0.88-1.72],0.2194826369647363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR2,Cadherin-related family member 2,4161,121,0.74 [0.60-0.92],0.0074580964666384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR5,Cadherin-related family member 5,4181,121,0.56 [0.39-0.80],0.0017800818536443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK1,Cyclin-dependent kinase 1,3482,86,0.94 [0.54-1.65],0.8389109292419674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,3616,90,1.23 [0.89-1.68],0.2096748987391795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,3493,84,0.85 [0.53-1.35],0.4886518913845005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,4161,121,1.14 [0.98-1.32],0.0920831741033726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,4161,121,0.99 [0.83-1.17],0.8705727387780728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,4161,121,16.71 [10.52-26.53],7.689835340031726e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,4185,120,1.76 [0.98-3.16],0.0604999021578489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDSN,Corneodesmosin,4209,121,4.64 [3.50-6.16],1.8741117105641958e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,4176,121,1.42 [0.78-2.60],0.2488951485956837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,3602,89,0.79 [0.62-1.02],0.0661918198694506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,3566,88,0.95 [0.71-1.26],0.7082414316110331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,3602,89,3.06 [2.19-4.27],5.4559264800505426e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,3566,88,1.54 [1.07-2.22],0.0210121809174544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,4174,120,1.44 [1.21-1.70],2.622869373602939e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,4058,119,1.13 [0.82-1.55],0.4477179441336405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,4013,117,1.64 [1.32-2.05],1.1187878136154144e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,3629,87,2.06 [1.30-3.26],0.0019528562375521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,4107,122,2.40 [1.86-3.09],1.5085054286612054e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,3506,87,1.10 [0.64-1.90],0.7208610078747374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,4107,122,0.99 [0.65-1.49],0.9491606381246668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,3629,87,0.82 [0.62-1.08],0.1566379048208482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,4226,123,0.88 [0.70-1.11],0.290671154695206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,3556,85,7.39 [4.53-12.08],1.3863676098827612e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEMIP2,Cell surface hyaluronidase,3506,87,1.40 [0.86-2.27],0.1734595142609878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,3493,84,1.45 [1.19-1.77],0.000280169120782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPF,Centromere protein F,3566,88,0.53 [0.35-0.80],0.0025400995822685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPJ,Centromere protein J,3566,88,0.91 [0.67-1.23],0.5519693781744426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP112,Centrosomal protein of 112 kDa,3499,84,0.96 [0.60-1.55],0.8769620440125699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP152,Centrosomal protein of 152 kDa,3482,86,1.65 [1.21-2.25],0.0016532047149117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP164,Centrosomal protein of 164 kDa,4080,118,1.13 [0.92-1.39],0.2446591845594276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP170,Centrosomal protein of 170 kDa,3520,84,0.97 [0.73-1.29],0.8172790942988839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP20,Centrosomal protein 20,4058,119,1.04 [0.84-1.29],0.694850428262554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP290,Centrosomal protein of 290 kDa,3566,88,0.74 [0.47-1.17],0.1943390285675832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP350,Centrosome-associated protein 350,3482,86,1.40 [0.93-2.12],0.106621354497011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP43,Centrosomal protein 43,4080,120,0.90 [0.71-1.14],0.3792372954698849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP85,Centrosomal protein of 85 kDa,4058,119,1.08 [0.85-1.38],0.5309589670696385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CERT,Ceramide transfer protein,4054,117,1.05 [0.80-1.38],0.7404288829049573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES1,Liver carboxylesterase 1,4189,123,0.78 [0.67-0.92],0.0023229636329489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES2,Cocaine esterase,4161,121,1.39 [1.07-1.80],0.0130431203462525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES3,Carboxylesterase 3,4161,121,0.98 [0.78-1.23],0.8723483021465073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN2,Centrin-2,4054,117,1.07 [0.84-1.35],0.594834133830789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN3,Centrin-3,3602,89,1.04 [0.80-1.36],0.7580368259828913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFB,Complement factor B,3563,87,0.80 [0.43-1.49],0.4785906561671017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFC1,Cryptic protein,4058,119,1.71 [1.35-2.17],1.0745282572650494e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFD,Complement factor D,3631,89,10.42 [6.03-18.02],4.824508650329182e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFH,Complement factor H,3409,85,0.56 [0.23-1.40],0.216587936505937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR2,Complement factor H-related protein 2,3605,88,1.57 [1.05-2.35],0.0289040498916151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR4,Complement factor H-related protein 4,3624,89,0.94 [0.71-1.24],0.6561736056996939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR5,Complement factor H-related protein 5,3576,89,1.50 [0.93-2.42],0.0961871171334061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFI,Complement factor I,3631,89,0.60 [0.23-1.60],0.3087565414265212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFP,Properdin,3631,89,0.22 [0.10-0.47],8.86635945825796e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,4195,121,1.94 [1.65-2.28],5.3716747403632325e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,3632,90,1.36 [1.09-1.71],0.0069457327710284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGN,Cingulin,3532,86,1.22 [0.79-1.87],0.3724352978329305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,4181,121,4.95 [3.80-6.45],1.2283303320536432e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,4058,119,0.82 [0.61-1.10],0.1828549355844116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAD,Chondroadherin,3556,85,0.66 [0.46-0.96],0.0314082289519034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",3602,87,5.90 [4.52-7.71],5.7571726490406056e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,3607,90,2.37 [1.74-3.22],3.96254134311894e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,4107,122,0.77 [0.47-1.28],0.3147621932114202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGA,Chromogranin-A,3629,87,1.58 [1.38-1.81],3.811215818392748e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGB,Secretogranin-1,4195,121,5.12 [3.98-6.59],4.5949935089253584e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,4085,119,1.77 [1.51-2.07],1.459731555689925e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHIT1,Chitotriosidase-1,4198,121,1.01 [0.92-1.12],0.788766041743152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,4190,121,1.92 [1.23-3.01],0.00444802896853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,3532,86,0.80 [0.55-1.14],0.2140543680140369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,4145,120,0.97 [0.78-1.19],0.7402503269462279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP6,Charged multivesicular body protein 6,3615,89,0.80 [0.56-1.15],0.229050199774435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHP1,Calcineurin B homologous protein 1,3493,84,0.93 [0.68-1.28],0.6690924907896995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL1,Chordin-like protein 1,4192,120,11.13 [7.75-15.99],8.00902539284568e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL2,Chordin-like protein 2,4181,121,1.33 [0.98-1.80],0.0660368327702034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,3532,86,0.60 [0.31-1.17],0.1337121156744761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIAPIN1,Anamorsin,4185,121,1.08 [0.83-1.41],0.552864777332922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,3629,87,2.85 [2.05-3.95],3.717298866542724e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,3566,88,0.78 [0.46-1.31],0.3468132342644895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,3602,89,0.93 [0.75-1.15],0.4869772793704079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIT,Citron Rho-interacting kinase,3532,86,0.98 [0.63-1.52],0.9148349090037052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,4211,121,5.15 [4.18-6.33],5.560037649791046e-54
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKB,Creatine kinase B-type,3629,87,3.22 [2.50-4.14],1.1523493086458722e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",4165,120,1.26 [0.98-1.62],0.0763636840108677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLASP1,CLIP-associating protein 1,3482,86,0.81 [0.59-1.12],0.1997672272168722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLC,Galectin-10,4174,121,1.79 [1.47-2.18],6.701168048466633e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,4145,120,4.07 [2.65-6.26],1.6371088980011535e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,4187,121,1.17 [0.84-1.61],0.3536603768401347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,3506,87,3.96 [1.90-8.27],0.0002441769302034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,4195,121,11.76 [8.50-16.26],3.491556636009352e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,4107,122,7.04 [5.31-9.33],4.358338006583279e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,4212,121,1.06 [0.90-1.26],0.4711673824439365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,3532,86,0.86 [0.53-1.39],0.5401837669286275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC3B,Tetranectin,3543,87,0.34 [0.16-0.73],0.0053662538029437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,4174,120,1.22 [0.78-1.90],0.3839211731392796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,4174,120,1.13 [0.81-1.56],0.4756423357111811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,4174,120,2.37 [1.93-2.89],4.6032845032038167e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,4174,120,2.35 [1.46-3.77],0.000444052694899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,3625,87,1.17 [0.76-1.80],0.4780329226390127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,4172,121,6.74 [4.70-9.65],2.6134212629780302e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,4058,119,2.58 [2.02-3.30],5.1465988718712734e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,4228,121,4.49 [3.44-5.87],3.4711024501345555e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLGN,Calmegin,3532,86,2.52 [1.74-3.65],9.173725796592816e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIC5,Chloride intracellular channel protein 5,3532,86,1.79 [1.25-2.56],0.0013713496154075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLINT1,Clathrin interactor 1,3482,86,1.21 [0.82-1.79],0.3334551570054139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,4174,120,0.99 [0.86-1.14],0.8963598518779207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLMP,CXADR-like membrane protein,4215,123,31.18 [20.51-47.42],3.221924040875921e-58
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLNS1A,Methylosome subunit pICln,3532,86,0.61 [0.31-1.20],0.1517742966093188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",4137,120,1.09 [0.93-1.29],0.2912644828426039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPS,Colipase,4186,121,1.05 [0.86-1.28],0.6298665030300491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSPN,Claspin,4046,117,1.28 [0.90-1.82],0.1621919432580628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN1,Calsyntenin-1,4054,117,1.06 [0.78-1.43],0.7241338723346552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN2,Calsyntenin-2,4228,121,1.76 [1.29-2.39],0.000333175664117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN3,Calsyntenin-3,3602,87,1.75 [0.95-3.25],0.0738022960881865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLTA,Clathrin light chain A,4107,122,1.12 [0.79-1.57],0.5325798615804691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLU,Clusterin,3631,89,0.62 [0.22-1.77],0.3724112145438925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLUL1,Clusterin-like protein 1,4174,121,1.14 [0.82-1.59],0.4379067651742802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,3615,89,0.96 [0.77-1.21],0.7462647623367311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMIP,C-Maf-inducing protein,3607,90,0.93 [0.74-1.19],0.5743714426982873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,4197,122,0.79 [0.57-1.08],0.1331616117062612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,3493,84,1.03 [0.72-1.47],0.8733719684780904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",3512,84,0.81 [0.62-1.06],0.1292556361475387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY2,Protein canopy homolog 2,4107,122,1.09 [0.85-1.39],0.5036790888583698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY4,Protein canopy homolog 4,4161,121,1.15 [0.93-1.43],0.2001445591818585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNST,Consortin,4181,121,0.94 [0.81-1.09],0.4150245768297963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTF,Ciliary neurotrophic factor,3493,84,0.87 [0.47-1.60],0.6443404164454583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN1,Contactin-1,4232,123,4.70 [2.71-8.14],3.5760936733284566e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN2,Contactin-2,4215,123,2.29 [1.64-3.20],1.0037168645830365e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN3,Contactin-3,4195,121,0.92 [0.56-1.51],0.735696962832914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN4,Contactin-4,4195,121,2.24 [1.17-4.30],0.0147179667673339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN5,Contactin-5,4186,120,0.55 [0.36-0.83],0.005217847588402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,4174,120,1.79 [1.30-2.47],0.0003865134527189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,3532,86,1.02 [0.84-1.24],0.8693731455805664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COCH,Cochlin,3615,89,2.10 [1.50-2.95],1.675450266734978e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,3629,87,5.94 [3.72-9.50],9.107428374696892e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,4195,123,28.99 [17.81-47.19],8.681557576714201e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL1A1,Collagen alpha-1(I) chain,4232,123,2.81 [1.63-4.83],0.000198655224458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,3602,89,1.93 [1.33-2.79],0.0005159827334932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,3532,86,1.16 [0.92-1.48],0.2130845353199986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL2A1,Collagen alpha-1(II) chain,3520,84,1.10 [0.85-1.41],0.4615698420149194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL3A1,Collagen alpha-1(III) chain,3629,87,3.11 [1.54-6.30],0.0015821466421618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,4181,121,2.54 [1.98-3.26],2.7546063359528906e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,3557,88,0.86 [0.59-1.26],0.4417284466829901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL5A1,Collagen alpha-1(V) chain,3556,85,1.83 [1.38-2.42],2.276124513417801e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,4232,123,8.19 [6.32-10.62],7.793881812711504e-57
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,4174,120,1.56 [1.17-2.08],0.002347295996194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,3566,88,1.13 [0.73-1.74],0.5844250788708747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COLEC12,Collectin-12,4176,120,15.99 [11.26-22.70],3.471718147263653e-54
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD1,COMM domain-containing protein 1,3520,84,1.01 [0.71-1.43],0.9743501973874984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD9,COMM domain-containing protein 9,3607,90,1.01 [0.62-1.67],0.961823265155472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMP,Cartilage oligomeric matrix protein,4140,122,1.19 [0.76-1.87],0.4422000504375731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMT,Catechol O-methyltransferase,4069,120,0.88 [0.72-1.08],0.2171483303205023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPB2,Coatomer subunit beta',3499,84,0.96 [0.59-1.57],0.882327537380033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPE,Coatomer subunit epsilon,4054,117,1.08 [0.78-1.49],0.6327663545760144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",3520,84,1.13 [0.69-1.86],0.6316039688281714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO1A,Coronin-1A,4100,117,1.02 [0.85-1.23],0.8347023690344315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO6,Coronin-6,3493,84,1.82 [1.42-2.35],3.04048521247297e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",4161,121,1.40 [1.13-1.75],0.0022779040873523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,3615,89,1.17 [0.64-2.13],0.614504604942349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA1,Carboxypeptidase A1,4232,123,1.00 [0.81-1.24],0.965125093046338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA2,Carboxypeptidase A2,4201,121,1.54 [1.26-1.87],1.6472277031177536e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA4,Carboxypeptidase A4,3471,82,3.33 [2.09-5.32],4.769276872962496e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB1,Carboxypeptidase B,4232,123,1.17 [0.94-1.46],0.1635659656554504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB2,Carboxypeptidase B2,3622,89,0.65 [0.28-1.56],0.3367768163764717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPE,Carboxypeptidase E,4179,121,1.43 [0.91-2.22],0.1179927153928091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPLX2,Complexin-2,3482,86,1.65 [1.02-2.68],0.0420218786746449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPM,Carboxypeptidase M,4190,121,1.24 [0.81-1.89],0.3178920758753818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",3506,87,0.82 [0.38-1.75],0.6035735010577171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,4212,121,1.00 [0.78-1.27],0.98932910901953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPQ,Carboxypeptidase Q,3626,87,1.70 [0.99-2.92],0.0564474053496792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,3499,84,1.82 [1.21-2.75],0.0041847860948301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,4209,123,2.15 [1.42-3.25],0.0002721195927515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM1,Probable carboxypeptidase X1,4185,121,1.26 [1.01-1.57],0.0433659748033644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,3615,89,10.81 [6.13-19.08],2.1281915163018188e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR1,Complement receptor type 1,3622,90,2.03 [1.21-3.43],0.0075394343211494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR2,Complement receptor type 2,4197,122,1.89 [1.40-2.56],3.438971324677082e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,4058,119,1.11 [0.93-1.33],0.247113034496788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRADD,Death domain-containing protein CRADD,4137,120,0.91 [0.73-1.14],0.4098898330161811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,3482,86,0.87 [0.57-1.34],0.5283673549810851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,3482,86,1.05 [0.45-2.46],0.9116824056763428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREG1,Protein CREG1,4127,118,0.76 [0.51-1.12],0.1590720278513762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,3556,85,4.61 [2.92-7.29],6.049215857080638e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,4192,120,2.40 [1.90-3.02],9.724095430012309e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRH,Corticoliberin,4052,119,0.87 [0.72-1.06],0.1777563525714361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,4176,120,6.85 [3.92-11.98],1.5187035813554756e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,4107,122,0.85 [0.64-1.13],0.2682570496675575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,4198,120,17.81 [9.77-32.48],5.660543431906468e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIP2,Cysteine-rich protein 2,4145,120,3.23 [2.45-4.26],8.526961760012564e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,4215,123,0.87 [0.67-1.12],0.2770614888141611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,3597,89,0.60 [0.29-1.23],0.1656175649235865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRKL,Crk-like protein,4184,120,0.97 [0.83-1.14],0.725181684168556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRLF1,Cytokine receptor-like factor 1,4198,120,2.80 [1.51-5.21],0.0010945976666555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRNN,Cornulin,4056,121,1.47 [1.20-1.81],0.000193739749945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAC1,Cartilage acidic protein 1,4232,123,0.87 [0.53-1.44],0.5985835952465339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,4145,120,2.62 [1.95-3.50],1.1499445587206435e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAP,Cartilage-associated protein,3532,86,0.89 [0.55-1.43],0.6344076017200299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRX,Cone-rod homeobox protein,4107,122,1.16 [1.03-1.32],0.0160566185641216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB1,Beta-crystallin B1,3615,89,1.03 [0.75-1.40],0.8712889866108473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB2,Beta-crystallin B2,3602,87,1.12 [0.92-1.37],0.241784784648775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYGD,Gamma-crystallin D,3602,87,0.96 [0.78-1.18],0.7263163728815846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYM,Ketimine reductase mu-crystallin,3493,84,0.96 [0.72-1.30],0.8095462523573232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,3520,84,0.77 [0.61-0.98],0.0319691557693809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSDE1,Cold shock domain-containing protein E1,3499,84,1.02 [0.85-1.22],0.8417880062451439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,4198,120,13.38 [8.97-19.96],4.946524323094744e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,3632,90,2.29 [1.48-3.55],0.000204089938955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,3499,84,1.44 [0.90-2.31],0.1260743509730075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,4145,120,1.34 [1.05-1.72],0.0200245943682132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,3506,87,1.05 [0.65-1.70],0.8311863350681681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3,Granulocyte colony-stimulating factor,4080,118,1.10 [0.78-1.55],0.581138102612883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,3506,87,1.68 [1.05-2.68],0.0293455472233297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,3632,90,0.94 [0.47-1.88],0.8672714977094076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK1D,Casein kinase I isoform delta,3506,87,1.04 [0.75-1.46],0.7998158636309941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,3616,90,0.67 [0.42-1.07],0.0953058898513262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,3629,87,6.51 [3.80-11.13],8.216478106259632e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,3493,84,1.34 [0.94-1.92],0.1096660301830232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,3499,84,1.31 [1.11-1.55],0.0016594720951229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST1,Cystatin-SN,3174,73,1.56 [1.29-1.88],3.140737976375191e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST3,Cystatin-C,4181,121,10.27 [7.45-14.15],6.6171825920679835e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST5,Cystatin-D,4106,118,1.72 [1.31-2.26],0.0001096840142215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST6,Cystatin-M,4064,121,3.72 [2.82-4.89],8.105285565988523e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST7,Cystatin-F,4188,120,1.19 [1.04-1.37],0.0145237611906615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSTB,Cystatin-B,4131,120,3.07 [2.21-4.27],2.14418583511478e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,3558,88,0.98 [0.65-1.49],0.9352229866073328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTBS,Di-N-acetylchitobiase,3571,89,1.22 [0.60-2.49],0.585961123191945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTF1,Cardiotrophin-1,4107,122,1.00 [0.82-1.21],0.9940372782247632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,3629,87,5.82 [3.84-8.83],1.2202747713385587e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,3629,87,0.88 [0.45-1.73],0.7160837538498579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTNNA1,Catenin alpha-1,3493,84,1.03 [0.53-1.99],0.9370984892788504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRB1,Chymotrypsinogen B,4195,121,1.06 [0.84-1.34],0.6027900210569925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRC,Chymotrypsin-C,4180,120,0.69 [0.57-0.84],0.0002655596908027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,3602,87,0.72 [0.56-0.91],0.0056896293659632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSB,Cathepsin B,4182,123,2.45 [1.89-3.17],1.621271697124421e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSC,Dipeptidyl peptidase 1,4175,120,0.94 [0.65-1.34],0.7193379856480033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSD,Cathepsin D,3929,114,1.49 [1.06-2.07],0.0199325901439568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSE,Cathepsin E,3556,85,1.90 [1.34-2.69],0.0003218444200688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSF,Cathepsin F,4185,121,1.70 [1.16-2.47],0.0060014762707537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSH,Pro-cathepsin H,4101,122,1.70 [1.37-2.11],1.394338660164799e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSL,Cathepsin L1,4181,121,5.13 [3.14-8.36],6.147030037665919e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSO,Cathepsin O,4228,121,3.62 [2.38-5.52],2.102434859013531e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSS,Cathepsin S,3307,103,4.82 [2.38-9.74],1.2142096635227111e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSV,Cathepsin L2,4202,123,0.53 [0.37-0.78],0.0010997528401945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSZ,Cathepsin Z,4186,122,6.20 [4.16-9.23],2.61760350697311e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,3532,86,0.83 [0.49-1.41],0.4914639348843976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,3582,88,1.24 [0.95-1.61],0.111483249947485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CX3CL1,Fractalkine,4145,120,5.93 [4.40-7.99],1.85947573345565e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,4174,120,3.25 [2.52-4.18],5.231454964962095e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL1,Growth-regulated alpha protein,4182,120,1.13 [0.96-1.33],0.1336146683867411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL10,C-X-C motif chemokine 10,4198,120,1.28 [1.03-1.60],0.0279524955346286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL11,C-X-C motif chemokine 11,4212,121,1.19 [0.99-1.43],0.0676220328759246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL12,Stromal cell-derived factor 1,4080,118,0.90 [0.60-1.35],0.60430700133287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL13,C-X-C motif chemokine 13,4212,121,1.41 [1.19-1.68],0.0001014297024592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL14,C-X-C motif chemokine 14,4080,118,1.39 [1.15-1.68],0.0005666903217273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,4228,123,14.05 [8.74-22.59],1.0279336400103807e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL17,C-X-C motif chemokine 17,4228,121,1.49 [1.04-2.14],0.0311254648077748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL3,C-X-C motif chemokine 3,4182,120,0.94 [0.80-1.12],0.4911559450092523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL5,C-X-C motif chemokine 5,4170,120,0.99 [0.87-1.14],0.9402087053571212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL6,C-X-C motif chemokine 6,4228,121,1.30 [1.06-1.60],0.0118752883448658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL8,Interleukin-8,4144,122,1.33 [1.11-1.58],0.0014875765639354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,4198,120,1.98 [1.66-2.35],1.0127143500297315e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5A,Cytochrome b5,3482,86,1.08 [0.82-1.42],0.588508785459346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,3560,88,1.60 [1.18-2.17],0.0024396871002293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",3499,84,0.79 [0.58-1.07],0.1302446892999931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTH3,Cytohesin-3,3482,86,1.15 [0.88-1.50],0.2950086023698442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTL1,Cytokine-like protein 1,3629,87,6.79 [3.94-11.69],5.290391739107116e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,3556,85,0.92 [0.71-1.18],0.5066531246894745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAB2,Disabled homolog 2,4215,123,1.02 [0.88-1.17],0.8381241659488492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAG1,Dystroglycan,4198,120,1.47 [1.04-2.09],0.0303370493736655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAND5,DAN domain family member 5,3506,87,0.72 [0.53-0.98],0.0376637989366721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPK2,Death-associated protein kinase 2,3506,87,1.02 [0.72-1.45],0.9152252924841004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,4174,120,0.93 [0.82-1.05],0.2476022883832354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",4137,120,0.82 [0.66-1.03],0.0851711110941726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBH,Dopamine beta-hydroxylase,3628,90,0.96 [0.81-1.14],0.6538028805636122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBI,Acyl-CoA-binding protein,4170,120,1.36 [1.10-1.68],0.0043515631357797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBN1,Drebrin,3506,87,1.35 [0.92-1.97],0.1216233167945971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBNL,Drebrin-like protein,4198,120,0.95 [0.80-1.13],0.5753832224388429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",4185,121,6.38 [4.26-9.55],2.218537598523036e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCC,Netrin receptor DCC,3532,86,0.31 [0.13-0.76],0.0101465293991763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,3482,86,0.89 [0.63-1.28],0.536933114948952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCLRE1C,Protein artemis,3482,86,1.18 [0.58-2.39],0.6432333923837621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCN,Decorin,4107,122,11.87 [7.16-19.68],8.86689567747361e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTD,Deoxycytidylate deaminase,3556,85,0.90 [0.72-1.12],0.357545716260772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN1,Dynactin subunit 1,4215,123,0.99 [0.77-1.27],0.9174628399394184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN2,Dynactin subunit 2,4161,121,0.93 [0.78-1.11],0.4197476935062912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN6,Dynactin subunit 6,4054,117,0.93 [0.74-1.18],0.5746928126756206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,4181,121,2.55 [1.60-4.07],8.909084817878163e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D1,DCN1-like protein 1,3493,84,1.00 [0.75-1.33],0.9924904657172208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D2,DCN1-like protein 2,3482,86,0.96 [0.74-1.26],0.782468541252178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCXR,L-xylulose reductase,4185,121,0.60 [0.45-0.79],0.0003429843934012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,3499,84,0.83 [0.45-1.51],0.5405939083025444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",4161,121,2.34 [1.72-3.18],5.4327301534076767e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,4181,121,1.11 [0.82-1.50],0.4991872478701245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDHD2,Phospholipase DDHD2,3616,90,0.86 [0.63-1.18],0.3452171188578286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDI2,Protein DDI1 homolog 2,3556,85,0.65 [0.49-0.85],0.0019260421130535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,4212,121,6.48 [3.81-10.99],4.570673705975348e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDT,D-dopachrome decarboxylase,3629,87,0.75 [0.46-1.22],0.2452839092211864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,3602,89,1.30 [0.92-1.83],0.1343908725298352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,3532,86,0.91 [0.50-1.67],0.7689973563917032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,3506,87,0.86 [0.34-2.18],0.7515888889849215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,3506,87,0.71 [0.44-1.15],0.1653094757328981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,3532,86,0.37 [0.20-0.67],0.0011761887116713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,4058,119,1.00 [0.77-1.31],0.99152932389203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",4174,120,0.99 [0.83-1.18],0.9203136355873562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,4088,118,2.29 [1.91-2.75],5.035247650861299e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,3486,87,1.12 [0.75-1.68],0.5824935616455442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,3493,84,0.92 [0.60-1.40],0.6896226310488067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB116,Beta-defensin 116,3493,84,0.93 [0.69-1.26],0.651948907246152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB118,Beta-defensin 118,3493,84,0.91 [0.61-1.34],0.6284200993525499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,4130,120,1.10 [0.99-1.22],0.0789764378656732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENND2B,DENN domain-containing protein 2B,3499,84,0.85 [0.52-1.41],0.535203508090437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENR,Density-regulated protein,3506,87,0.80 [0.54-1.19],0.2795876348907271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,4228,121,0.90 [0.70-1.15],0.3903255898049288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGCR6,Protein DGCR6,3493,84,1.11 [0.68-1.82],0.6715489059133375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKA,Diacylglycerol kinase alpha,3506,87,1.05 [0.72-1.52],0.8119868820613364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKZ,Diacylglycerol kinase zeta,4080,118,0.60 [0.37-0.97],0.0363923175531303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHODH,Dihydroorotate dehydrogenase,3499,84,1.00 [0.63-1.59],0.9910203273286742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHPS,Deoxyhypusine synthase,3607,90,1.43 [0.94-2.18],0.0946097764016422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,3602,87,1.24 [0.84-1.83],0.2848142937863782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",4172,121,0.90 [0.78-1.04],0.1580804996138568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,3532,86,0.98 [0.60-1.63],0.9522316366422416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,3556,85,2.43 [1.42-4.14],0.0011054460560367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK1,Dickkopf-related protein 1,4212,121,1.19 [0.91-1.56],0.1982010780118173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK3,Dickkopf-related protein 3,4232,123,8.13 [5.10-12.98],1.5378200984948261e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK4,Dickkopf-related protein 4,4140,120,3.39 [2.70-4.26],5.188685131158293e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKKL1,Dickkopf-like protein 1,4161,121,1.15 [0.94-1.41],0.1843467283497436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLG4,Disks large homolog 4,3602,87,0.94 [0.70-1.26],0.6945225002858422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLGAP5,Disks large-associated protein 5,3616,90,1.27 [0.93-1.73],0.1288306877589343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLK1,Protein delta homolog 1,4232,123,2.47 [1.91-3.18],3.418753728707079e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL1,Delta-like protein 1,4185,121,14.53 [10.54-20.02],3.4714433929140473e-60
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL4,Delta-like protein 4,3520,84,0.75 [0.49-1.15],0.1901686280946146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMD,Dystrophin,3520,84,1.92 [1.51-2.46],1.7201198672349229e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,3520,84,0.51 [0.39-0.66],2.541722836233457e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,3482,86,0.89 [0.52-1.53],0.6834165590251454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,4219,121,1.01 [0.83-1.24],0.8998350827002786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,3602,87,0.77 [0.58-1.02],0.065491476446765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,4161,121,1.00 [0.83-1.20],0.9617356532535964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,3602,89,1.07 [0.79-1.45],0.6655409045684987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,3556,85,0.66 [0.45-0.99],0.0429373379282659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,3523,84,0.97 [0.75-1.25],0.8026826689228661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,4107,122,1.26 [0.98-1.63],0.0745237175571767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,3602,87,0.76 [0.43-1.32],0.327148518635424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,3520,84,0.89 [0.69-1.14],0.3441315764950741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,3602,89,0.86 [0.65-1.12],0.2639789774819819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,4171,120,0.71 [0.39-1.27],0.2476957641290877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNLZ,DNL-type zinc finger protein,3493,84,0.98 [0.75-1.28],0.8903112912393736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM1,Dynamin-1,3602,89,0.90 [0.75-1.07],0.2160671144917928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM3,Dynamin-3,3616,90,1.94 [1.45-2.60],9.440879289985804e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNMBP,Dynamin-binding protein,4145,120,1.46 [1.16-1.84],0.0014301311111665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPEP,Aspartyl aminopeptidase,3602,87,1.11 [0.78-1.57],0.5630611920714866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,4190,120,0.69 [0.51-0.95],0.0208536799624944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,3532,86,0.79 [0.43-1.48],0.4692666166942454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,3493,84,0.94 [0.77-1.15],0.5330348157856635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK1,Docking protein 1,3602,87,0.92 [0.80-1.07],0.2864506938959441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK2,Docking protein 2,4181,121,0.96 [0.84-1.10],0.5803771035220238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP1,Dipeptidase 1,4137,120,0.64 [0.47-0.87],0.0043958918302992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP2,Dipeptidase 2,4161,121,1.82 [1.09-3.03],0.0226016713338673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,4174,120,0.93 [0.63-1.39],0.7411399647212235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP4,Dipeptidyl peptidase 4,4126,120,0.61 [0.37-0.99],0.0465082912989994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,4161,121,2.28 [1.53-3.38],4.919714568171824e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP7,Dipeptidyl peptidase 2,4153,120,1.09 [0.84-1.41],0.5408628076602691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPT,Dermatopontin,4232,123,35.41 [18.47-67.91],6.68232665006028e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPY30,Protein dpy-30 homolog,4202,123,1.97 [1.63-2.38],3.037075652809654e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRAXIN,Draxin,4145,120,4.53 [3.33-6.16],7.5958859401080125e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,4161,121,1.04 [0.78-1.39],0.775109861934745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSC2,Desmocollin-2,4152,119,3.74 [3.16-4.44],1.3257269247250882e-52
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,3616,90,1.93 [1.18-3.14],0.0084343440681712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG2,Desmoglein-2,4195,121,5.92 [3.95-8.88],8.500515585400593e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG3,Desmoglein-3,4202,123,4.98 [3.36-7.37],9.858167123603617e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG4,Desmoglein-4,4145,121,1.61 [1.20-2.15],0.0014514432630804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,3556,85,0.87 [0.68-1.11],0.2541930800874589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTNB,Dystrobrevin beta,3601,89,3.07 [2.30-4.11],4.2202389683295064e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,3532,86,1.03 [0.73-1.46],0.8695331330159798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,4161,121,8.59 [5.61-13.17],5.1624909484774633e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTYMK,Thymidylate kinase,3615,89,0.86 [0.63-1.15],0.305310091010115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUOX2,Dual oxidase 2,4107,122,0.97 [0.77-1.23],0.8004403154686146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,3607,90,1.32 [0.90-1.93],0.1484732289789838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP29,Dual specificity phosphatase 29,3532,86,1.19 [0.90-1.59],0.2256696669554902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,4054,117,1.06 [0.88-1.28],0.5448455065488746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",3602,89,0.97 [0.80-1.18],0.7730146537674738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DXO,Decapping and exoribonuclease protein,3602,87,0.81 [0.51-1.29],0.3775736223537769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,3607,90,1.40 [0.95-2.07],0.0883894117701033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,3532,86,1.01 [0.78-1.31],0.9157336043611864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,3607,90,0.79 [0.49-1.25],0.3073817219896186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,4145,120,0.96 [0.81-1.14],0.6735319877881163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBI3_IL27,Interleukin-27,4207,123,6.64 [4.35-10.14],1.7944063660291015e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECE1,Endothelin-converting enzyme 1,4054,117,1.03 [0.65-1.62],0.9094948903777648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",3615,89,0.99 [0.78-1.26],0.943565907056062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",3520,84,0.98 [0.79-1.21],0.8469328998740875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,3499,84,1.14 [0.84-1.55],0.3846395501505262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECM1,Extracellular matrix protein 1,3531,88,0.88 [0.51-1.51],0.6369684254087637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,3493,84,1.12 [0.74-1.70],0.5825803323308978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,4215,123,6.19 [5.01-7.64],2.040532234947837e-64
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,4174,120,1.11 [0.93-1.33],0.2596450249766861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,3607,90,1.43 [1.03-1.99],0.0331433858389402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,3499,84,1.25 [0.72-2.18],0.4224179395267161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDF1,Endothelial differentiation-related factor 1,3616,90,1.08 [0.80-1.45],0.6363470054496769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,4107,122,2.43 [1.76-3.36],8.495949861758987e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDN1,Endothelin-1,3520,84,8.50 [5.03-14.35],1.241865973936984e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDNRB,Endothelin receptor type B,3506,87,1.50 [1.00-2.24],0.047666967567426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EEF1D,Elongation factor 1-delta,3615,89,1.07 [0.86-1.34],0.5200019205601072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,3602,89,7.95 [5.60-11.27],2.8460398407257584e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,3566,88,1.08 [0.61-1.92],0.7949136231279094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,4193,122,9.40 [6.56-13.46],2.876791149011285e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,3616,90,3.52 [2.70-4.60],1.997031568061742e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA1,Ephrin-A1,4191,121,11.67 [8.73-15.61],1.563820090946891e-61
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA4,Ephrin-A4,4138,120,10.69 [8.21-13.92],2.467908976043724e-69
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNB2,Ephrin-B2,3532,86,1.64 [1.38-1.96],2.354859482976312e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGF,Pro-epidermal growth factor,4171,120,0.98 [0.84-1.14],0.8005818958723699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,4058,119,2.46 [1.77-3.42],7.427514798816007e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFLAM,Pikachurin,3602,89,3.44 [2.36-5.03],1.5063957900384283e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFR,Epidermal growth factor receptor,4232,123,0.55 [0.23-1.36],0.1975762686242089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGLN1,Egl nine homolog 1,4174,120,1.17 [0.92-1.49],0.1892909131560298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHBP1,EH domain-binding protein 1,3615,89,0.99 [0.75-1.30],0.9289261106957296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHD3,EH domain-containing protein 3,3520,84,0.87 [0.73-1.04],0.1193389178596679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",3602,87,0.68 [0.43-1.08],0.1058789821456347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",3586,88,0.97 [0.81-1.17],0.7726142699536759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,3499,84,0.95 [0.69-1.31],0.751731960033126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,3520,84,0.52 [0.28-0.94],0.0320833587051417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,4145,120,0.73 [0.55-0.96],0.027016233889806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,3506,87,0.86 [0.68-1.09],0.2272060220018879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,4181,121,0.91 [0.71-1.17],0.452500650482621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,4228,121,1.05 [0.88-1.24],0.5845288694646316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,3616,90,1.14 [0.85-1.53],0.3689534206472021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,3499,84,1.21 [0.81-1.80],0.3587739189810743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,4080,118,0.48 [0.27-0.88],0.0177713774038299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,3616,90,0.90 [0.70-1.14],0.3811925773253404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAVL4,ELAV-like protein 4,3493,84,1.15 [0.93-1.43],0.2019600594280153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELN,Elastin,3615,89,6.58 [4.17-10.37],5.014619832204218e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOA,Elongin-A,4161,121,0.96 [0.72-1.29],0.8048530955550076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOB,Elongin-B,3499,84,1.75 [1.31-2.33],0.0001653481544144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENAH,Protein enabled homolog,4080,118,2.01 [1.60-2.53],1.6746184908344187e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,3334,81,2.71 [2.16-3.41],1.5744049039563653e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENG,Endoglin,4232,123,3.69 [1.60-8.49],0.0021785527000972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO1,Alpha-enolase,4183,120,0.95 [0.77-1.18],0.6429860731659819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO2,Gamma-enolase,4212,121,1.03 [0.81-1.33],0.7874658572794042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO3,Beta-enolase,3520,84,0.63 [0.44-0.90],0.0102623794736543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOPH1,Enolase-phosphatase E1,3607,90,0.75 [0.49-1.13],0.1683901140994552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,3499,84,1.06 [0.53-2.12],0.8716007832175854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPEP,Glutamyl aminopeptidase,3499,84,0.97 [0.61-1.54],0.8949782803945605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,4232,123,1.24 [0.72-2.11],0.4362776235820238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,4198,120,0.82 [0.59-1.13],0.2263828254797621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,3520,84,1.91 [1.08-3.37],0.025489035334363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,4038,116,1.07 [0.89-1.28],0.4901356396458287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENSA,Alpha-endosulfine,3607,90,1.04 [0.72-1.51],0.8299196532280454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,4058,119,0.99 [0.70-1.40],0.9624451696303076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,4107,122,1.14 [0.54-2.39],0.7296801832048949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,4107,122,2.42 [1.22-4.81],0.0118399247744575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,3520,84,0.86 [0.62-1.19],0.3548583677820911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EP300,Histone acetyltransferase p300,3506,87,1.53 [0.89-2.61],0.122350421727165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPB41L5,Band 4.1-like protein 5,3532,86,1.19 [0.90-1.57],0.22755900108697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPCAM,Epithelial cell adhesion molecule,4177,120,1.12 [0.95-1.34],0.1856722607880292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPGN,Epigen,3607,90,0.79 [0.44-1.42],0.4301422583021521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,4190,120,8.33 [5.33-13.01],1.2345209584014062e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA10,Ephrin type-A receptor 10,4054,117,1.07 [0.85-1.36],0.5558043519810046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,4027,119,7.89 [6.25-9.96],1.991992425184941e-67
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,3556,85,11.00 [5.89-20.54],5.120017695181044e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,4232,123,13.31 [9.95-17.79],2.5286662524557488e-68
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,4137,120,9.07 [6.51-12.63],6.578777304896355e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,4107,122,0.85 [0.64-1.14],0.275807510809434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPN1,Epsin-1,3566,88,0.73 [0.41-1.31],0.2967755064536169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPO,Erythropoietin,4174,120,1.27 [1.06-1.52],0.0105146280664498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPPK1,Epiplakin,3520,84,1.22 [0.93-1.59],0.1472241100336827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,4210,123,4.90 [3.53-6.81],3.0328966131342895e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,4185,121,0.58 [0.36-0.93],0.0239660142025578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,4167,120,1.36 [0.61-3.02],0.4536298447480333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,4185,121,2.09 [1.23-3.55],0.0066776444510481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBIN,Erbin,4161,121,1.02 [0.87-1.20],0.8035280455928482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERC2,ERC protein 2,3532,86,1.17 [0.91-1.52],0.2230848443609479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,3482,86,0.80 [0.39-1.64],0.5362334826626234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EREG,Proepiregulin,4137,120,0.97 [0.80-1.19],0.7864823103479363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERI1,3'-5' exoribonuclease 1,3566,88,0.81 [0.44-1.52],0.5210477824443291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERMAP,Erythroid membrane-associated protein,3506,87,2.20 [1.42-3.41],0.0003996319054004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,3607,90,0.52 [0.30-0.92],0.0234255570088287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,3556,85,0.90 [0.75-1.07],0.2221647153052559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,4157,121,0.91 [0.49-1.69],0.7690232446790185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,3499,84,0.89 [0.53-1.50],0.6694859023188521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,4232,123,8.62 [6.16-12.07],4.009378999137929e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESM1,Endothelial cell-specific molecule 1,4176,120,1.70 [1.10-2.62],0.0160652775957718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESPL1,Separin,3482,86,1.19 [0.90-1.57],0.2289025949201197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESR1,Estrogen receptor,3506,87,0.95 [0.62-1.46],0.8294993848673687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESYT2,Extended synaptotagmin-2,3602,87,1.10 [0.86-1.41],0.4262568928413509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI2B,Protein EVI2B,3482,86,1.34 [0.89-2.03],0.1658881387949311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,3506,87,0.92 [0.73-1.16],0.4677638460262772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVPL,Envoplakin,3566,88,1.68 [1.00-2.85],0.0516536026798282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXOSC10,Exosome component 10,3499,84,0.76 [0.48-1.20],0.2341173177166514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXTL1,Exostosin-like 1,3499,84,1.23 [0.85-1.77],0.2698319230711509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EZR,Ezrin,4212,121,1.48 [0.78-2.80],0.2251929219656987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F10,Coagulation factor X,3632,90,0.78 [0.40-1.52],0.4711437455919504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11,Coagulation factor XI,3584,88,1.16 [0.57-2.36],0.6844973336655091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11R,Junctional adhesion molecule A,4195,121,1.56 [1.19-2.06],0.0015246278678638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F12,Coagulation factor XII,3631,89,0.51 [0.33-0.80],0.0031043639961031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F13B,Coagulation factor XIII B chain,3612,89,1.30 [0.61-2.76],0.4983052285107979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2,Prothrombin,3631,89,0.32 [0.09-1.13],0.0777626472843854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2R,Proteinase-activated receptor 1,4192,120,1.95 [1.47-2.57],2.929670882638402e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F3,Tissue factor,4188,123,9.23 [5.98-14.26],1.2406104555634652e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F7,Coagulation factor VII,4191,122,1.78 [1.10-2.89],0.0199423416354322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F9,Coagulation factor IX,4196,122,1.06 [0.44-2.58],0.8933570622183878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",4176,120,1.98 [1.72-2.28],6.254193925895428e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",4181,121,1.84 [1.58-2.15],9.180971868644614e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",3615,89,3.21 [2.59-3.97],7.546410871458147e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",4232,123,3.02 [2.48-3.67],1.037046709800883e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP5,Fatty acid-binding protein 5,4203,121,1.51 [1.20-1.89],0.0004658954334417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP6,Gastrotropin,4101,121,2.00 [1.65-2.42],1.722732093885587e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP9,Fatty acid-binding protein 9,4174,120,1.83 [1.40-2.39],9.733947055729529e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FADD,FAS-associated death domain protein,4181,121,0.85 [0.68-1.05],0.1373321351184327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM13A,Protein FAM13A,3602,89,0.97 [0.71-1.32],0.8511399079676394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171A2,Protein FAM171A2,3616,90,1.04 [0.92-1.17],0.5568504359251009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171B,Protein FAM171B,3607,90,2.43 [1.46-4.05],0.0006248762759944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,3520,84,0.82 [0.58-1.17],0.2824721218982488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM20A,Pseudokinase FAM20A,3615,89,1.45 [0.71-2.95],0.3038611287404111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3B,Protein FAM3B,4161,121,5.31 [3.72-7.57],2.913808154142602e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3C,Protein FAM3C,4181,121,15.04 [10.75-21.05],2.0322348510895208e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3D,Protein FAM3D,3602,89,1.99 [1.58-2.51],6.175441319074618e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAP,Prolyl endopeptidase FAP,4232,123,1.39 [0.83-2.34],0.2093083015038199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,3532,86,0.88 [0.64-1.22],0.4561167406728966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,4222,123,2.37 [1.93-2.91],1.4273347433757436e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,4228,121,1.70 [1.11-2.59],0.0145202058361483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBLN2,Fibulin-2,3629,87,6.85 [4.50-10.41],2.3230268310456983e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBN2,Fibrillin-2,3532,86,1.27 [0.88-1.83],0.1972501467536471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",4181,121,0.92 [0.75-1.13],0.4396657600322046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3615,89,1.41 [1.08-1.83],0.0116616780685071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,4174,120,1.23 [0.90-1.69],0.1915630745581722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,3616,90,2.46 [1.43-4.23],0.0010915044018367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,4195,121,2.13 [1.79-2.52],4.819842483414265e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,4178,122,1.46 [1.07-2.00],0.0186499414689712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,4058,119,1.07 [0.82-1.41],0.6163749325863728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,4187,121,1.68 [1.20-2.35],0.0025427983081798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN1,Ficolin-1,3628,90,1.06 [0.73-1.54],0.74195306286583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN2,Ficolin-2,4168,122,0.66 [0.46-0.95],0.0270220537758637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL1,Fc receptor-like protein 1,4181,121,1.71 [1.24-2.36],0.0011778793037603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL2,Fc receptor-like protein 2,4209,120,1.91 [1.51-2.41],7.959198012429018e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL3,Fc receptor-like protein 3,4080,118,1.24 [0.94-1.64],0.1198354448192221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL5,Fc receptor-like protein 5,4195,121,1.09 [0.84-1.42],0.5227152002138269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL6,Fc receptor-like protein 6,4174,120,1.80 [1.43-2.28],9.196513100157182e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRLB,Fc receptor-like B,4058,119,1.39 [1.11-1.74],0.0040694029301727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",3499,84,1.63 [1.33-1.99],2.485053560338149e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",3499,84,1.06 [0.71-1.56],0.7850011000610484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FEN1,Flap endonuclease 1,4058,119,1.00 [0.80-1.26],0.971833524384273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,4058,119,0.97 [0.70-1.35],0.8606942801002486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FETUB,Fetuin-B,4196,122,1.14 [0.70-1.85],0.5916810115948665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGA,Fibrinogen alpha chain,3538,87,2.28 [1.23-4.20],0.0084580897291825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",3616,90,0.99 [0.77-1.28],0.9623433725638516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF12,Fibroblast growth factor 12,3506,87,1.12 [0.77-1.62],0.5682721562019974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF16,Fibroblast growth factor 16,3506,87,0.76 [0.47-1.23],0.2609259149760641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF19,Fibroblast growth factor 19,4198,120,1.31 [1.08-1.59],0.007013713239572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF2,Fibroblast growth factor 2,4174,120,1.13 [0.90-1.42],0.2919222459214767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF20,Fibroblast growth factor 20,3506,87,1.06 [0.65-1.71],0.8252118668778554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF21,Fibroblast growth factor 21,4207,123,1.30 [1.15-1.47],1.7521992223480696e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF23,Fibroblast growth factor 23,4204,123,1.98 [1.71-2.29],4.0459181153878916e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF3,Fibroblast growth factor 3,3506,87,2.62 [1.55-4.43],0.000333872964694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF5,Fibroblast growth factor 5,4080,118,3.89 [2.93-5.15],3.822165245794308e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF6,Fibroblast growth factor 6,3506,87,1.31 [0.92-1.86],0.1403128927785323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF7,Fibroblast growth factor 7,3482,86,1.09 [0.86-1.39],0.4660330504733118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF9,Fibroblast growth factor 9,3476,86,1.34 [0.80-2.24],0.2592641902718473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,4185,121,0.51 [0.35-0.75],0.0005767144175936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,3629,87,0.53 [0.35-0.79],0.0019119868936818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,3602,87,0.82 [0.48-1.41],0.4745774404164855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,4185,121,5.87 [3.83-9.00],4.544296808147642e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,3556,85,1.85 [1.26-2.72],0.0015684689860203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGL1,Fibrinogen-like protein 1,3632,90,2.48 [1.89-3.25],5.0448552331712365e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGR,Tyrosine-protein kinase Fgr,4054,117,0.96 [0.74-1.24],0.7508347702639749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FH,"Fumarate hydratase, mitochondrial",3493,84,0.91 [0.69-1.20],0.4930681873294779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,3499,84,0.67 [0.42-1.09],0.10704987470571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,4054,117,0.75 [0.60-0.95],0.014963743794432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FIS1,Mitochondrial fission 1 protein,4180,120,1.14 [0.93-1.40],0.2023112154856908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,3616,90,0.94 [0.76-1.16],0.5559927522372836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,4192,119,0.98 [0.85-1.13],0.7340498972101506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,4145,120,1.32 [0.89-1.97],0.1663258979142673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,4145,120,1.06 [0.89-1.27],0.5194159760510371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,4046,117,1.25 [0.96-1.64],0.0996853464740357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBPL,FK506-binding protein-like,3602,89,0.80 [0.56-1.15],0.2214514759057969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,4058,119,1.02 [0.88-1.19],0.7537270690494723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,4145,120,6.14 [4.35-8.68],7.745734094584338e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,4156,121,2.70 [2.00-3.63],5.943854912080951e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,4058,119,1.32 [0.77-2.26],0.3197014258206028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,4228,121,1.91 [1.21-3.02],0.0052835881846977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,4185,121,1.31 [0.82-2.12],0.2598353005127156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMNL1,Formin-like protein 1,4054,117,0.99 [0.79-1.25],0.9455514067388628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMR1,Synaptic functional regulator FMR1,4058,119,1.05 [0.67-1.64],0.8451044496558839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FN1,Fibronectin,3631,89,0.30 [0.14-0.64],0.0016473332025225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,3602,87,2.58 [1.75-3.81],1.6488911588006752e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,3607,90,1.23 [0.67-2.26],0.5023717868714885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,3506,87,1.07 [0.87-1.30],0.5293192661618439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR1,Folate receptor alpha,4167,121,12.02 [8.42-17.17],1.3840264964646957e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR2,Folate receptor beta,4212,121,6.54 [4.16-10.29],4.392192867950844e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR3,Folate receptor gamma,4171,121,1.03 [0.96-1.11],0.409306943958853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOS,Proto-oncogene c-Fos,3476,86,1.88 [1.04-3.40],0.0360802961592431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOSB,Protein fosB,4054,117,1.05 [0.68-1.62],0.8366122005513301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXJ3,Forkhead box protein J3,3506,87,0.91 [0.58-1.44],0.6931103072501295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO1,Forkhead box protein O1,4174,120,0.94 [0.78-1.14],0.5517648325687821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO3,Forkhead box protein O3,4058,119,0.91 [0.75-1.10],0.3146831835083752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD4B,FERM domain-containing protein 4B,3499,84,1.10 [0.82-1.48],0.5076445824817112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD7,FERM domain-containing protein 7,3532,86,0.68 [0.37-1.23],0.1997711477253851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRZB,Secreted frizzled-related protein 3,4132,120,0.60 [0.34-1.07],0.0853244890425056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSHB,Follitropin subunit beta,3520,84,1.55 [1.07-2.24],0.0204877431574444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FST,Follistatin,4192,120,1.36 [0.97-1.91],0.0710631324860202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL1,Follistatin-related protein 1,3520,84,16.61 [8.27-33.35],2.7521340554337122e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL3,Follistatin-related protein 3,4174,119,8.88 [6.69-11.79],1.3173128105018838e-51
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,3596,86,0.91 [0.74-1.11],0.3523899369401783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,4213,123,0.98 [0.81-1.19],0.8492139551946678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUOM,Fucose mutarotase,3556,85,0.91 [0.68-1.22],0.541537024519283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FURIN,Furin,4185,121,0.73 [0.47-1.15],0.1718808703521462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUS,RNA-binding protein FUS,4047,119,1.96 [1.38-2.78],0.0001826352602191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",3558,88,1.02 [0.74-1.40],0.9110736884581204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,4212,121,2.10 [1.52-2.89],5.765475930651147e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",4145,120,1.19 [0.91-1.57],0.2091831091286423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXN,"Frataxin, mitochondrial",4215,123,1.03 [0.82-1.28],0.8227460597439091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,4080,118,1.06 [0.83-1.35],0.6623672480495377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FYB1,FYN-binding protein 1,4186,121,0.96 [0.81-1.14],0.6476483238250293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD10,Frizzled-10,3532,86,1.01 [0.70-1.44],0.9701601351754384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD8,Frizzled-8,3493,84,1.68 [1.23-2.31],0.0012521682729142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,3607,90,1.47 [1.08-2.01],0.0149941386347025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,3566,88,0.75 [0.51-1.11],0.1558804050510196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,3493,84,1.07 [0.77-1.47],0.6961226140858069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD1,Glutamate decarboxylase 1,3482,86,0.77 [0.35-1.74],0.535023961579008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD2,Glutamate decarboxylase 2,3506,87,1.03 [0.67-1.60],0.8802550244439388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,3566,88,0.83 [0.50-1.39],0.4772061678264878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,3520,84,0.82 [0.54-1.23],0.3331187846363217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAGE2A,G antigen 2A,3482,86,0.76 [0.52-1.13],0.1798161812234762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAL,Galanin peptides,4198,120,1.02 [0.80-1.30],0.8694247337174015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,4161,121,1.47 [0.85-2.53],0.164592263377833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,4215,123,1.17 [0.68-2.04],0.5688040074708391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,4080,118,1.66 [1.17-2.35],0.0041339420500251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,3615,89,1.24 [0.63-2.46],0.5286654299071143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,4161,121,1.51 [0.71-3.21],0.2896998280726336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,3499,84,1.08 [0.63-1.86],0.7703719847280324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,3468,82,0.78 [0.37-1.62],0.5026517871005001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,3616,90,0.58 [0.24-1.41],0.2298112774838186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS2,Growth arrest-specific protein 2,3566,88,0.90 [0.59-1.36],0.6126105265904256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS6,Growth arrest-specific protein 6,4209,123,9.13 [5.16-16.15],2.928637417332659e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GASK1A,Golgi-associated kinase 1A,3499,84,0.58 [0.37-0.93],0.0222380711667209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAST,Gastrin,3602,87,1.22 [1.09-1.37],0.0005607377260418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,3482,86,1.03 [0.46-2.30],0.938681796070977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",3520,84,0.99 [0.76-1.31],0.9693979038381242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBA,Lysosomal acid glucosylceramidase,3532,86,1.19 [0.87-1.64],0.2798020312744285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP1,Guanylate-binding protein 1,3597,87,1.15 [0.84-1.58],0.3671376648052807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP2,Guanylate-binding protein 2,4080,118,1.32 [1.02-1.70],0.0333698360802521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP4,Guanylate-binding protein 4,4054,117,1.10 [0.79-1.54],0.5695364192546795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP6,Guanylate-binding protein 6,3499,84,0.82 [0.47-1.41],0.4751866789169854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GC,Vitamin D-binding protein,3631,89,1.41 [0.66-3.03],0.3780518179304091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,3602,87,0.97 [0.80-1.18],0.7948088255376407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCG,Pro-glucagon,4058,119,1.52 [1.34-1.72],4.3918273278398524e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,3459,81,1.84 [1.41-2.40],6.474282507409521e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,3499,84,0.85 [0.52-1.39],0.5153720468434257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",4161,121,3.13 [2.07-4.73],6.414044407456251e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF15,Growth/differentiation factor 15,4232,123,3.38 [2.87-3.99],4.6915037014671355e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF2,Growth/differentiation factor 2,4181,121,1.22 [0.79-1.88],0.3751912010579152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,4054,117,2.10 [1.51-2.92],1.1253787039163947e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GET3,ATPase GET3,3615,89,0.85 [0.57-1.26],0.4126379328543444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFAP,Glial fibrillary acidic protein,4052,118,1.42 [1.01-1.99],0.0432635567150393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,4058,119,1.41 [1.10-1.80],0.0062496611955852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,4058,119,0.96 [0.83-1.11],0.5647030286844678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,4207,123,21.26 [14.89-30.36],1.7393787314630078e-63
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,4161,121,9.21 [4.47-18.96],1.6775969299360571e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,4136,120,8.37 [5.66-12.39],2.3831519971114988e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRAL,GDNF family receptor alpha-like,3490,85,0.72 [0.51-1.03],0.0695624604775276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,4054,117,0.94 [0.72-1.23],0.6542519548485184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,3615,89,0.89 [0.66-1.20],0.4418057346784566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,3612,89,0.85 [0.54-1.33],0.4758137752034377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGH,Gamma-glutamyl hydrolase,4114,118,0.81 [0.49-1.32],0.3940198618197142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,4191,121,0.80 [0.59-1.08],0.1504293919505807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,4145,120,8.92 [5.61-14.19],2.1845920135317627e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH1,Somatotropin,4181,121,1.15 [1.05-1.26],0.0018814797900391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH2,Growth hormone variant,4058,119,0.96 [0.86-1.07],0.4207912645674875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHR,Growth hormone receptor,3556,85,0.37 [0.20-0.68],0.0014005171001793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,4054,117,1.28 [0.98-1.65],0.0654882218154673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRL,Appetite-regulating hormone,4181,121,1.57 [1.30-1.90],3.1272800380443057e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,3616,90,1.42 [0.91-2.20],0.1200082783617989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,3616,90,1.44 [1.12-1.84],0.0042042072039229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP7,GTPase IMAP family member 7,3556,85,1.14 [0.61-2.12],0.6817354991412272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP8,GTPase IMAP family member 8,3482,86,0.95 [0.62-1.46],0.8053332607894628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIP,Gastric inhibitory polypeptide,3520,84,1.84 [1.31-2.58],0.0004008212478189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,3602,87,6.91 [4.49-10.63],1.4589791721380925e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,3602,89,0.93 [0.76-1.15],0.5193631653895125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,3506,87,1.28 [0.87-1.89],0.2124363153760595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,3506,87,0.95 [0.76-1.17],0.6060894624225343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GJA8,Gap junction alpha-8 protein,3482,86,1.17 [0.86-1.58],0.3124258773016519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GKN1,Gastrokine-1,3978,112,2.12 [1.28-3.51],0.0035350880027375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLA,Alpha-galactosidase A,3551,84,1.23 [0.72-2.09],0.4534223234941564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLB1,Beta-galactosidase,4145,120,0.63 [0.42-0.93],0.0217435377172626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLI2,Zinc finger protein GLI2,3506,87,0.78 [0.37-1.66],0.5255737669719582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLO1,Lactoylglutathione lyase,4107,122,0.99 [0.75-1.31],0.928171736760136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,4174,120,0.94 [0.59-1.51],0.8056752424944413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,3493,84,1.31 [0.79-2.16],0.2981514273269195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX,Glutaredoxin-1,4154,118,0.83 [0.62-1.10],0.1960810489037884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",3556,85,0.93 [0.73-1.19],0.5824983872287235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,4054,117,0.97 [0.68-1.39],0.8695515730385222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,3607,90,1.02 [0.71-1.46],0.9128404385193007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GM2A,Ganglioside GM2 activator,3549,86,0.31 [0.16-0.59],0.0003661926999101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMFG,Glia maturation factor gamma,3615,89,0.86 [0.65-1.15],0.3191849558095652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR,GMP reductase 1,4228,121,0.69 [0.51-0.94],0.0180846855056831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR2,GMP reductase 2,3556,85,0.74 [0.53-1.02],0.0664323165457646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNAS,Neuroendocrine secretory protein 55,3616,90,1.17 [0.96-1.43],0.1187184214847562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,4058,119,0.98 [0.76-1.26],0.8554531934158782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,3532,86,1.10 [0.79-1.53],0.587833607973457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNLY,Granulysin,4195,121,1.31 [0.97-1.77],0.076286011251512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,3520,84,0.70 [0.34-1.46],0.3440867575420505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,3556,85,0.38 [0.21-0.66],0.000625499611191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLGA3,Golgin subfamily A member 3,3616,90,1.07 [0.83-1.40],0.5922630460270946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLM2,Protein GOLM2,4212,121,2.22 [1.59-3.10],2.9821649427299646e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,4174,120,0.93 [0.80-1.09],0.3882590606445778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,3602,89,0.91 [0.59-1.42],0.6911269942158897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",3629,87,0.79 [0.51-1.23],0.3043888916342284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,4171,122,1.59 [1.01-2.50],0.045783054316786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,3499,84,1.19 [0.88-1.62],0.2639376939670948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,4053,121,1.14 [0.98-1.34],0.099195120655654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP5,Platelet glycoprotein V,3556,85,0.84 [0.47-1.48],0.5408811475126534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP6,Platelet glycoprotein VI,4186,121,1.04 [0.87-1.26],0.6558118019209669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPA33,Cell surface A33 antigen,4161,121,0.94 [0.83-1.06],0.3193268995082322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC1,Glypican-1,4215,123,10.92 [6.77-17.61],1.0883722645851471e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC5,Glypican-5,4145,120,0.97 [0.73-1.28],0.8146648782998397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,3607,90,1.30 [0.97-1.76],0.0836474455504753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,3602,89,1.62 [1.22-2.16],0.0009429435651729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPI,Glucose-6-phosphate isomerase,3632,90,0.94 [0.61-1.44],0.7671742777443229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,3602,89,2.23 [1.66-3.01],1.3817718036763908e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,4054,117,1.66 [1.21-2.29],0.0018055488727107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,4079,116,6.45 [3.87-10.76],8.779480214361542e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR101,Probable G-protein coupled receptor 101,3493,84,0.79 [0.50-1.25],0.3140736471036905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR158,Probable G-protein coupled receptor 158,3616,90,2.32 [1.65-3.26],1.3503898794429132e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR15L,Protein GPR15L,3602,89,1.60 [1.21-2.12],0.0010825023075636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR37,Prosaposin receptor GPR37,4107,122,4.10 [3.32-5.07],2.1911715757375326e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,3607,90,1.44 [1.11-1.88],0.00621502052539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRAP2,GRB2-related adapter protein 2,4181,121,0.95 [0.84-1.07],0.3697601960295642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,3615,89,0.86 [0.62-1.19],0.3692124109709608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",3616,90,0.79 [0.46-1.37],0.4044305727808781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",3493,84,1.17 [0.81-1.68],0.4050945107680992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRK5,G protein-coupled receptor kinase 5,4107,122,0.93 [0.68-1.28],0.6597674014182939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRN,Progranulin,4174,121,9.41 [5.63-15.75],1.3468880907467557e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRP,Gastrin-releasing peptide,3520,84,1.86 [1.43-2.43],4.085198841179247e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",4161,121,1.62 [1.30-2.01],1.4972624424374632e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRSF1,G-rich sequence factor 1,3462,86,1.01 [0.78-1.31],0.9346457680751276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSAP,Gamma-secretase-activating protein,4058,119,0.98 [0.80-1.20],0.8436213085416129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSN,Gelsolin,3619,90,2.33 [0.80-6.75],0.1189082585959845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSR,"Glutathione reductase, mitochondrial",3616,90,0.63 [0.30-1.31],0.2151233405460517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA1,Glutathione S-transferase A1,4174,121,0.73 [0.61-0.87],0.0005836582227406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA3,Glutathione S-transferase A3,4058,119,0.76 [0.63-0.93],0.0076270498468706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,3499,84,1.06 [0.82-1.38],0.6442569614338673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTP1,Glutathione S-transferase P,4028,116,0.97 [0.75-1.24],0.79648248522686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,3602,87,1.01 [0.93-1.10],0.8569774569250787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,3566,88,1.02 [0.75-1.37],0.9201736192820684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTPBP2,GTP-binding protein 2,3532,86,0.79 [0.61-1.04],0.0902827416096343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCA2A,Guanylin,4175,121,6.40 [4.99-8.20],1.0508228001115755e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,3566,88,1.12 [0.90-1.40],0.305713893223881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUK1,Guanylate kinase,3499,84,1.50 [0.93-2.41],0.0980884018230878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUSB,Beta-glucuronidase,4205,123,0.76 [0.61-0.96],0.018475103553307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",4107,122,0.99 [0.83-1.18],0.906919630003421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMA,Granzyme A,4228,121,2.40 [1.56-3.69],6.155217030703411e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMB,Granzyme B,4174,120,0.97 [0.75-1.27],0.8369294521222965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMH,Granzyme H,4107,122,1.20 [1.00-1.45],0.0548656679226105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",H2AP,Huntingtin-interacting protein M,3482,86,0.79 [0.46-1.35],0.3869389913642477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",3499,84,1.18 [0.94-1.49],0.1454795397697016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",4203,123,0.74 [0.59-0.92],0.0081070549859806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAO1,Hydroxyacid oxidase 1,4215,123,0.96 [0.85-1.08],0.4887788151562665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",4195,121,0.90 [0.73-1.12],0.345886669900868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,4211,123,3.14 [2.76-3.56],1.3004760315062634e-69
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,4195,121,7.89 [5.86-10.62],2.9063472901272025e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,4203,123,0.99 [0.80-1.22],0.8961506594193084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBQ1,Hemoglobin subunit theta-1,4215,123,0.60 [0.45-0.79],0.0002917343462783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBZ,Hemoglobin subunit zeta,3615,89,0.68 [0.55-0.84],0.0003553421510595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCG22,Protein PBMUCL2,3499,84,0.91 [0.61-1.37],0.6586584371156128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,4228,121,0.96 [0.71-1.30],0.8130574255838238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC8,Histone deacetylase 8,3506,87,0.68 [0.40-1.14],0.1404166608751485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC9,Histone deacetylase 9,3493,84,1.17 [0.90-1.52],0.2281821437788805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,3602,89,0.58 [0.36-0.94],0.0273346980677474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGF,Hepatoma-derived growth factor,4207,123,0.96 [0.81-1.14],0.6489635078008318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,3602,87,1.17 [0.86-1.59],0.3210997022257953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEBP1,Heme-binding protein 1,4107,122,0.75 [0.53-1.06],0.099569271771269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEG1,Protein HEG homolog 1,3556,85,2.54 [1.29-5.01],0.0072842684519499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPACAM2,HEPACAM family member 2,3602,87,0.86 [0.54-1.36],0.5208205366639935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPH,Hephaestin,3615,89,12.76 [6.17-26.43],6.884073394824094e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEXIM1,Protein HEXIM1,4174,120,0.97 [0.79-1.19],0.7631444586432121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGF,Hepatocyte growth factor,4228,121,1.63 [1.09-2.44],0.0184028943627183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGFAC,Hepatocyte growth factor activator,3603,89,1.45 [0.68-3.06],0.3354297632746773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,4058,119,0.88 [0.71-1.10],0.2642722692052595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,3602,87,1.31 [1.00-1.72],0.0537601567236336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,3506,87,1.20 [0.93-1.55],0.156502913846535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1,Huntingtin-interacting protein 1,3499,84,0.86 [0.43-1.70],0.6622576331072534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,3598,87,1.66 [1.42-1.94],1.5063851599740372e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HJV,Hemojuvelin,3616,90,1.69 [1.27-2.24],0.0002866478153365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HK2,Hexokinase-2,4107,122,0.95 [0.53-1.70],0.8556586164066289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",3616,90,2.92 [1.56-5.46],0.000814940096366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",4162,119,1.43 [0.95-2.16],0.0870243798942164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",4174,120,5.64 [4.37-7.28],3.509347196689387e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMBS,Porphobilinogen deaminase,4215,123,0.47 [0.33-0.67],3.04801882344694e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMCN2,Hemicentin-2,3549,84,2.57 [1.80-3.66],1.8976170889064601e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",3520,84,0.90 [0.58-1.40],0.6301936858398602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",3499,84,0.77 [0.45-1.33],0.3553199523964039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMMR,Hyaluronan mediated motility receptor,3476,85,1.16 [0.79-1.69],0.4430743701191162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX1,Heme oxygenase 1,4149,119,0.74 [0.53-1.03],0.0739936490130003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX2,Heme oxygenase 2,4054,117,1.62 [1.25-2.10],0.0002713393289428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,3532,86,1.14 [0.92-1.42],0.2267888298252851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNMT,Histamine N-methyltransferase,4126,119,2.24 [1.72-2.93],2.4328698827056164e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,4097,122,0.98 [0.79-1.21],0.8498910099378363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,3616,90,1.45 [1.04-2.02],0.0296554059618939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPCAL1,Hippocalcin-like protein 1,4228,121,0.98 [0.79-1.21],0.8203827484405508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,4058,119,0.42 [0.27-0.65],0.0001210537798435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPSE,Heparanase,3592,87,1.07 [0.86-1.34],0.5243443394906293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRAS,GTPase Hras,3557,88,1.09 [0.92-1.31],0.3118139045207145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,3520,84,2.45 [1.89-3.17],9.826804002212018e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRG,Histidine-rich glycoprotein,3612,89,0.54 [0.29-1.00],0.0485906092120626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS1BP3,HCLS1-binding protein 3,3520,84,1.01 [0.80-1.29],0.9093319489032736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,4161,121,2.26 [1.52-3.35],4.80952110478173e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,4215,123,1.84 [1.34-2.52],0.0001373949495487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,3506,87,3.77 [2.71-5.24],3.422151100634705e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSBP1,Heat shock factor-binding protein 1,3520,84,1.05 [0.84-1.31],0.6907573009879238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,4174,120,1.02 [0.70-1.48],0.9215858136602472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,3602,87,1.21 [0.89-1.63],0.2267795527746011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,3499,84,0.92 [0.59-1.44],0.7250367238634817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,3520,84,1.53 [1.01-2.31],0.0455959849549037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSP90B1,Endoplasmin,4039,116,1.12 [0.89-1.40],0.3357285003987121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,4190,120,1.06 [0.85-1.33],0.5911656843181787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,3607,90,2.70 [2.12-3.44],8.83969193333515e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB1,Heat shock protein beta-1,4116,118,0.85 [0.68-1.06],0.1545486386637534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB6,Heat shock protein beta-6,4215,123,4.65 [3.54-6.11],1.5488303926651687e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,4161,122,8.29 [6.22-11.05],2.916108950170386e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,3493,84,1.11 [0.89-1.39],0.3494293007560193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,3493,84,0.76 [0.44-1.33],0.333733126643451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",4185,121,1.13 [0.87-1.46],0.364012698310694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYAL1,Hyaluronidase-1,4152,120,3.07 [1.78-5.29],5.768825053218343e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,4232,123,31.24 [18.71-52.17],1.619370683676791e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICA1,Islet cell autoantigen 1,4080,118,0.95 [0.77-1.17],0.6174507349563745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM1,Intercellular adhesion molecule 1,4170,122,1.73 [1.07-2.78],0.0252090901485997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM2,Intercellular adhesion molecule 2,4232,123,5.26 [3.19-8.66],7.610148136965269e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM3,Intercellular adhesion molecule 3,4232,123,2.89 [1.74-4.78],3.797050049323112e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM4,Intercellular adhesion molecule 4,4174,120,0.81 [0.59-1.10],0.1703981726538507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM5,Intercellular adhesion molecule 5,4181,121,1.53 [1.08-2.16],0.0154054597980134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICOSLG,ICOS ligand,4161,121,5.24 [2.49-11.01],1.2516915265471166e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,3566,88,1.18 [0.80-1.75],0.4073790808338028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,4054,117,1.53 [1.19-1.96],0.0008425493503398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",3520,84,1.30 [0.98-1.73],0.0660598736714152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDS,Iduronate 2-sulfatase,4228,121,1.39 [0.22-8.58],0.7255207084877555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDUA,Alpha-L-iduronidase,4215,123,1.40 [0.99-1.99],0.0577350323495384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,3511,86,3.52 [2.26-5.47],2.2847844945727546e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,3566,88,0.77 [0.50-1.19],0.2450153728241615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,3566,88,0.91 [0.54-1.55],0.7314595646836931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,3602,89,1.85 [0.95-3.61],0.0697627701793143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNG,Interferon gamma,4080,118,1.30 [1.14-1.48],0.0001148314641525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,4198,120,22.63 [13.86-36.92],9.191619122886319e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR2,Interferon gamma receptor 2,4145,120,1.07 [0.80-1.43],0.6704738376070262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL1,Interferon lambda-1,4054,117,1.61 [1.28-2.03],5.62973474183767e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL2,Interferon lambda-2,3493,84,1.23 [0.92-1.64],0.1585231583661887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNLR1,Interferon lambda receptor 1,4174,120,1.58 [1.10-2.27],0.0125044419958349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNW1,Interferon omega-1,3499,84,0.56 [0.26-1.21],0.1408244973761638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,3532,86,1.11 [0.69-1.80],0.6594282784384684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,3616,90,0.74 [0.53-1.04],0.0878006108050236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,3493,84,0.79 [0.46-1.34],0.3778528794024343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,3629,87,3.22 [1.56-6.66],0.0015710703452538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,4161,121,11.37 [7.56-17.09],1.5644396509680638e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,3499,84,1.00 [0.61-1.63],0.9925490306404108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,4195,121,2.83 [1.48-5.43],0.0017162948512788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,4228,123,1.65 [1.46-1.88],5.4995788074358916e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,4225,123,3.24 [2.64-3.98],4.897398320323064e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,4197,122,0.64 [0.45-0.92],0.0155657729336144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,4143,118,4.57 [3.84-5.45],2.655393160340953e-64
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,4174,121,6.53 [5.08-8.39],1.3986600761027084e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,4232,123,3.83 [2.98-4.91],4.0922162535392703e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,4181,121,3.47 [2.55-4.71],2.1127565882685977e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFL4,Insulin growth factor-like family member 4,3506,87,0.73 [0.49-1.08],0.1125715184672233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,3499,84,1.18 [0.82-1.70],0.3671848182376959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,3621,89,3.39 [2.25-5.10],5.177203853856576e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLON5,IgLON family member 5,3482,86,0.93 [0.71-1.21],0.5851718324024519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,3520,84,0.79 [0.45-1.37],0.3999798724268639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,4161,121,1.68 [1.23-2.29],0.0011531850172711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,4181,121,3.34 [2.59-4.31],1.7565377881405746e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF9,Protein turtle homolog A,3615,89,0.81 [0.66-1.00],0.0455568993881153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKBKG,NF-kappa-B essential modulator,4174,120,0.95 [0.79-1.14],0.5760511794991056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKZF2,Zinc finger protein Helios,4058,119,0.99 [0.81-1.20],0.8940257284510111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10,Interleukin-10,4080,118,1.37 [1.18-1.59],4.344678417099536e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,4080,118,1.21 [0.95-1.53],0.1214526116074663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,4198,120,10.09 [7.12-14.29],9.96564824044688e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL11,Interleukin-11,4080,118,1.06 [0.82-1.36],0.6597174418524254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12A_IL12B,Interleukin-12,4161,121,2.01 [1.70-2.36],9.312962127472436e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12B,Interleukin-12 subunit beta,4228,121,2.73 [2.10-3.54],6.151981463561187e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,4080,118,4.22 [3.05-5.85],5.046320466670017e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,3506,87,1.23 [0.76-1.99],0.4102872851947103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13,Interleukin-13,4080,118,0.75 [0.49-1.15],0.1829897584346481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,4123,119,0.91 [0.48-1.76],0.7885251483519911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,3493,84,1.15 [0.54-2.43],0.7152225883541923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15,Interleukin-15,4174,120,2.54 [1.78-3.62],2.654846730998356e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,4080,118,5.70 [4.21-7.73],3.0747162435132825e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL16,Pro-interleukin-16,4228,121,1.96 [1.55-2.48],2.3041749507742692e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17A,Interleukin-17A,4072,117,1.60 [1.22-2.08],0.000573632677688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17C,Interleukin-17C,4080,118,1.99 [1.73-2.29],2.3163998555649512e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17D,Interleukin-17D,4080,118,1.67 [1.32-2.12],1.5827721946951012e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17F,Interleukin-17F,4080,118,1.18 [0.97-1.44],0.1008573731818393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RA,Interleukin-17 receptor A,4195,121,1.31 [0.92-1.86],0.1294489176238854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RB,Interleukin-17 receptor B,4128,120,1.91 [1.44-2.54],8.415943598553617e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18,Interleukin-18,4166,120,2.05 [1.49-2.82],1.0789255890141034e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18BP,Interleukin-18-binding protein,4197,122,9.01 [6.50-12.49],1.121800101200962e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,4228,121,3.16 [2.12-4.71],1.7392843803998352e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,4115,119,0.98 [0.89-1.08],0.6999103754663418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL19,Interleukin-19,4088,118,1.62 [1.41-1.86],8.13765096248864e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1A,Interleukin-1 alpha,4080,118,1.30 [1.07-1.60],0.0097967482924275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1B,Interleukin-1 beta,4060,118,1.12 [0.87-1.44],0.3898920353339062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,4191,121,13.03 [8.18-20.74],2.7780268768208047e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R2,Interleukin-1 receptor type 2,4170,120,0.87 [0.43-1.78],0.7124510893390849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,4195,121,1.19 [0.85-1.67],0.3143258952561878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,4222,123,2.33 [1.67-3.24],5.70184945553327e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,4080,118,1.10 [0.72-1.69],0.6554717172400282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,4171,120,1.40 [1.11-1.75],0.0043011043827607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2,Interleukin-2,4080,118,0.69 [0.42-1.14],0.1474840082695684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20,Interleukin-20,4080,118,0.91 [0.64-1.29],0.5885770267752642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,4080,118,1.30 [0.97-1.75],0.0758347757542822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,3506,87,1.02 [0.63-1.66],0.9216152481534344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL21R,Interleukin-21 receptor,3506,87,0.91 [0.60-1.37],0.6473787523182263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22,Interleukin-22,3607,90,1.37 [1.05-1.78],0.0195273627540345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,4080,118,1.60 [1.22-2.09],0.0006117099672767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL24,Interleukin-24,4080,118,1.33 [1.03-1.73],0.0311948852729928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL25,Interleukin-25,3471,86,1.46 [0.80-2.67],0.219248188083847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,4158,121,3.96 [3.12-5.03],7.872674379568612e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,4080,118,1.39 [1.05-1.83],0.022111355083317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,3607,90,1.68 [1.28-2.20],0.0001593073110985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3,Interleukin-3,3482,86,1.07 [0.75-1.53],0.7171138013740723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31,Interleukin-31,3506,87,0.95 [0.65-1.39],0.7889414664412523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,3492,87,2.15 [1.34-3.43],0.0014362250923406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL32,Interleukin-32,4174,120,1.44 [1.11-1.88],0.0057065551286883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL33,Interleukin-33,4080,118,1.51 [1.01-2.25],0.0455763136411656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL34,Interleukin-34,4047,116,1.35 [0.86-2.14],0.1925312313421654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36A,Interleukin-36 alpha,3506,87,1.14 [0.85-1.54],0.3703366075115264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36G,Interleukin-36 gamma,3499,87,1.29 [1.03-1.61],0.0275996951846585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,4080,118,1.68 [1.05-2.68],0.0305867627373084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4,Interleukin-4,4080,118,0.98 [0.83-1.16],0.8374592437641566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,4174,120,4.57 [3.46-6.06],2.3634980966334806e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5,Interleukin-5,4080,118,1.00 [0.88-1.13],0.9423160790677252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,4174,120,1.63 [1.27-2.11],0.000143388282662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6,Interleukin-6,4161,121,1.24 [1.05-1.46],0.0116635114480343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,4165,122,3.28 [2.09-5.16],2.665821595908835e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,4181,121,10.40 [4.69-23.08],8.344334001190774e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7,Interleukin-7,4174,120,0.81 [0.62-1.05],0.1071342348497512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,4195,121,1.29 [0.95-1.77],0.1042725517813682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL9,Interleukin-9,3566,88,0.76 [0.49-1.20],0.2441787496216019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,4047,117,0.97 [0.72-1.30],0.8339400662470073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMMT,MICOS complex subunit MIC60,3607,90,2.16 [1.63-2.85],6.960377891068834e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPA1,Inositol monophosphatase 1,4145,120,0.87 [0.66-1.14],0.3078991991549116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPACT,Protein IMPACT,3602,87,0.76 [0.52-1.10],0.1433904887174001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,3493,84,1.02 [0.52-1.97],0.963487372678526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ING1,Inhibitor of growth protein 1,4046,117,1.07 [0.78-1.46],0.6767087159157679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBB,Inhibin beta B chain,3556,85,3.45 [2.58-4.61],4.616861095464382e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBC,Inhibin beta C chain,4195,121,1.44 [0.93-2.21],0.1023074840173888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,4161,121,1.46 [1.12-1.91],0.0058417341478387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",3520,84,0.92 [0.63-1.34],0.6746724364800502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",3616,90,0.78 [0.44-1.36],0.3809769759805764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",4161,121,1.03 [0.88-1.22],0.6871550239125028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL3,Insulin-like 3,3602,87,1.01 [0.79-1.28],0.9405174961281684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL4,Early placenta insulin-like peptide,3607,90,2.15 [1.74-2.65],1.8477832297502215e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL5,Insulin-like peptide INSL5,3602,89,1.38 [1.15-1.65],0.0005100173773474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSR,Insulin receptor,3506,87,5.77 [2.02-16.48],0.0010672599206324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,4138,120,1.06 [0.88-1.27],0.5670235601706701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,4161,121,1.19 [0.91-1.57],0.2068747721793765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",4107,122,1.08 [0.91-1.28],0.3898405089245466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,4080,118,1.08 [0.85-1.37],0.5293034836444968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,4174,120,0.93 [0.79-1.08],0.3358616257504718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,3994,113,1.49 [0.97-2.30],0.0713210172988378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM1,Isthmin-1,4174,120,1.68 [1.27-2.21],0.0002897068487518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM2,Isthmin-2,3629,87,1.10 [0.71-1.71],0.6692031761231811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IST1,IST1 homolog,3575,89,0.91 [0.73-1.12],0.3657874623903218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA11,Integrin alpha-11,4174,120,0.83 [0.53-1.30],0.4119578651288481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA2,Integrin alpha-2,3556,85,0.60 [0.34-1.08],0.0892316619888392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA5,Integrin alpha-5,4195,121,1.57 [0.89-2.76],0.1159783174107312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA6,Integrin alpha-6,4174,120,1.07 [0.79-1.46],0.6493357546563565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAL,Integrin alpha-L,3506,87,2.16 [1.37-3.40],0.0008639183032027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAM,Integrin alpha-M,4195,121,1.55 [0.98-2.45],0.0599921680335325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAV,Integrin alpha-V,4215,123,0.81 [0.34-1.95],0.6359262362751846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAX,Integrin alpha-X,3566,88,0.85 [0.54-1.32],0.4563854480992605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1,Integrin beta-1,4180,122,2.15 [1.11-4.15],0.0231407870850408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,4058,119,1.20 [0.81-1.78],0.3595569743258002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,4107,122,0.97 [0.84-1.12],0.6711211481825217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB2,Integrin beta-2,4166,121,2.76 [1.73-4.42],2.1295481156299816e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB5,Integrin beta-5,4185,121,1.44 [1.01-2.06],0.0440752022814592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB6,Integrin beta-6,4080,118,7.07 [4.33-11.55],5.654789376652958e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB7,Integrin beta-7,4215,123,1.74 [1.29-2.36],0.0003134907133236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,3629,87,2.36 [1.77-3.16],6.572399272329507e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,3631,89,1.57 [0.59-4.19],0.3709716833085262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,4197,122,4.27 [2.80-6.49],1.2199966101351292e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,3631,89,1.38 [0.65-2.91],0.4032360471208924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,3607,90,1.25 [0.82-1.92],0.3032453460596574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITM2A,Integral membrane protein 2A,4174,120,1.64 [1.28-2.10],8.297522927576763e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,3499,84,0.66 [0.48-0.91],0.0103562485646151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",3520,84,1.23 [0.95-1.59],0.1089045842451993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",3493,84,1.49 [1.03-2.14],0.0327710685059792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",4054,117,1.18 [0.88-1.58],0.2643146124361197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,3482,86,1.16 [0.78-1.72],0.4749277442994765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM2,Junctional adhesion molecule B,4212,121,13.26 [9.80-17.94],4.3483474731817865e-63
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM3,Junctional adhesion molecule C,3556,85,1.88 [1.46-2.43],1.2359737644523391e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JCHAIN,Immunoglobulin J chain,4080,118,1.49 [1.15-1.93],0.0027785527848268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,3482,86,1.13 [0.80-1.61],0.491345935000881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,3602,89,0.91 [0.72-1.16],0.4358474120927131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JUN,Transcription factor AP-1,4080,118,1.50 [1.24-1.81],3.282726922970734e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,4161,121,3.76 [2.65-5.33],9.022245640681436e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZN,Kazrin,3602,89,0.91 [0.75-1.11],0.356169457401273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,3493,84,1.35 [1.01-1.81],0.0409292628290095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,3532,86,0.85 [0.61-1.18],0.3271628235820409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNIP4,Kv channel-interacting protein 4,4054,117,1.06 [0.80-1.41],0.6798514701522651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,3538,84,1.25 [0.86-1.83],0.2470308327154578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDM3A,Lysine-specific demethylase 3A,3506,87,0.97 [0.75-1.25],0.7994672008951235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,4185,121,1.47 [0.77-2.80],0.2434955100708111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KEL,Kell blood group glycoprotein,4054,117,0.72 [0.47-1.12],0.1466889807600337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHDC3L,KH domain-containing protein 3,3482,86,0.98 [0.71-1.35],0.8922947993092317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHK,Ketohexokinase,3520,84,0.90 [0.65-1.23],0.4974990749288871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,3602,87,3.89 [2.72-5.56],8.682900678155375e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,3566,88,0.91 [0.68-1.21],0.504793736830928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,3566,88,0.61 [0.28-1.35],0.2246461879199989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,3607,90,0.92 [0.61-1.41],0.7119570497567285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF1C,Kinesin-like protein KIF1C,3499,84,2.31 [1.48-3.61],0.0002141445297388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF20B,Kinesin-like protein KIF20B,3493,84,0.93 [0.71-1.23],0.6237463013592316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF22,Kinesin-like protein KIF22,3499,84,0.83 [0.70-0.98],0.031017575665453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIFBP,KIF-binding protein,4161,121,1.02 [0.84-1.24],0.8217259568605224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,3607,90,1.20 [0.97-1.49],0.0922906319856988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,4058,119,1.33 [1.10-1.61],0.0033527938265843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,3602,89,1.08 [0.97-1.21],0.1761484751444225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,4058,119,1.08 [0.95-1.23],0.2216735808603962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,3482,86,1.02 [0.80-1.30],0.8791627134814852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,3493,84,1.00 [0.66-1.51],0.9838684331365074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,4054,117,2.66 [1.99-3.55],3.4374140092645746e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,4196,122,1.55 [0.93-2.60],0.0959928324872278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KITLG,Kit ligand,4181,121,3.52 [2.37-5.22],3.63617990224952e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLB,Beta-klotho,4054,117,1.46 [1.20-1.79],0.0001902415367923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLF4,Krueppel-like factor 4,3493,84,1.59 [1.04-2.43],0.0339080332283303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLHL41,Kelch-like protein 41,3616,90,1.53 [1.17-1.99],0.001957425934303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK1,Kallikrein-1,4137,118,1.12 [0.99-1.27],0.0619188263257303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK10,Kallikrein-10,4172,121,2.41 [1.79-3.26],7.58409491616598e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK11,Kallikrein-11,4140,121,5.67 [4.52-7.11],1.1952298102394973e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK12,Kallikrein-12,4058,119,1.11 [0.98-1.25],0.1011970219064924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK13,Kallikrein-13,4075,120,1.55 [1.15-2.09],0.0041336768329579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK14,Kallikrein-14,4215,123,2.51 [1.84-3.42],7.290341882040796e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK15,Kallikrein-15,3600,90,1.67 [1.12-2.48],0.0114852304392339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK3,Prostate-specific antigen,3629,87,0.76 [0.61-0.93],0.0088191825154935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK4,Kallikrein-4,4215,123,2.44 [2.10-2.85],3.757741815171952e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK6,Kallikrein-6,4179,121,6.29 [4.31-9.19],1.6728631940245824e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK7,Kallikrein-7,3459,82,0.98 [0.58-1.69],0.9559860927921342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK8,Kallikrein-8,4026,118,4.46 [3.32-5.99],3.352160398193699e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLKB1,Plasma kallikrein,3553,89,0.43 [0.19-0.93],0.032846614201808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,4228,121,7.57 [5.78-9.92],1.0344997426443804e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,3493,84,1.07 [0.77-1.49],0.7028246334924111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,4228,121,3.14 [2.32-4.26],1.712118408549829e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,3506,87,1.63 [1.30-2.05],2.470226892984904e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,3602,87,3.32 [2.39-4.61],7.956465708162276e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",3933,110,1.29 [0.76-2.21],0.3465456224307813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",3499,84,1.12 [0.67-1.85],0.6668323835305943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",4161,121,1.18 [1.02-1.37],0.0267276101878399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",4165,119,2.39 [2.02-2.83],3.0729280005855862e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",4054,117,1.47 [1.12-1.93],0.0055774792212582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",3499,84,1.06 [0.64-1.78],0.816070086796706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",3493,84,1.13 [0.99-1.29],0.0738262833510435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,4177,121,0.69 [0.52-0.92],0.0117500834167583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYNU,Kynureninase,4228,121,0.64 [0.47-0.88],0.0055794540117067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L1CAM,Neural cell adhesion molecule L1,4185,121,1.75 [1.05-2.93],0.0321304323534386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,3615,89,1.00 [0.79-1.26],0.9876296685974914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACRT,Extracellular glycoprotein lacritin,3592,90,1.08 [0.71-1.64],0.7253697353050648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACTB2,Endoribonuclease LACTB2,4181,121,0.87 [0.67-1.12],0.2653285577150198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,4161,121,2.41 [1.99-2.92],2.686114799970824e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,4176,120,3.54 [2.95-4.26],1.4571256669559106e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,4145,120,1.43 [1.21-1.68],2.1332377609168325e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA1,Laminin subunit alpha-1,3499,84,0.72 [0.43-1.21],0.2109812197636648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA4,Laminin subunit alpha-4,4198,120,3.64 [2.45-5.40],1.3526926897685618e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMB1,Laminin subunit beta-1,3520,84,4.66 [2.43-8.93],3.559160397687096e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,3540,87,1.49 [0.73-3.06],0.277234702248498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,4066,116,0.43 [0.20-0.94],0.0356223017931538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,4220,121,2.17 [1.63-2.90],1.446293672679895e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,3607,90,1.03 [0.62-1.71],0.9160957560393398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAP3,Cytosol aminopeptidase,4080,118,0.90 [0.63-1.29],0.5784569717834447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LARP1,La-related protein 1,3607,90,0.97 [0.70-1.36],0.868272306238192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT,Linker for activation of T-cells family member 1,4228,121,1.02 [0.83-1.26],0.8466872679709342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT2,Linker for activation of T-cells family member 2,4161,121,1.06 [0.93-1.20],0.395832074889959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,3506,87,1.05 [0.82-1.34],0.713984404464094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAYN,Layilin,4137,120,7.53 [6.02-9.42],1.0468160777001592e-69
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBP,Lipopolysaccharide-binding protein,4197,122,1.72 [1.31-2.25],9.062462205712096e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBR,Delta(14)-sterol reductase LBR,4212,121,1.20 [0.99-1.46],0.0596822851727345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,3632,90,0.51 [0.22-1.17],0.1122951471140401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN15,Lipocalin-15,3616,90,1.71 [1.44-2.02],4.802157938027634e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,4057,117,3.72 [2.98-4.64],2.9839797678243846e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCP1,Plastin-2,3629,87,0.82 [0.53-1.27],0.3721399894495297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLR,Low-density lipoprotein receptor,4189,120,0.90 [0.67-1.22],0.4998929053392501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,3616,90,0.92 [0.75-1.12],0.3941762787572949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,3615,89,1.65 [1.32-2.07],1.3137508521422037e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEFTY2,Left-right determination factor 2,4207,123,1.68 [1.26-2.24],0.0004547327926581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEG1,Protein LEG1 homolog,3432,84,1.36 [1.03-1.79],0.0304465291383322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,3493,84,0.90 [0.64-1.25],0.5122684995967919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,3616,90,1.55 [1.10-2.17],0.0115785756018772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEP,Leptin,4181,121,1.16 [0.90-1.49],0.2580060484647506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEPR,Leptin receptor,4181,121,3.11 [2.02-4.78],2.5826098938252725e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,3616,90,1.85 [1.40-2.45],1.5265683134837212e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS1,Galectin-1,4181,121,4.46 [3.14-6.32],5.0911313148117275e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3,Galectin-3,4184,122,5.00 [3.15-7.95],1.0398580994308068e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3BP,Galectin-3-binding protein,3631,89,0.98 [0.53-1.79],0.9443236772826412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS4,Galectin-4,4176,120,3.34 [2.73-4.09],1.0081984283285358e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,4174,122,2.85 [2.28-3.56],3.180246328783111e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS8,Galectin-8,4212,121,1.22 [0.94-1.59],0.1267071205615879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS9,Galectin-9,4182,120,8.97 [5.96-13.51],7.257107250718891e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGMN,Legumain,4198,120,1.96 [1.29-2.97],0.0015493477463047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHB,Lutropin subunit beta,4058,119,1.08 [0.90-1.29],0.4145086742239404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,4181,120,0.72 [0.57-0.93],0.0098941021601904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIF,Leukemia inhibitory factor,4054,117,1.04 [0.76-1.43],0.791892225724513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,4174,120,7.06 [4.73-10.53],1.060981757923898e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,4195,121,1.44 [0.93-2.25],0.1024999679567569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,3629,87,1.01 [0.87-1.17],0.939548560972762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,3499,84,0.81 [0.50-1.31],0.3904247840067217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,4181,121,5.81 [3.61-9.34],4.333702944831889e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,3615,89,1.13 [0.87-1.47],0.3464762902771795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,4232,123,1.84 [1.05-3.22],0.033271124190484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,4215,123,2.51 [1.61-3.93],5.5198039274728254e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,4080,118,4.26 [3.19-5.68],7.866176716139092e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,4232,123,1.02 [0.81-1.29],0.8380367156473683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIPF,Gastric triacylglycerol lipase,3520,84,0.81 [0.59-1.10],0.1781962906086109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB1,Lamin-B1,3595,89,1.14 [0.87-1.48],0.3474951098667082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB2,Lamin-B2,3602,87,5.12 [3.63-7.23],1.2817876037974635e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD1,Leiomodin-1,3616,90,4.34 [3.28-5.74],8.374438297219788e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD2,Leiomodin-2,3493,84,0.79 [0.53-1.16],0.2248244199187951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",3520,84,1.04 [0.82-1.33],0.7275742934325848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPA,Apolipoprotein(a),3538,88,1.08 [0.96-1.20],0.1953774672765144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,4161,121,1.19 [0.92-1.54],0.174884323249066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPL,Lipoprotein lipase,4181,121,1.53 [1.09-2.15],0.0139735933638667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPO,Lactoperoxidase,4040,116,1.58 [1.25-2.00],0.0001472449925324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPP,Lipoma-preferred partner,3499,84,0.82 [0.60-1.14],0.245173280954784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,3499,84,1.31 [0.97-1.76],0.0814058702270165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,3532,86,1.28 [0.88-1.85],0.19199057493642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,3631,89,6.38 [3.26-12.50],6.45875477986361e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,4203,123,3.05 [2.13-4.38],1.2820508933934522e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,3496,87,1.85 [1.14-3.01],0.0132171952372408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,4161,121,1.76 [1.01-3.07],0.0454635077267608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,4181,121,8.16 [6.01-11.09],4.3091517313128254e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,3532,86,0.92 [0.50-1.69],0.7874426773340522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2BP,LRP2-binding protein,3532,86,1.03 [0.81-1.31],0.8235803476782297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,4212,121,1.02 [0.76-1.36],0.9046606976015866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,4161,121,1.74 [1.40-2.16],6.965695356191321e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,3602,89,1.57 [0.99-2.49],0.0566533994436083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,3532,86,1.34 [0.91-1.98],0.1420995269509018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,3615,89,1.00 [0.66-1.52],0.9915792850683552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,3607,90,1.03 [0.69-1.55],0.8681998319267591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,4080,118,0.59 [0.40-0.88],0.0093789225488302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,3532,86,1.04 [0.62-1.75],0.8833530350413215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,3616,90,2.28 [1.24-4.17],0.0076154645200488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,4058,119,1.01 [0.74-1.36],0.973035388579336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,3566,88,0.95 [0.74-1.21],0.6586662800982483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSP1,Lymphocyte-specific protein 1,4174,120,1.82 [1.25-2.66],0.0016896192259407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA,Lymphotoxin-alpha,4174,120,1.33 [0.89-1.98],0.1629385079010283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,4215,123,1.20 [0.94-1.55],0.1488917837510348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTB,Lymphotoxin-beta,3607,90,1.45 [0.94-2.25],0.0922428345103329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,4232,123,5.94 [4.37-8.09],1.0409258023389652e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,4058,119,1.57 [1.32-1.88],6.303061750691502e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,4158,120,8.37 [6.41-10.93],6.297390131392932e-55
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTO1,Protein LTO1 homolog,4080,118,0.84 [0.54-1.31],0.4373678229985963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LUZP2,Leucine zipper protein 2,3607,90,1.70 [1.36-2.13],4.224824644496068e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LXN,Latexin,4119,120,0.63 [0.48-0.82],0.0005250181989862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY6D,Lymphocyte antigen 6D,4155,120,3.87 [3.11-4.83],2.077228716031739e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY75,Lymphocyte antigen 75,4174,120,1.76 [1.16-2.67],0.0077087216752833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,4129,118,2.81 [1.75-4.50],1.7642861515231402e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY96,Lymphocyte antigen 96,4145,120,1.23 [0.80-1.88],0.3536792226967966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,4058,119,0.83 [0.58-1.19],0.3123619347612537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYN,Tyrosine-protein kinase Lyn,4161,121,1.04 [0.86-1.26],0.671455044185999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,4054,117,0.94 [0.71-1.25],0.6608397299607794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,4142,120,1.31 [0.84-2.05],0.2256886103122392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,4058,119,1.33 [1.10-1.61],0.0027933876006245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,3493,84,0.90 [0.72-1.12],0.3426811814704751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,3532,86,1.09 [0.91-1.31],0.3319763255859999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,3631,89,5.23 [2.00-13.64],0.0007212683018091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYZL2,Lysozyme-like protein 2,3482,86,1.50 [0.89-2.54],0.1289950019654479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,3556,85,0.86 [0.64-1.17],0.3440724873783636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,3520,84,0.77 [0.43-1.38],0.3770708975683788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,4126,120,1.61 [1.35-1.91],8.01932627952277e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,4058,119,0.83 [0.53-1.29],0.4117381986092124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAG,Myelin-associated glycoprotein,3532,86,0.81 [0.52-1.26],0.3554906388879219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGEA3,Melanoma-associated antigen 3,3566,88,0.91 [0.74-1.13],0.3894901540210794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGED1,Melanoma-associated antigen D1,4058,119,1.29 [0.95-1.74],0.0983473517353297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,3615,89,4.98 [3.49-7.11],9.640920305545269e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC4,Apical endosomal glycoprotein,3607,90,1.19 [0.85-1.66],0.3199468016564841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",3520,84,5.77 [2.56-13.00],2.339265535969333e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,3615,89,0.89 [0.64-1.23],0.4833464333595001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",3482,86,1.05 [0.70-1.58],0.8005822567262078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,4198,120,0.97 [0.85-1.10],0.6250878561277858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,4185,121,11.27 [7.41-17.14],9.86473753009122e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC4,MANSC domain-containing protein 4,3499,84,1.27 [0.96-1.68],0.0890922264141226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,3493,84,0.95 [0.48-1.88],0.8856229183030223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,3499,84,0.99 [0.72-1.37],0.9559079522674788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2,Microtubule-associated protein 2,3602,87,1.52 [1.04-2.21],0.0290812017559538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,3602,89,1.32 [0.96-1.82],0.0842156137362628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,4174,120,0.95 [0.80-1.11],0.4980161401546656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,4058,119,1.02 [0.86-1.21],0.8163695510987269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,4137,120,0.97 [0.84-1.13],0.7147034930218479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,3482,86,1.35 [0.98-1.87],0.06971087045289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,4174,120,1.64 [1.14-2.36],0.0071561220056549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,3566,88,0.90 [0.68-1.20],0.4822600806810593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,3482,86,0.97 [0.84-1.13],0.735826817961728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPT,Microtubule-associated protein tau,4054,117,1.37 [0.99-1.88],0.0560632384723255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARCO,Macrophage receptor MARCO,4181,121,2.44 [1.35-4.43],0.003151584243802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",3551,84,0.96 [0.75-1.23],0.7312650078869207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,4137,120,0.92 [0.47-1.80],0.8033938715519516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN2,Matrilin-2,4185,120,5.15 [3.14-8.43],7.88569002863311e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN3,Matrilin-3,4138,120,1.47 [0.93-2.31],0.0991006899388891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,4058,119,1.07 [0.89-1.28],0.4847415344936985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAX,Protein max,4054,117,1.02 [0.87-1.19],0.8355146643169385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MB,Myoglobin,4232,123,2.03 [1.66-2.49],9.58433339897642e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MBL2,Mannose-binding protein C,3577,88,1.00 [0.83-1.19],0.9721173685337154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,4197,122,2.67 [1.87-3.81],6.477620981709057e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",3616,90,0.69 [0.40-1.20],0.1875806660453324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,3506,87,0.90 [0.71-1.15],0.4139183111213858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,4159,120,2.03 [1.45-2.84],3.495277827925129e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,3602,89,1.73 [0.99-3.03],0.054683359450326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,4145,120,1.50 [1.20-1.87],0.0003809956761996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",3612,90,0.49 [0.28-0.85],0.010558230524864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDK,Midkine,4173,121,2.21 [1.82-2.68],8.732120863800028e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDM1,Nuclear protein MDM1,3532,86,0.84 [0.42-1.66],0.6160241689436996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",3520,84,1.00 [0.79-1.25],0.9678307360871252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,4058,119,1.05 [0.85-1.31],0.6419070243930189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,3499,84,1.22 [0.86-1.74],0.2568507194119437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,4176,120,1.91 [1.29-2.81],0.001158002548795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,3499,84,1.62 [0.91-2.91],0.1022881410952782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,4222,123,2.30 [1.08-4.89],0.0311276768435494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MELTF,Melanotransferrin,3615,89,4.89 [2.97-8.06],4.4780425207848734e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MENT,Protein MENT,3556,85,0.47 [0.20-1.06],0.0700828663654623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1A,Meprin A subunit alpha,3602,89,0.92 [0.71-1.20],0.5538877162133973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1B,Meprin A subunit beta,4181,121,0.79 [0.70-0.90],0.0002807792467814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,4176,120,2.06 [1.09-3.88],0.0252992241223644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,4228,121,4.55 [2.76-7.48],2.5639074181529046e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MESD,LRP chaperone MESD,4195,121,0.97 [0.85-1.11],0.6337071529563072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MET,Hepatocyte growth factor receptor,4193,119,3.78 [1.79-7.98],0.0004816899981777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1,Methionine aminopeptidase 1,4054,117,0.84 [0.47-1.50],0.5499255226484097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",4174,120,0.99 [0.81-1.21],0.90381047903138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP2,Methionine aminopeptidase 2,4207,123,0.96 [0.72-1.29],0.7979347562269696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,4107,122,1.27 [0.96-1.67],0.0881472874625374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,3532,86,0.89 [0.63-1.27],0.5309118308158591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,3556,85,4.48 [2.59-7.74],7.973989416286594e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,4232,123,5.76 [4.16-7.96],4.179183256477747e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFGE8,Lactadherin,4195,121,1.60 [1.19-2.16],0.0019137393172033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGLL,Monoglyceride lipase,4192,120,0.99 [0.82-1.19],0.9116471604992225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,4174,120,0.98 [0.86-1.13],0.8043517960756185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,4185,121,3.33 [2.33-4.77],3.909373053994348e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICALL2,MICAL-like protein 2,3532,86,1.15 [0.86-1.54],0.3449645638093117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,4174,120,1.29 [1.10-1.50],0.0016740065295355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIF,Macrophage migration inhibitory factor,4188,121,0.80 [0.63-1.02],0.0759952213394324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MILR1,Allergin-1,4080,118,1.99 [1.50-2.64],2.255933081216044e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,3607,90,0.91 [0.75-1.09],0.3085799472687092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINK1,Misshapen-like kinase 1,3602,87,0.92 [0.73-1.15],0.462592924918458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MITD1,MIT domain-containing protein 1,4145,120,0.97 [0.82-1.15],0.7378959428572912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MKI67,Proliferation marker protein Ki-67,3506,87,0.97 [0.59-1.61],0.9090550542089874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLLT1,Protein ENL,3482,86,0.95 [0.69-1.31],0.7526215432672072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLN,Promotilin,4174,120,1.57 [1.30-1.89],3.128994021243953e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MME,Neprilysin,4161,121,1.13 [0.94-1.36],0.2037198242882266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP1,Interstitial collagenase,4046,116,1.33 [1.10-1.60],0.0031592606692187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP10,Stromelysin-2,4172,120,2.62 [2.12-3.24],6.824106286869191e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP12,Macrophage metalloelastase,4185,123,2.31 [1.85-2.88],1.9644720108529058e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP13,Collagenase 3,4054,117,2.63 [1.65-4.18],4.739768504444231e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP15,Matrix metalloproteinase-15,3615,89,0.90 [0.55-1.47],0.6761055978040921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP3,Stromelysin-1,4195,121,2.30 [1.82-2.92],5.036940429413366e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP7,Matrilysin,4102,122,6.08 [4.56-8.10],9.181192165028178e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP8,Neutrophil collagenase,4206,121,1.36 [1.12-1.64],0.0015468388063454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP9,Matrix metalloproteinase-9,4191,121,1.27 [0.98-1.64],0.0728163715202429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",3499,84,0.99 [0.64-1.54],0.9748835650958568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MN1,Transcriptional activator MN1,3532,86,0.95 [0.66-1.37],0.792219427518834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,3566,88,1.27 [0.86-1.87],0.2369504421855004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,4174,121,0.95 [0.81-1.11],0.5100016457270372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,3556,85,1.05 [0.77-1.45],0.7420209260463589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,4215,123,5.51 [3.95-7.69],9.59804647652899e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,3602,87,0.63 [0.27-1.46],0.2812683491088238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,3566,88,0.70 [0.39-1.26],0.2402955946557702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,3482,86,1.10 [0.64-1.88],0.7295840104623954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORN4,MORN repeat-containing protein 4,3482,86,0.76 [0.55-1.05],0.0979744690552455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,4107,122,1.00 [0.81-1.24],0.9952523874954368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPI,Mannose-6-phosphate isomerase,4161,121,1.21 [1.00-1.46],0.0458133282889361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,4192,120,0.99 [0.80-1.23],0.9388592613357938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPO,Myeloperoxidase,4195,121,1.27 [0.93-1.73],0.1354790147199795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,3599,90,0.73 [0.46-1.17],0.1945131384365105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRC1,Macrophage mannose receptor 1,3632,90,6.62 [3.64-12.05],5.939654506504703e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,3532,86,0.72 [0.54-0.96],0.0231613244772293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",3499,84,1.47 [1.04-2.09],0.0299582039279917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",3616,90,1.02 [0.60-1.72],0.9453253089338276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",4054,117,0.82 [0.44-1.50],0.5130219014497492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",3476,85,1.84 [0.95-3.58],0.070213929665826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",3616,90,0.83 [0.61-1.13],0.236187080204509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",3506,87,0.31 [0.11-0.87],0.0256211043829245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLN,Mesothelin,4149,120,1.89 [1.50-2.38],7.51326588413231e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLNL,Mesothelin-like protein,3532,86,0.87 [0.47-1.59],0.6413237290281225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSMB,Beta-microseminoprotein,4180,120,2.40 [2.00-2.87],1.9250860331662906e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,4212,121,2.66 [1.94-3.65],1.0736976638254471e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,4185,121,0.99 [0.79-1.24],0.9283973350171087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MST1,Hepatocyte growth factor-like protein,3574,89,1.66 [1.04-2.67],0.0346633787003131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSTN,Growth/differentiation factor 8,4107,122,1.56 [1.16-2.08],0.0029123390182839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTDH,Protein LYRIC,3506,87,1.04 [0.84-1.29],0.7136154487064441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",3602,87,0.85 [0.37-1.98],0.7136464738016282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,3566,88,0.92 [0.76-1.10],0.3531701391879206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",3602,89,0.96 [0.76-1.20],0.7076748933249868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTPN,Myotrophin,4107,122,0.73 [0.41-1.29],0.2784372275258552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTR,Methionine synthase,3499,84,0.79 [0.54-1.17],0.2401236861957701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS1,Protein MTSS 1,3602,89,0.97 [0.81-1.16],0.7236545455796987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS2,Protein MTSS 2,3607,90,0.97 [0.79-1.19],0.7755896324047105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,3566,88,1.06 [0.75-1.49],0.7548332088814573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC13,Mucin-13,4054,117,2.18 [1.77-2.68],3.053326440194543e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC16,Mucin-16,4161,121,1.01 [0.93-1.10],0.7958676535656319
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC2,Mucin-2,3629,87,1.01 [0.82-1.25],0.9150730018868504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUCL3,Mucin-like protein 3,3482,86,1.32 [0.92-1.89],0.1331432739541742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MVK,Mevalonate kinase,4080,118,1.11 [0.93-1.32],0.260741717814734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,3556,85,4.34 [2.35-8.01],2.6281826191604075e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",3615,89,1.61 [1.30-1.99],1.406241360331626e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",3520,84,1.33 [1.12-1.59],0.0013435592118872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,3616,90,0.93 [0.68-1.27],0.6358467071765413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYDGF,Myeloid-derived growth factor,3615,89,1.05 [0.85-1.29],0.6809050295360857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH4,Myosin-4,3499,84,0.83 [0.49-1.42],0.5009215909847617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH7B,Myosin-7B,3482,86,1.29 [0.85-1.96],0.2300966803956124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH9,Myosin-9,3629,87,0.96 [0.80-1.15],0.6761770678928218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",3499,84,1.53 [1.20-1.94],0.0004851884284999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL3,Myosin light chain 3,3520,84,1.48 [1.14-1.92],0.002828593835081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL4,Myosin light chain 4,3520,84,0.84 [0.56-1.26],0.4017466710365703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL6B,Myosin light chain 6B,3532,86,0.99 [0.79-1.25],0.9452091347369156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",3532,86,1.82 [1.45-2.29],3.141514824965624e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO6,Unconventional myosin-VI,3616,90,1.72 [1.21-2.43],0.0023510233856948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO9B,Unconventional myosin-IXb,4080,118,1.12 [0.89-1.42],0.3314377479069206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOC,Myocilin,4195,121,1.99 [1.41-2.81],8.749817849807801e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM1,Myomesin-1,3493,84,1.23 [0.83-1.81],0.3020319732043516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM2,Myomesin-2,3499,84,1.46 [1.10-1.95],0.0093346867079675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM3,Myomesin-3,3556,85,1.11 [0.90-1.38],0.3359972687663453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,4191,120,2.16 [1.64-2.84],5.272499835263253e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,4058,119,0.97 [0.71-1.34],0.8641314885863672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA10,N-alpha-acetyltransferase 10,3499,84,1.22 [0.81-1.83],0.34152764213603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA80,N-alpha-acetyltransferase 80,3532,86,0.93 [0.78-1.10],0.3912041226484763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,4127,120,1.14 [0.87-1.49],0.348981365657677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,3607,90,1.24 [0.89-1.72],0.2032813533236695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NADK,NAD kinase,4181,121,1.17 [0.90-1.50],0.2374665944673502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,3496,87,1.14 [0.80-1.64],0.4627909549368105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,3512,84,0.54 [0.37-0.78],0.0010573065904458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,3556,85,1.70 [0.71-4.08],0.2339199177505026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,4058,119,1.05 [0.81-1.36],0.7173356424044761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,3596,88,0.51 [0.32-0.81],0.0045832395315836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,3602,87,0.67 [0.35-1.28],0.22376803717955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",3616,90,0.87 [0.57-1.33],0.5289687383408175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,4185,121,20.96 [14.38-30.56],1.9135396480608814e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBN,Nibrin,4080,118,0.97 [0.70-1.32],0.8267723698205314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM1,Neural cell adhesion molecule 1,4197,122,1.46 [0.93-2.30],0.1022513497332989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM2,Neural cell adhesion molecule 2,4195,121,1.71 [0.96-3.02],0.0661471493707419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAN,Neurocan core protein,4212,121,0.59 [0.41-0.87],0.006991037059565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCF2,Neutrophil cytosol factor 2,4167,120,1.00 [0.84-1.20],0.9869524323786708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCK2,Cytoplasmic protein NCK2,4198,120,0.97 [0.84-1.13],0.7336161377404805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCLN,Nicalin,4080,118,0.80 [0.53-1.20],0.2831407893643261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,4171,120,6.71 [5.12-8.78],1.4852186488689429e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,3602,89,9.25 [6.12-13.97],3.96944054968924e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCS1,Neuronal calcium sensor 1,4215,123,10.27 [6.52-16.18],1.0523993563316105e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDRG1,Protein NDRG1,4054,117,1.09 [0.87-1.36],0.4752738105557968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,3607,90,1.07 [0.79-1.46],0.6513589450238544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,3500,87,1.98 [1.15-3.42],0.0143843711190653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,3602,89,0.83 [0.66-1.05],0.11922712343908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",4058,119,1.41 [1.22-1.63],2.816514823445541e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEB,Nebulin,3499,84,1.63 [1.05-2.54],0.0297674052514706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,3499,84,1.10 [0.81-1.50],0.533263224355195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN1,Nectin-1,3506,87,1.44 [0.82-2.53],0.2084643152168935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN2,Nectin-2,4181,121,10.34 [7.76-13.77],2.0610369816624491e-57
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN4,Nectin-4,4185,121,4.52 [3.77-5.43],2.369613551683898e-59
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,3506,87,0.63 [0.43-0.93],0.0198148988400245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD9,Enhancer of filamentation 1,3506,87,1.71 [1.07-2.74],0.0242955789591357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEFL,Neurofilament light polypeptide,4040,115,3.32 [2.83-3.90],1.4682040089076314e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,3566,88,0.85 [0.62-1.16],0.301829459089884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,4185,121,0.38 [0.29-0.50],5.859163403213601e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,4198,120,1.33 [0.79-2.23],0.2847193776534529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NENF,Neudesin,3607,90,1.04 [0.87-1.24],0.6681657475378229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEO1,Neogenin,3616,90,3.26 [2.17-4.91],1.494223134849868e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEXN,Nexilin,3632,90,1.04 [0.78-1.37],0.8105898040152815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFASC,Neurofascin,4228,121,6.21 [4.02-9.60],2.0905900261946795e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,3506,87,1.13 [0.90-1.42],0.3088823205788853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",4174,120,0.95 [0.81-1.13],0.572015782501667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",4080,118,1.12 [0.87-1.43],0.391245334493029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,3520,84,0.96 [0.72-1.28],0.7880793567789264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFIC,Nuclear factor 1 C-type,3616,90,1.23 [0.85-1.78],0.2743165625447817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,3499,84,0.93 [0.69-1.25],0.6281620278801073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,3566,88,1.27 [0.98-1.66],0.0720045193355812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,4058,119,1.40 [1.03-1.91],0.0343355446649687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",3602,89,1.01 [0.83-1.24],0.8957766953608807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFX1,Transcriptional repressor NF-X1,3499,84,1.04 [0.78-1.38],0.7923259628461508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,3499,84,1.06 [0.63-1.78],0.8379831026402609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGF,Beta-nerve growth factor,4145,120,1.69 [0.47-6.09],0.422029020056068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,3615,89,1.90 [1.35-2.67],0.000219552517604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGRN,Neugrin,3602,87,4.43 [2.28-8.60],1.1000600747090916e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NHLRC3,NHL repeat-containing protein 3,3465,81,4.43 [2.24-8.73],1.763967217221327e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID1,Nidogen-1,4192,122,1.65 [1.09-2.48],0.0169268700176889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID2,Nidogen-2,4195,121,1.22 [0.99-1.51],0.0616154902015871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NINJ1,Ninjurin-1,4058,119,1.15 [0.89-1.49],0.285792535899961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT1,Deaminated glutathione amidase,3520,84,0.47 [0.31-0.71],0.0004010110824739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT2,Omega-amidase NIT2,3595,89,0.81 [0.61-1.08],0.1516515956889229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN1,Neuroligin-1,3532,86,0.91 [0.65-1.28],0.6017430792468181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN2,Neuroligin-2,3493,84,0.72 [0.41-1.27],0.2595633774854546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME1,Nucleoside diphosphate kinase A,3506,87,0.99 [0.38-2.60],0.9874073420275358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME3,Nucleoside diphosphate kinase 3,4185,120,1.33 [0.69-2.53],0.3940039579920934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMI,N-myc-interactor,3592,90,1.03 [0.77-1.37],0.8404115749332942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,4145,120,0.97 [0.79-1.19],0.7725025337508467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,3482,86,0.69 [0.35-1.34],0.2683599183940359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,3616,90,0.86 [0.61-1.22],0.3989298475302343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOMO1,Nodal modulator 1,4195,121,1.27 [0.66-2.45],0.4773802749651425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOP56,Nucleolar protein 56,3499,84,1.14 [0.97-1.34],0.1180050264645574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",4054,117,2.30 [1.88-2.82],6.98261015847984e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS2,"Nitric oxide synthase, inducible",3499,84,1.22 [0.73-2.03],0.4528516568812272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",4054,117,1.40 [1.09-1.79],0.0076982540103214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,4232,123,28.81 [12.09-68.67],3.3733770751303794e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,3629,87,8.41 [4.55-15.55],1.0888601858780491e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,4232,123,3.68 [2.53-5.37],1.2651657462077094e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,3578,86,13.45 [8.91-20.30],3.5829895523616697e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,4181,121,5.77 [4.58-7.27],3.969883971138149e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS1,Nephrin,3506,87,0.33 [0.19-0.59],0.0001411633565811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS2,Podocin,3506,87,0.95 [0.77-1.17],0.6297519789073609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPL,N-acetylneuraminate lyase,3615,89,1.01 [0.67-1.53],0.965098045842358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPB,Natriuretic peptides B,4107,122,1.41 [1.27-1.56],5.760627207839215e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPC,C-type natriuretic peptide,4174,120,2.06 [1.68-2.52],3.712230073260013e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,3499,84,0.59 [0.30-1.18],0.1369938944422434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTN,Neuroplastin,4058,119,1.06 [0.87-1.30],0.5387923143821189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX1,Neuronal pentraxin-1,4195,121,1.28 [0.90-1.83],0.1723474509967559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX2,Neuronal pentraxin-2,3629,87,1.97 [1.11-3.49],0.0205455221711253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTXR,Neuronal pentraxin receptor,4181,121,1.45 [1.00-2.09],0.0500501066850076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPY,Pro-neuropeptide Y,4215,123,2.45 [1.89-3.18],1.9171775417889985e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,4181,121,2.76 [1.78-4.30],6.527371747914327e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRGN,Neurogranin,3632,90,0.89 [0.72-1.12],0.3245313403578721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRN1,Neuritin,3616,90,0.86 [0.45-1.63],0.634374651220841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP1,Neuropilin-1,4200,122,5.36 [3.26-8.81],3.624349185318212e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP2,Neuropilin-2,4195,121,1.94 [1.16-3.25],0.0120885843328159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRTN,Neurturin,4080,118,0.80 [0.57-1.13],0.2095320390239516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRXN3,Neurexin-3,3532,86,0.80 [0.40-1.58],0.5179054494636562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NSFL1C,NSFL1 cofactor p47,4212,121,0.80 [0.62-1.03],0.0822267554011953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",3615,89,1.00 [0.75-1.33],0.9830504320272794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,3602,87,3.06 [2.33-4.02],1.0558935098434368e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,4169,120,0.78 [0.65-0.94],0.0095279561289096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5E,5'-nucleotidase,4185,121,1.07 [0.81-1.43],0.6238119409008709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF3,Neurotrophin-3,4174,120,1.65 [1.16-2.34],0.0048293550869391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF4,Neurotrophin-4,4058,119,1.32 [0.94-1.86],0.1099656074989284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,4181,121,2.17 [1.21-3.89],0.0089295612194664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK3,NT-3 growth factor receptor,4212,121,1.80 [0.90-3.61],0.0966228599296022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,4181,121,1.59 [1.45-1.76],4.3905831934539015e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUB1,NEDD8 ultimate buster 1,4174,120,0.92 [0.75-1.12],0.3940694040700218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,3607,90,0.88 [0.70-1.12],0.3015548186281022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUCB2,Nucleobindin-2,4210,123,4.73 [3.33-6.71],4.243964424265821e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDC,Nuclear migration protein nudC,4228,121,1.02 [0.79-1.33],0.8594858663558432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,3520,84,0.81 [0.33-2.02],0.6518059638222151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,3499,84,0.79 [0.49-1.27],0.3351382878253699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,3597,89,1.12 [0.89-1.42],0.3285743594357063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],4161,121,0.78 [0.57-1.06],0.1105100359750334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,4195,121,1.44 [1.06-1.96],0.0181391884170516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUMB,Protein numb homolog,3506,87,0.94 [0.73-1.20],0.6011843590851766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUP50,Nuclear pore complex protein Nup50,3499,84,0.89 [0.44-1.81],0.7540809218958128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPE4,NXPE family member 4,3499,84,1.09 [0.63-1.91],0.7507650794916028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH1,Neurexophilin-1,4054,117,2.16 [1.61-2.90],2.489551137591643e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH3,Neurexophilin-3,3506,87,10.69 [5.96-19.15],1.7658758637260077e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OBP2B,Odorant-binding protein 2b,4134,120,1.33 [1.02-1.73],0.0324556930215863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OCLN,Occludin,3616,90,4.58 [3.37-6.24],3.2799923702645253e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,4047,116,1.38 [1.09-1.73],0.0063249071451905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,3566,88,1.03 [0.77-1.40],0.8260246181752041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGA,Protein O-GlcNAcase,3602,89,0.96 [0.71-1.29],0.7695990683442469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGFR,Opioid growth factor receptor,4161,121,3.24 [2.10-4.99],9.889082887690632e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGN,Mimecan,4195,121,5.98 [4.73-7.56],1.6736020378620804e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,3566,88,0.89 [0.62-1.29],0.5525943798003317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLFM4,Olfactomedin-4,3419,80,1.21 [1.02-1.43],0.0304058511273647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,4150,121,1.38 [1.10-1.73],0.0048194262339597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMD,Osteomodulin,4198,120,1.04 [0.74-1.46],0.8397973859325724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,4161,121,0.71 [0.56-0.89],0.0033374375737426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMP,Olfactory marker protein,3493,84,1.11 [0.74-1.69],0.609041373965729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPHN1,Oligophrenin-1,3602,87,0.98 [0.81-1.18],0.8005218209385143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPLAH,5-oxoprolinase,3520,84,0.91 [0.67-1.25],0.572067337096857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPTC,Opticin,4161,121,1.75 [1.37-2.25],9.888175794622682e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,3622,89,3.03 [1.22-7.50],0.0166067014387878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,3602,87,0.75 [0.39-1.42],0.3774244712314046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,4185,120,6.39 [4.15-9.84],3.5034283796270376e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSM,Oncostatin-M,4157,120,1.30 [1.05-1.62],0.0181134894505729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,4200,122,2.76 [1.35-5.62],0.005186726666665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSTN,Osteocrin,3532,86,1.09 [0.69-1.73],0.7038452467887113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTOA,Otoancorin,3493,84,1.09 [0.78-1.53],0.6225415600363476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,3602,89,0.75 [0.52-1.07],0.1158830011628802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD7B,OTU domain-containing protein 7B,3616,90,1.36 [0.99-1.88],0.0561154834155081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",3520,84,0.83 [0.61-1.11],0.208483140815835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXT,Oxytocin-neurophysin 1,4212,121,1.05 [0.94-1.17],0.4152085480700528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",P4HB,Protein disulfide-isomerase,4149,120,2.42 [1.61-3.65],2.196305727036554e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,3499,84,1.01 [0.72-1.43],0.9436929758384046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI2,Protein-arginine deiminase type-2,4080,118,1.36 [1.12-1.64],0.0016858750994674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI4,Protein-arginine deiminase type-4,4047,116,0.93 [0.75-1.15],0.4814415373003927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAEP,Glycodelin,4145,120,1.04 [0.90-1.20],0.5715651275388923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,3616,90,1.01 [0.85-1.21],0.8749007372003587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",3566,88,0.71 [0.45-1.11],0.129222067944836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,4107,122,1.32 [1.01-1.73],0.0400184809042029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,3520,84,0.72 [0.42-1.24],0.2331706006282743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,3476,86,0.96 [0.65-1.42],0.8282656484744645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,4054,117,0.98 [0.75-1.29],0.9108359280481052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALLD,Palladin,3506,87,1.02 [0.60-1.75],0.9309091161722216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM,Paralemmin-1,3584,88,7.67 [5.42-10.84],9.383210555615454e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM2,Paralemmin-2,3602,87,5.22 [3.82-7.14],4.136660391139722e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM3,Paralemmin-3,3499,84,1.00 [0.74-1.36],0.9914784625283416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,4215,123,9.17 [5.78-14.55],4.480194628686944e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAMR1,Inactive serine protease PAMR1,4195,121,1.37 [0.77-2.42],0.280386658325984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAPPA,Pappalysin-1,4080,118,0.74 [0.52-1.05],0.0956922912934724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARD3,Partitioning defective 3 homolog,3566,88,1.02 [0.78-1.34],0.8784520950397334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARK7,Parkinson disease protein 7,4195,121,0.85 [0.62-1.18],0.3359201350508007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,4174,120,1.06 [0.81-1.38],0.685326702296823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAXX,Protein PAXX,3556,85,1.53 [1.01-2.31],0.0457945061639518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,3482,86,0.87 [0.45-1.68],0.6743845518778877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,4054,117,0.75 [0.55-1.02],0.069722899867322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,3602,89,4.34 [2.79-6.73],5.980150978849475e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCARE,Photoreceptor cilium actin regulator,3493,84,0.83 [0.61-1.13],0.2354938516882467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,3550,85,0.85 [0.59-1.23],0.386292275872522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBP2,Poly(rC)-binding protein 2,3616,90,0.87 [0.66-1.16],0.3508916379937526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH1,Protocadherin-1,4208,121,3.81 [2.38-6.09],2.498920621338512e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH12,Protocadherin-12,3616,90,1.47 [0.70-3.11],0.3114443947547587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH17,Protocadherin-17,4181,121,1.89 [1.32-2.70],0.0004660192969691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH7,Protocadherin-7,3602,89,2.70 [2.03-3.60],1.1831726041266305e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH9,Protocadherin-9,3602,89,0.98 [0.56-1.72],0.9574102999236354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDHB15,Protocadherin beta-15,3607,90,2.19 [1.54-3.10],1.1010235004481344e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCNA,Proliferating cell nuclear antigen,3482,86,0.99 [0.72-1.35],0.9454369046825024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,3607,90,0.88 [0.57-1.38],0.5845293162224747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,4232,123,2.17 [1.48-3.19],7.924644083689e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,3602,89,0.91 [0.68-1.21],0.512847532649783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,3615,89,0.91 [0.74-1.13],0.4012213427533866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1,Programmed cell death protein 1,4211,123,2.63 [2.08-3.32],9.332536810206589e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,4161,121,5.97 [4.47-7.98],1.485540905683574e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD5,Programmed cell death protein 5,4212,121,1.24 [0.94-1.64],0.1351565866829805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD6,Programmed cell death protein 6,4181,121,1.18 [0.90-1.53],0.2315271244563689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCL2,Phosducin-like protein 2,3482,86,0.93 [0.61-1.42],0.7381464163466096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",3482,86,1.27 [0.94-1.73],0.1237471917553225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",3499,84,1.05 [0.75-1.48],0.766523110879905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",3556,85,0.88 [0.72-1.07],0.1977846124081482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,4232,123,0.95 [0.76-1.17],0.6179780496407024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,4198,120,0.98 [0.82-1.18],0.8567844327596842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFC,Platelet-derived growth factor C,4058,119,1.34 [0.81-2.21],0.260675393521387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,4181,121,5.86 [3.91-8.78],1.182126116929704e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,4232,123,1.23 [0.78-1.94],0.3658500465643209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA2,Protein disulfide-isomerase A2,3482,86,0.83 [0.47-1.47],0.5285298796191935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,3556,85,4.46 [2.55-7.82],1.7119475168039548e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA4,Protein disulfide-isomerase A4,3629,87,0.95 [0.68-1.34],0.7885410273872888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA5,Protein disulfide-isomerase A5,3482,86,0.92 [0.65-1.31],0.6406419259128153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,3616,90,0.93 [0.79-1.10],0.4086674663466324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,4198,120,1.11 [0.98-1.27],0.0986894815459075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",4058,119,1.10 [0.82-1.49],0.5280898570678052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,3532,86,0.83 [0.53-1.29],0.4116607668255622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,3482,86,0.83 [0.54-1.29],0.4088440637196348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZD2,PDZ domain-containing protein 2,3499,84,1.17 [0.86-1.59],0.3129678415088346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,3506,87,1.59 [1.15-2.19],0.004581499899592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,4232,123,7.78 [4.07-14.88],5.684849463471225e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,4195,121,0.96 [0.73-1.28],0.8037069030326286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,4195,121,1.22 [0.74-2.03],0.4338144096630414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,3520,84,0.55 [0.23-1.30],0.175652917272847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PENK,Proenkephalin-A,3556,85,6.36 [4.51-8.97],4.653923945041443e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEPD,Xaa-Pro dipeptidase,3632,90,0.54 [0.27-1.09],0.0833118059836528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PER3,Period circadian protein homolog 3,3506,87,0.90 [0.76-1.07],0.2177318919405279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PF4,Platelet factor 4,3607,89,0.94 [0.76-1.17],0.6001533579285803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN2,Prefoldin subunit 2,4054,117,0.98 [0.72-1.35],0.9220761532848164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN4,Prefoldin subunit 4,3482,86,0.79 [0.50-1.23],0.287180547593626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN6,Prefoldin subunit 6,3532,86,0.62 [0.39-0.98],0.0405931710257325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",4157,121,0.99 [0.81-1.22],0.9485421041778056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGA4,Pepsin A-4,3632,90,1.65 [1.33-2.05],5.206485342070915e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",3615,89,1.34 [0.95-1.89],0.0930868959256952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGF,Placenta growth factor,4228,121,10.39 [7.62-14.16],1.1711091992034714e-49
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,4215,123,2.80 [2.18-3.60],7.057032354855917e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,3590,89,0.91 [0.46-1.81],0.7934396701781562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,3499,84,0.90 [0.60-1.35],0.6047835025422492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGM2,Phosphoglucomutase-2,3532,86,0.76 [0.48-1.19],0.2300508360543351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGR,Progesterone receptor,3506,87,0.96 [0.75-1.22],0.720720096141011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,3616,90,0.94 [0.79-1.12],0.4903861685216418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,3602,89,3.80 [2.82-5.12],1.4197648623065522e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,3482,86,1.05 [0.85-1.29],0.6824344883592613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,4145,120,7.08 [4.62-10.83],2.0976357135699432e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,3556,85,0.79 [0.50-1.27],0.3362899987839185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI16,Peptidase inhibitor 16,3632,90,18.64 [8.60-40.41],1.2857122558422314e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI3,Elafin,4130,122,2.26 [1.94-2.63],8.908972796982272e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",3616,90,1.02 [0.79-1.33],0.8566724783886792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,4139,119,3.23 [2.40-4.35],1.1844330015458202e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,4174,120,0.81 [0.62-1.05],0.1172291069208812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,4195,121,12.16 [9.29-15.93],9.112125820215393e-74
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,3506,87,1.04 [0.71-1.52],0.8418562042847909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,4195,121,6.26 [4.34-9.02],8.119483074830155e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,4181,121,3.77 [2.73-5.20],8.017023997449919e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,3556,85,0.99 [0.73-1.33],0.9245318884505096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PITHD1,PITH domain-containing protein 1,3476,86,1.01 [0.80-1.29],0.9068504238730732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD1,Polycystin-1,3615,89,8.97 [4.56-17.63],2.0110147135909077e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD2,Polycystin-2,3499,84,1.53 [1.12-2.10],0.0074934527842137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKLR,Pyruvate kinase PKLR,4184,120,0.67 [0.52-0.87],0.0026498021166909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKN3,Serine/threonine-protein kinase N3,3566,88,0.97 [0.74-1.29],0.8526082448711798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,4145,120,2.15 [1.65-2.80],1.2723378348806056e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G15,Phospholipase A2 group XV,4185,121,1.83 [1.08-3.09],0.0248312409796857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G1B,Phospholipase A2,4227,123,1.35 [1.00-1.83],0.0493907812839575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",4168,119,1.38 [1.12-1.70],0.0028169116292652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,4198,120,0.96 [0.80-1.16],0.6937971074635771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,4195,121,0.35 [0.24-0.51],5.042899495555922e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAT,Tissue-type plasminogen activator,4222,123,0.72 [0.55-0.95],0.0218454247601175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAU,Urokinase-type plasminogen activator,4195,121,1.56 [0.98-2.50],0.0621262605012127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,4157,120,10.84 [7.53-15.61],1.4684421761564126e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",3602,87,0.92 [0.64-1.32],0.6560702485194241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",3506,87,0.52 [0.28-0.99],0.0474067771432059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",3602,87,0.86 [0.70-1.06],0.163453435850053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,3602,87,1.04 [0.78-1.38],0.7981984325820755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLG,Plasminogen,3536,87,0.36 [0.15-0.86],0.0220518852404615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN1,Perilipin-1,4054,117,1.47 [1.01-2.13],0.0416769486609331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN3,Perilipin-3,4181,121,2.34 [1.72-3.19],6.590044166888724e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,4181,121,0.79 [0.62-1.01],0.0589391081378493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLSCR3,Phospholipid scramblase 3,3594,86,1.46 [1.02-2.11],0.0393624817747038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLTP,Phospholipid transfer protein,4217,123,1.18 [0.79-1.77],0.4232501501568197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC1,Plexin domain-containing protein 1,4058,119,1.65 [1.13-2.41],0.0097293574114193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC2,Plexin domain-containing protein 2,3602,87,1.95 [1.09-3.46],0.0232398514516707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNA4,Plexin-A4,4174,120,0.97 [0.79-1.18],0.7483180566556311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB2,Plexin-B2,4212,122,6.28 [4.16-9.50],3.092871084007359e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB3,Plexin-B3,4167,121,0.93 [0.66-1.31],0.6701766303661232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,4169,121,1.02 [0.94-1.11],0.5962875131972175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMCH,Pro-MCH,3499,84,1.03 [0.79-1.34],0.8401255420704696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMM2,Phosphomannomutase 2,3499,84,0.87 [0.60-1.25],0.438233414027543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMS1,PMS1 protein homolog 1,3532,86,1.13 [0.79-1.63],0.4923608192088596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMVK,Phosphomevalonate kinase,4050,117,0.95 [0.82-1.10],0.5037946824228443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,3632,90,1.10 [0.85-1.43],0.4749802190687632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,3602,87,1.41 [1.14-1.75],0.0018289504531328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,4176,120,1.00 [0.95-1.06],0.8956087518118608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,3520,84,0.78 [0.53-1.15],0.2025646327984845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,3493,84,0.98 [0.61-1.56],0.9218618519609284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",4080,118,1.03 [0.89-1.19],0.6878973212089734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL,Podocalyxin,4161,121,0.94 [0.34-2.58],0.9022069121945449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,4185,121,4.66 [2.98-7.30],1.5861524012879275e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POF1B,Protein POF1B,3506,87,2.24 [1.71-2.93],3.5314311124796222e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,3506,87,0.78 [0.37-1.66],0.5159759771641509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",4161,121,2.26 [1.79-2.84],4.425181889866271e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POMC,Pro-opiomelanocortin,3520,84,1.01 [0.76-1.34],0.94390091646657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,3632,90,0.33 [0.21-0.53],2.332547594078936e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,4107,122,0.95 [0.61-1.46],0.8095036879200437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON3,Serum paraoxonase/lactonase 3,4198,120,0.57 [0.38-0.87],0.0090214209388278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POSTN,Periostin,3629,87,1.66 [1.00-2.78],0.0519451274974692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPBP,Platelet basic protein,3602,89,1.02 [0.80-1.31],0.8529467819754809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,4212,121,0.77 [0.54-1.08],0.130050408839341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,4185,122,0.98 [0.82-1.16],0.778845808194546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,3566,88,1.11 [0.82-1.50],0.519555994829423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",3629,87,0.83 [0.59-1.17],0.2919100582880124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPL,Periplakin,3506,87,2.82 [1.96-4.05],2.0169169370231505e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1A,Protein phosphatase 1A,4058,119,0.92 [0.55-1.55],0.7633157285994803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1B,Protein phosphatase 1B,3506,87,0.90 [0.60-1.36],0.6221596870085415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1F,Protein phosphatase 1F,3615,89,0.87 [0.59-1.29],0.4946595720840693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPME1,Protein phosphatase methylesterase 1,4161,121,0.81 [0.62-1.05],0.1176520420942019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,3607,90,0.92 [0.72-1.18],0.5186796759171223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,4185,121,1.10 [0.93-1.29],0.267918840733389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,3566,88,1.00 [0.75-1.34],0.9873440335472524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,3616,90,0.94 [0.72-1.22],0.6276531443714177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,3616,90,2.60 [2.06-3.29],7.17132975149838e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,4181,121,1.05 [0.86-1.29],0.6293543938217765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R9B,Neurabin-2,4228,121,1.12 [0.95-1.33],0.1767288586232933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,3602,89,1.01 [0.85-1.19],0.9389503617788726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP3R1,Calcineurin subunit B type 1,4145,120,1.51 [1.04-2.20],0.0307590925319462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,3532,86,0.94 [0.70-1.26],0.6876279947013788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPY,Pancreatic prohormone,4163,115,1.46 [1.27-1.69],2.021864342406016e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PQBP1,Polyglutamine-binding protein 1,4058,119,1.20 [0.95-1.52],0.1215413163009581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,3482,86,0.87 [0.38-1.99],0.7351026088383356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,3629,87,5.52 [3.19-9.57],1.0965470699313507e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRC1,Protein regulator of cytokinesis 1,3607,90,0.88 [0.54-1.43],0.5957872691872076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,4210,123,2.38 [1.58-3.58],3.3229332820275445e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX1,Peroxiredoxin-1,4049,118,0.85 [0.70-1.03],0.1062240994570756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX2,Peroxiredoxin-2,3570,90,0.52 [0.37-0.74],0.0003099208577432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",4080,118,1.11 [0.89-1.39],0.3426337217278689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",4228,121,0.91 [0.71-1.16],0.4338295938805487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX6,Peroxiredoxin-6,4215,123,0.69 [0.52-0.90],0.0064274890168504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,4080,118,2.70 [1.97-3.72],9.660392354081184e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRELP,Prolargin,4176,120,8.15 [5.18-12.81],9.834770681547084e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG2,Bone marrow proteoglycan,3629,87,3.43 [2.53-4.64],1.609516212872037e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG3,Proteoglycan 3,3629,87,1.54 [1.05-2.27],0.027647593155099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,4080,118,1.37 [1.05-1.80],0.0219896412230174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,3532,86,1.14 [0.64-2.03],0.6540615608448748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,4181,121,0.94 [0.78-1.15],0.5653474842652235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,3597,86,0.95 [0.72-1.24],0.6999552764150101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKCQ,Protein kinase C theta type,4080,118,0.97 [0.66-1.42],0.8630750377979962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,3499,84,0.97 [0.55-1.70],0.906810990014039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,3556,85,0.95 [0.81-1.12],0.5559182650515648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,4058,119,1.06 [0.84-1.35],0.6213640331224202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRL,Prolactin,4212,121,1.21 [1.00-1.46],0.04674414304476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRND,Prion-like protein doppel,3602,87,2.10 [1.53-2.88],4.668496583018014e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROC,Vitamin K-dependent protein C,4196,122,0.56 [0.31-1.02],0.0593291754896037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROCR,Endothelial protein C receptor,3499,84,1.45 [0.89-2.36],0.1366150804154346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROK1,Prokineticin-1,4174,120,1.38 [1.07-1.78],0.013247749296439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROS1,Vitamin K-dependent protein S,3631,89,0.43 [0.21-0.88],0.0215822620196869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR4,Proline-rich protein 4,3524,84,1.71 [1.34-2.17],1.1907258489088755e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR5,Proline-rich protein 5,3506,87,0.74 [0.45-1.20],0.2189308132948951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,3520,84,4.12 [3.07-5.52],2.482219498215893e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS2,Trypsin-2,4197,122,1.61 [1.33-1.95],7.554280771418578e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS22,Brain-specific serine protease 4,3506,87,2.55 [1.90-3.42],4.5902388194342766e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS27,Serine protease 27,4172,121,4.08 [2.85-5.86],2.192771042844448e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS53,Serine protease 53,3602,87,1.24 [0.78-1.99],0.3658220720899717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS8,Prostasin,4167,120,4.62 [3.31-6.47],3.788323061106175e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,4054,117,0.93 [0.81-1.08],0.3520383895991799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTG,Protogenin,4215,123,4.01 [2.28-7.06],1.469470930286437e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTN3,Myeloblastin,4080,118,1.61 [1.24-2.08],0.0002962634556156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRUNE2,Protein prune homolog 2,3566,88,0.80 [0.39-1.64],0.5352977781393983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAP,Prosaposin,3604,87,13.13 [7.43-23.20],7.6917729323597935e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,3602,89,2.49 [1.84-3.38],4.381357100705366e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSCA,Prostate stem cell antigen,3602,89,1.15 [1.05-1.25],0.0028859530443295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,4145,120,1.45 [1.24-1.70],3.4907612865738505e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,4174,120,1.12 [0.89-1.40],0.3404902568125266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMA1,Proteasome subunit alpha type-1,4058,119,0.65 [0.43-0.99],0.04228381171913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,3482,86,0.82 [0.41-1.64],0.5789019284280368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,3616,90,1.30 [0.92-1.83],0.1390473425960328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,3532,86,1.22 [0.89-1.68],0.2153338196424759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,4161,121,0.67 [0.50-0.92],0.01192888203224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME1,Proteasome activator complex subunit 1,4142,120,0.78 [0.50-1.23],0.2851408617986404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME2,Proteasome activator complex subunit 2,4123,118,0.78 [0.49-1.25],0.2989579214347884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG3,Proteasome assembly chaperone 3,4174,120,0.62 [0.45-0.87],0.0050505625806944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG4,Proteasome assembly chaperone 4,3506,87,0.76 [0.52-1.11],0.1587459374212229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSPN,Persephin,4174,120,1.20 [1.02-1.42],0.0251997410993317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,4058,119,1.30 [1.03-1.64],0.0292505828925769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,3447,82,0.92 [0.76-1.11],0.3841282433203071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",4054,117,1.41 [0.84-2.35],0.1932621924271968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,4155,122,6.32 [4.97-8.03],1.5595858250364234e-51
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGES2,Prostaglandin E synthase 2,3482,87,1.21 [0.83-1.77],0.3148156501904656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGR1,Prostaglandin reductase 1,3615,89,1.01 [0.82-1.25],0.904019723688828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH,Parathyroid hormone,3532,86,1.46 [1.19-1.80],0.0002626645034808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,4174,120,1.86 [1.52-2.29],2.4707353050609663e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,4054,117,3.70 [2.65-5.17],1.4746192211539664e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTN,Pleiotrophin,4107,122,1.47 [1.11-1.94],0.0069998357030167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,3506,87,1.41 [1.00-1.98],0.0491189718644038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,4145,120,1.05 [0.85-1.30],0.6326517930557292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,4192,120,0.92 [0.77-1.10],0.3545520160975088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,3503,87,1.16 [0.70-1.92],0.5548210946548212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,3615,89,0.96 [0.50-1.85],0.9129122763004258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,3629,87,4.40 [1.91-10.15],0.0005061970503853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,4232,123,3.97 [2.37-6.65],1.556233569347927e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,3602,89,1.53 [1.07-2.18],0.0183368885570548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,3602,89,2.30 [1.22-4.33],0.0099539891599646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,4165,119,1.34 [0.72-2.51],0.3566939106621904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,4132,120,4.70 [3.72-5.93],2.358189425064748e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,3602,87,3.72 [2.54-5.43],1.183505893393541e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,4232,123,8.18 [5.54-12.09],4.453955138553743e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,3615,89,2.26 [1.23-4.15],0.0084705145481229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,3556,85,0.69 [0.48-0.99],0.0443977499822634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,4037,116,0.73 [0.56-0.95],0.0213402865250644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTTG1,Securin,3566,88,0.76 [0.44-1.30],0.3196386274528955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTX3,Pentraxin-related protein PTX3,4174,120,2.07 [1.39-3.09],0.0003607941622121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVALB,Parvalbumin alpha,4196,123,1.06 [0.92-1.23],0.4011401572873577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVR,Poliovirus receptor,4212,121,1.65 [1.15-2.37],0.0063305809052326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXDNL,Peroxidasin-like protein,3607,90,1.25 [0.94-1.68],0.1248457151790823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXN,Paxillin,4054,117,1.60 [1.25-2.05],0.0002320064507163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYDC1,Pyrin domain-containing protein 1,3520,84,1.64 [1.13-2.39],0.0100071029051901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYY,Peptide YY,3499,84,1.57 [1.34-1.84],4.0012050429340094e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PZP,Pregnancy zone protein,3631,89,1.00 [0.66-1.52],0.9899145745279196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QDPR,Dihydropteridine reductase,4163,119,0.69 [0.47-1.02],0.0650583392771858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,4191,123,17.15 [10.81-27.23],1.793811879312415e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QSOX1,Sulfhydryl oxidase 1,3553,88,1.50 [1.07-2.12],0.0189281523643159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB10,Ras-related protein Rab-10,3615,89,0.81 [0.55-1.19],0.2841108180142214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,3615,89,0.96 [0.80-1.16],0.6801960507233712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB27B,Ras-related protein Rab-27B,3615,89,0.86 [0.67-1.09],0.2093011749302712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB2B,Ras-related protein Rab-2B,3607,90,0.75 [0.53-1.06],0.1014580840155831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB33A,Ras-related protein Rab-33A,3499,84,0.93 [0.67-1.28],0.6372558554733616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB37,Ras-related protein Rab-37,4080,118,1.06 [0.88-1.28],0.5364482025157655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB39B,Ras-related protein Rab-39B,3499,84,0.89 [0.68-1.17],0.4032700634759261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,3493,84,1.15 [0.84-1.59],0.3851112003684558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB44,Ras-related protein Rab-44,3607,90,1.24 [0.93-1.65],0.1414247938009354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6A,Ras-related protein Rab-6A,4174,120,0.55 [0.40-0.75],0.000189428070918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6B,Ras-related protein Rab-6B,4054,117,1.25 [0.93-1.67],0.1389592612846449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,3556,85,0.81 [0.62-1.08],0.1468142457431807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,4058,119,1.05 [0.80-1.38],0.7067928488615005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,4080,118,0.85 [0.64-1.12],0.2419199045228054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,3532,86,0.87 [0.60-1.25],0.4438736117571717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,4058,119,0.99 [0.70-1.41],0.9596600734886408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,3566,88,1.00 [0.64-1.55],0.9994721494883771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALB,Ras-related protein Ral-B,3506,87,0.94 [0.46-1.90],0.8565882212203634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALY,RNA-binding protein Raly,3607,90,1.37 [1.00-1.87],0.0468511339548598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,3520,84,0.49 [0.33-0.74],0.0006226529965829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,3493,84,0.90 [0.46-1.76],0.7624293495994706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,4058,119,1.05 [0.75-1.46],0.7849543333727499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAP1A,Ras-related protein Rap-1A,3506,87,1.13 [0.87-1.46],0.3552883477736601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,3566,88,0.88 [0.58-1.32],0.5218332447215743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,4058,119,2.58 [1.95-3.42],3.929689206367397e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,4200,122,2.27 [1.81-2.85],1.9950517915688807e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASA1,Ras GTPase-activating protein 1,4054,117,1.12 [0.69-1.80],0.6540363427101034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,3482,86,0.87 [0.54-1.40],0.5735740036193869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASSF2,Ras association domain-containing protein 2,4058,119,1.29 [1.06-1.57],0.0096221723610806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,3616,90,0.37 [0.19-0.72],0.0032332734274715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBKS,Ribokinase,4083,119,0.54 [0.43-0.68],1.0412198812024136e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM17,Splicing factor 45,3616,90,0.99 [0.76-1.30],0.950049362726367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM19,Probable RNA-binding protein 19,3499,84,1.42 [0.94-2.16],0.0990541070448224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM25,RNA-binding protein 25,3482,86,1.28 [0.85-1.93],0.2318245102397961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP1,Retinol-binding protein 1,3532,86,1.27 [1.00-1.60],0.0476955036676699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP2,Retinol-binding protein 2,4161,121,2.13 [1.84-2.48],3.570860464586075e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP5,Retinol-binding protein 5,4161,121,1.93 [1.54-2.42],9.570705619579745e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP7,Retinoid-binding protein 7,3602,89,1.51 [1.19-1.92],0.000758249056657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,3506,87,0.96 [0.67-1.37],0.8111180786665584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,3520,84,1.00 [0.81-1.22],0.9680939543051128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCC1,Regulator of chromosome condensation,3607,90,1.30 [0.95-1.78],0.0962604202475116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCOR1,REST corepressor 1,4107,122,1.09 [0.77-1.56],0.6148011523126742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,3520,84,3.21 [1.23-8.35],0.0167316587960672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REEP4,Receptor expression-enhancing protein 4,3616,90,1.24 [0.92-1.67],0.1641440995616668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1A,Lithostathine-1-alpha,4161,121,3.69 [3.09-4.41],8.695623289926344e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1B,Lithostathine-1-beta,4232,123,2.83 [2.38-3.37],2.2818625286114776e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,4232,123,2.83 [2.38-3.35],8.218070185500392e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,3607,90,1.62 [1.07-2.45],0.0237284607894558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG4,Regenerating islet-derived protein 4,4185,120,3.78 [2.99-4.78],9.093356733661352e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELB,Transcription factor RelB,3506,87,0.76 [0.46-1.24],0.2723106865861526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,4195,121,10.05 [7.39-13.66],3.845391237888397e-49
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REN,Renin,4181,121,1.85 [1.62-2.11],1.159601066541375e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,3506,87,0.98 [0.56-1.72],0.9443806897585332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REST,RE1-silencing transcription factor,3482,86,1.27 [0.75-2.14],0.3761588290200549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,4161,121,0.88 [0.60-1.31],0.5388477706703194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RETN,Resistin,4179,121,3.13 [2.47-3.97],4.4443275401423085e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",3499,84,1.00 [0.63-1.59],0.9937259508744716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RFC4,Replication factor C subunit 4,3607,90,1.23 [0.53-2.87],0.62716853365687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGCC,Regulator of cell cycle RGCC,3616,90,0.82 [0.63-1.07],0.1516557748032575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,3566,88,0.91 [0.63-1.29],0.5871702388320625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMA,Repulsive guidance molecule A,4212,121,6.75 [4.31-10.58],8.309816188706598e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMB,RGM domain family member B,4212,121,10.97 [7.59-15.83],2.228092825355441e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS10,Regulator of G-protein signaling 10,3616,90,0.88 [0.62-1.25],0.4715834526329467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS8,Regulator of G-protein signaling 8,4080,118,1.02 [0.80-1.31],0.8751294047326276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,4125,119,1.02 [0.88-1.17],0.804392381113002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,3506,87,0.76 [0.46-1.28],0.3054121763713369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,3556,85,1.50 [1.08-2.09],0.0157629786040298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILP,Rab-interacting lysosomal protein,4203,123,0.79 [0.61-1.02],0.0748604228902334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILPL2,RILP-like protein 2,3615,89,0.93 [0.76-1.14],0.4905464654110832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,3499,84,1.09 [0.82-1.45],0.5430425372108878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN1,Prorelaxin H1,3616,90,1.25 [0.96-1.62],0.0968952164933973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN2,Prorelaxin H2,3546,85,1.23 [1.04-1.46],0.0181372847090258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE1,Ribonuclease pancreatic,3632,90,11.09 [7.27-16.93],6.79151690953656e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,3520,84,2.37 [1.84-3.05],2.3995257387038943e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE3,Eosinophil cationic protein,4165,121,1.15 [1.02-1.30],0.0254741464297487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE4,Ribonuclease 4,3501,87,6.26 [4.20-9.35],2.5120396482089645e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE6,Ribonuclease K6,3602,89,2.60 [2.10-3.21],1.195926590410049e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,3616,90,0.95 [0.61-1.47],0.810744437079191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASET2,Ribonuclease T2,4218,123,5.51 [4.38-6.94],1.2022110455262301e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,3520,84,9.14 [6.28-13.31],8.034064935782802e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,3506,87,1.07 [0.64-1.80],0.7928202166261104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,3506,87,1.03 [0.62-1.72],0.8962664946321708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,3566,88,0.99 [0.72-1.37],0.9685685001192538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,4058,119,0.97 [0.76-1.24],0.7950539294831489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,3566,88,1.28 [0.96-1.70],0.097030860318635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,3520,84,0.78 [0.59-1.04],0.0887504987844874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO1,Roundabout homolog 1,4185,120,1.81 [1.06-3.08],0.0293317493952469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO2,Roundabout homolog 2,4212,121,1.96 [1.05-3.66],0.0335479910665666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO4,Roundabout homolog 4,3520,84,9.35 [3.04-28.75],9.626471167606123e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,4181,121,9.97 [6.94-14.33],1.4706312561293285e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RP2,Protein XRP2,4161,121,0.95 [0.66-1.35],0.7604329047532696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPA2,Replication protein A 32 kDa subunit,3506,87,1.02 [0.53-1.96],0.9428690433146584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,3566,88,0.70 [0.51-0.98],0.0364411285521563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,3532,86,0.85 [0.51-1.42],0.5419950397914417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPL14,60S ribosomal protein L14,3520,84,1.31 [0.81-2.13],0.2720374902618363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPS10,40S ribosomal protein S10,3499,84,0.96 [0.56-1.64],0.8788898651446777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRAS,Ras-related protein R-Ras,3532,86,0.97 [0.83-1.14],0.7264473010070209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,4058,119,1.33 [1.06-1.67],0.0145931190586804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,4058,119,1.15 [0.90-1.46],0.2535334276016828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRP15,RRP15-like protein,3493,84,0.94 [0.74-1.19],0.6091864757840872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO1,R-spondin-1,4145,120,4.09 [2.71-6.19],2.3491201742705484e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO3,R-spondin-3,4215,123,7.31 [5.45-9.81],4.9275708649449716e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTBDN,Retbindin,4161,121,3.08 [2.52-3.77],1.1775185228030316e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTKN2,Rhotekin-2,3499,84,1.27 [0.94-1.72],0.1208770515176576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",3616,90,0.89 [0.72-1.11],0.3168097603901182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4R,Reticulon-4 receptor,4215,123,5.17 [3.65-7.32],1.864850548232385e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RUVBL1,RuvB-like 1,4058,119,0.99 [0.84-1.16],0.871732014981159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RWDD1,RWD domain-containing protein 1,4212,121,0.89 [0.69-1.16],0.3846609366636131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RYR1,Ryanodine receptor 1,3499,84,0.92 [0.49-1.73],0.8061630707559817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A11,Protein S100-A11,4142,120,1.26 [0.95-1.65],0.1060985817385241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A12,Protein S100-A12,4120,120,1.11 [0.89-1.37],0.3581760248897059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A13,Protein S100-A13,3506,87,1.75 [1.11-2.76],0.0160906126344814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A14,Protein S100-A14,3616,90,0.94 [0.64-1.38],0.7531163556837376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A16,Protein S100-A16,4047,116,1.05 [0.81-1.37],0.6924383894211987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A3,Protein S100-A3,3607,90,0.80 [0.46-1.37],0.4126683418479272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A4,Protein S100-A4,4185,121,0.65 [0.50-0.85],0.0015599710621859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100G,Protein S100-G,3616,90,1.54 [1.09-2.17],0.0144492642067664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100P,Protein S100-P,4107,122,1.60 [1.34-1.91],2.537648977150344e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAA4,Serum amyloid A-4 protein,3631,89,0.92 [0.46-1.83],0.8053923709441652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAFB2,Scaffold attachment factor B2,3616,90,1.50 [0.74-3.03],0.2580043168508726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAG,S-arrestin,3493,84,1.10 [0.74-1.65],0.6423286541318773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,4174,120,1.12 [0.90-1.40],0.3143966441222391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,3566,88,0.97 [0.73-1.28],0.8285633005133191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SARG,Specifically androgen-regulated gene protein,3606,89,0.97 [0.81-1.17],0.7770047339700588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,3499,84,1.65 [1.17-2.33],0.0046450910762395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT1,Diamine acetyltransferase 1,3499,84,0.96 [0.62-1.50],0.8644336701831699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,3566,88,1.14 [0.88-1.48],0.3074149095002848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SATB1,DNA-binding protein SATB1,3616,90,1.10 [0.55-2.18],0.7860519156459906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SBSN,Suprabasin,3621,87,3.70 [2.33-5.89],3.35367858961089e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,4161,121,1.20 [1.00-1.45],0.0529268603401266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,4212,121,11.05 [7.97-15.31],3.484429916392282e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB1,Scavenger receptor class B member 1,4054,117,1.16 [0.90-1.50],0.2552547485919237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB2,Lysosome membrane protein 2,4060,120,7.35 [5.85-9.22],2.1896135515736225e-66
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,4232,123,2.76 [1.98-3.86],2.7091643002968283e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,4212,121,7.53 [5.61-10.11],3.5634615965825207e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG2,Secretogranin-2,4198,123,12.28 [8.63-17.47],4.2651036597713307e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG3,Secretogranin-3,4185,120,3.74 [2.39-5.87],8.550744645573208e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB1A1,Uteroglobin,4185,120,3.83 [2.82-5.19],5.400966902238386e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB2A2,Mammaglobin-A,3499,84,0.98 [0.45-2.11],0.958175032629878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,3556,85,3.47 [1.61-7.49],0.0015024706980156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,4192,120,1.35 [1.20-1.52],9.35885299026808e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGN,Secretagogin,4080,118,3.24 [2.50-4.19],4.0768797907876456e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCIN,Adseverin,3493,84,1.04 [0.79-1.38],0.7732804824160245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCLY,Selenocysteine lyase,4203,123,0.88 [0.65-1.19],0.4129179809238755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,3493,84,0.72 [0.43-1.20],0.2061154094573098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2B,Sodium channel subunit beta-2,3532,86,1.28 [0.65-2.55],0.4744123924837965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,3532,86,0.45 [0.22-0.92],0.0285723774442504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3B,Sodium channel subunit beta-3,3493,84,0.70 [0.40-1.21],0.1978387818933974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,3520,84,3.66 [2.75-4.88],9.372998308798145e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCP2,Non-specific lipid-transfer protein,4058,119,1.10 [0.90-1.35],0.3466416130787482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,3510,84,1.12 [0.74-1.70],0.5997083320127257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,3615,89,7.28 [4.49-11.80],8.237444086769251e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRIB,Protein scribble homolog,3520,84,1.16 [0.95-1.43],0.1445387805196329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRN1,Secernin-1,4174,120,1.25 [0.94-1.64],0.120353522229599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCT,Secretin,3532,86,2.00 [1.38-2.89],0.0002312455919271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC1,Syndecan-1,4181,121,3.11 [2.41-4.00],1.3067411932987797e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC4,Syndecan-4,4181,121,0.56 [0.41-0.77],0.0003048548800197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,3607,90,0.98 [0.82-1.18],0.8683141758430588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDHB,Succinate dehydrogenase,3602,89,1.00 [0.72-1.39],0.9992448095050892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDK2,Protein sidekick-2,3556,85,1.26 [0.77-2.06],0.3659389428074904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEC31A,Protein transport protein Sec31A,3520,84,0.81 [0.62-1.07],0.1388691846012546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,3520,84,2.68 [2.01-3.57],2.1189470674014872e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELE,E-selectin,4232,123,1.51 [1.14-2.00],0.0041557869672525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELENOP,Selenoprotein P,3631,89,0.53 [0.23-1.24],0.1442237693225374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELL,L-selectin,3631,89,0.66 [0.28-1.58],0.3517996815627503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELP,P-selectin,4197,122,1.10 [0.83-1.46],0.4887180097623934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,4174,120,0.90 [0.56-1.47],0.6819668854268683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3F,Semaphorin-3F,4181,121,9.28 [5.65-15.24],1.3656045115998637e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3G,Semaphorin-3G,3556,85,1.59 [1.08-2.33],0.0188369275702977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4C,Semaphorin-4C,4161,121,1.61 [1.24-2.09],0.0003979370691106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4D,Semaphorin-4D,4212,121,1.26 [0.73-2.18],0.4072709778183375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA6C,Semaphorin-6C,3506,87,2.18 [1.31-3.62],0.0027891146294144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA7A,Semaphorin-7A,4222,123,3.11 [2.09-4.64],2.41087588298727e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN3,Neuronal-specific septin-3,3616,90,1.10 [0.86-1.40],0.447188962716107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN7,Septin-7,3566,88,1.14 [0.83-1.57],0.4173283515999673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN8,Septin-8,3594,87,3.61 [2.66-4.89],1.4158267483412911e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN9,Septin-9,4161,121,1.29 [0.80-2.09],0.2975456099962631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA1,Alpha-1-antitrypsin,3566,89,6.86 [0.57-82.27],0.1286383818258625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA11,Serpin A11,4232,123,1.25 [0.86-1.82],0.2505698795497643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA12,Serpin A12,4080,114,0.91 [0.79-1.06],0.2200046110541891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,3617,89,2.44 [0.71-8.43],0.159111557700911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA4,Kallistatin,3551,88,0.31 [0.15-0.65],0.002129842272298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA5,Plasma serine protease inhibitor,3574,89,0.99 [0.51-1.90],0.9704405543281984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA6,Corticosteroid-binding globulin,3631,89,0.85 [0.25-2.87],0.7948962702398288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA7,Thyroxine-binding globulin,3631,89,0.23 [0.09-0.56],0.0013480506854145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA9,Serpin A9,4142,121,1.16 [0.94-1.43],0.1633064856359803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,4184,121,1.02 [0.86-1.22],0.8151439212183007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB5,Serpin B5,4107,122,1.38 [0.99-1.94],0.0591150024070253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB6,Serpin B6,4199,121,1.43 [1.09-1.87],0.0103181327566388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB8,Serpin B8,4228,121,1.53 [1.30-1.79],2.642906117146765e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB9,Serpin B9,4145,120,0.90 [0.55-1.49],0.69124042940029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINC1,Antithrombin-III,3622,89,0.56 [0.16-1.95],0.3655203641470509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPIND1,Heparin cofactor 2,3622,89,0.71 [0.37-1.39],0.3201010949259361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,4232,123,0.92 [0.73-1.17],0.513487538981245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE2,Glia-derived nexin,3615,89,0.88 [0.64-1.20],0.406855284428995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,3570,89,7.95 [3.99-15.84],3.711174599414322e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF2,Alpha-2-antiplasmin,3552,89,0.28 [0.09-0.87],0.0271437220328583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPING1,Plasma protease C1 inhibitor,3622,89,1.61 [0.57-4.59],0.3706789931853596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINH1,Serpin H1,3566,88,1.07 [0.92-1.26],0.3787035351766668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI1,Neuroserpin,3551,84,1.16 [0.60-2.22],0.6567972821840664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI2,Serpin I2,3602,89,1.01 [0.72-1.42],0.9328396835597416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,4054,117,0.98 [0.75-1.26],0.8524024206901277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,4131,120,0.68 [0.39-1.18],0.1673404095322996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6,Seizure protein 6 homolog,3532,86,2.08 [1.29-3.37],0.0028004285260038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L,Seizure 6-like protein,4185,121,6.88 [4.82-9.82],1.9928588849424908e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L2,Seizure 6-like protein 2,4161,121,2.85 [1.77-4.61],1.7524891972168266e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SF3B4,Splicing factor 3B subunit 4,4161,121,0.98 [0.79-1.23],0.8822347403683146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,4133,120,2.50 [2.01-3.10],9.577952955306008e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,3556,85,2.70 [1.69-4.31],3.2640765916331e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,4058,119,1.34 [1.08-1.68],0.0093202768798335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,4058,119,1.18 [0.87-1.59],0.2873564536818642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,4181,121,1.14 [0.90-1.44],0.2892230079103053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,3561,88,1.31 [0.94-1.84],0.1119465609064173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2B3,SH2B adapter protein 3,4058,119,0.96 [0.81-1.13],0.6172865758907481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,4174,120,1.25 [0.97-1.60],0.078928102311373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,3493,84,1.02 [0.72-1.45],0.9132234438699351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BP1,SH3 domain-binding protein 1,3602,89,0.87 [0.57-1.34],0.5354179238081983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GL3,Endophilin-A3,3543,88,1.02 [0.79-1.30],0.8923017085729158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GLB2,Endophilin-B2,3602,87,0.95 [0.70-1.28],0.7186303503911837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHBG,Sex hormone-binding globulin,3632,90,1.28 [0.88-1.84],0.1918825422063411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHC1,SHC-transforming protein 1,3482,86,1.00 [0.83-1.21],0.9831990319556508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHD,SH2 domain-containing adapter protein D,3489,84,1.17 [0.99-1.40],0.0723725843395562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHH,Sonic hedgehog protein,3506,87,0.86 [0.52-1.43],0.5569805243356064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHISA5,Protein shisa-5,3629,87,7.10 [5.12-9.84],6.483345119386259e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",4192,120,0.96 [0.79-1.17],0.7002209550515718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHPK,Sedoheptulokinase,3566,88,1.23 [0.80-1.88],0.3496031590141099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIAE,Sialate O-acetylesterase,4181,121,1.76 [1.26-2.45],0.0008548063683243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC1,Sialoadhesin,4198,120,3.58 [2.67-4.80],1.371071962997441e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,4174,120,4.17 [3.19-5.44],1.069411246081424e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,4054,117,1.20 [1.01-1.42],0.0350640054523137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,4195,121,1.72 [1.42-2.08],3.7688533386625364e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,4215,123,6.35 [4.33-9.31],3.1382479326795975e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,4181,121,3.46 [2.09-5.74],1.389122488325399e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,3520,84,1.79 [1.20-2.69],0.0045242004552607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,4211,123,1.61 [0.96-2.70],0.0722392628996299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIL1,Nucleotide exchange factor SIL1,3520,84,1.50 [0.95-2.37],0.0785218061608915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,4186,122,2.18 [1.55-3.07],8.247250613057468e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,4168,120,5.40 [4.13-7.08],1.6222091097255687e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,3506,87,1.05 [0.82-1.35],0.685838640992849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,4161,121,0.91 [0.75-1.10],0.3277734561485059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",4054,117,0.96 [0.70-1.30],0.7711268090831973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,4080,118,1.13 [0.84-1.50],0.4240010236547918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,4137,120,0.85 [0.67-1.07],0.1557991187280704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,4198,120,1.01 [0.86-1.18],0.8813230877494771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKIV2L,Helicase SKI2W,3499,84,0.91 [0.51-1.61],0.7373200228528571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLA2,Src-like-adapter 2,3616,90,0.93 [0.77-1.13],0.4918999308344637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,4080,118,2.08 [1.65-2.62],5.372408427676285e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF6,SLAM family member 6,4058,119,2.06 [1.53-2.79],2.497309597375253e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF7,SLAM family member 7,4174,120,1.98 [1.55-2.52],3.2618332829659125e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF8,SLAM family member 8,4058,119,2.10 [1.58-2.79],3.270134836590877e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC12A2,Solute carrier family 12 member 2,3499,84,1.02 [0.45-2.31],0.963222349912336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC13A1,Solute carrier family 13 member 1,3607,90,1.21 [0.93-1.57],0.1465317288724459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC16A1,Monocarboxylate transporter 1,4054,117,1.14 [0.87-1.50],0.3281689552123748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC1A4,Neutral amino acid transporter A,3532,86,1.30 [0.90-1.88],0.1586683935253315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,4054,117,1.18 [0.94-1.49],0.159337395374132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,3482,86,1.18 [0.87-1.60],0.2983185859075742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,3482,86,1.07 [0.68-1.67],0.7738817226056288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,4054,117,2.17 [1.81-2.60],9.538898599341182e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,4174,120,1.77 [1.53-2.05],1.7087115195977745e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC44A4,Choline transporter-like protein 4,3532,86,1.02 [0.76-1.38],0.8894776905726688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC4A1,Band 3 anion transport protein,3629,87,0.73 [0.46-1.16],0.1871575395323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC51B,Organic solute transporter subunit beta,3499,84,1.25 [0.99-1.56],0.0554270561207493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,3556,85,0.97 [0.76-1.24],0.8125450483431976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,3602,89,1.31 [0.98-1.74],0.068333434114573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",3482,86,1.35 [1.02-1.80],0.0360459149626678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIT2,Slit homolog 2 protein,4054,117,1.05 [0.77-1.43],0.7449204528284081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,3506,87,2.55 [1.46-4.48],0.0010672685790843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,4215,123,3.47 [2.38-5.06],9.052958585655331e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,4107,122,5.50 [4.01-7.55],5.514818148891235e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,3566,88,0.99 [0.75-1.31],0.9420433660559606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,3602,89,1.42 [1.13-1.77],0.0022178660348744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,3598,87,3.16 [2.34-4.28],9.10369288142354e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,4058,119,1.07 [0.88-1.30],0.482115647216195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,3607,90,0.85 [0.63-1.14],0.2756333552517198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,3607,90,1.03 [0.70-1.52],0.874834906792795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,4161,121,0.57 [0.26-1.25],0.1600899022999138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,4054,117,1.06 [0.85-1.33],0.6027792266300488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,3482,86,0.94 [0.62-1.43],0.7745994879554288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,3602,89,1.16 [0.88-1.52],0.2975731104866885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,4215,123,4.18 [2.92-5.99],5.633786691695176e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,4198,120,4.98 [3.88-6.40],3.323322636365217e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,4192,121,1.41 [1.05-1.89],0.0230845868502423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,3506,87,1.29 [0.96-1.73],0.0903988555553585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,4190,120,0.98 [0.77-1.24],0.8458881147668775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,3607,90,0.77 [0.55-1.08],0.1340414095216955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMS,Spermine synthase,3493,84,1.05 [0.77-1.43],0.7621299836228866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMTN,Smoothelin,3595,87,1.32 [1.09-1.60],0.0050292708568586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP23,Synaptosomal-associated protein 23,4181,121,0.91 [0.76-1.10],0.3291934767179408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP25,Synaptosomal-associated protein 25,3493,84,0.87 [0.57-1.34],0.5324466885732044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP29,Synaptosomal-associated protein 29,4185,121,1.07 [0.89-1.27],0.4772881030286178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAPIN,SNARE-associated protein Snapin,3616,90,0.69 [0.48-0.98],0.0371430245979596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCA,Alpha-synuclein,3556,85,0.88 [0.74-1.05],0.1589930759643631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCG,Gamma-synuclein,4145,120,3.44 [2.78-4.25],2.4322475982393453e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",3520,84,1.58 [0.91-2.76],0.1064057741849425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',3602,87,1.45 [1.14-1.83],0.0020838172586955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNU13,NHP2-like protein 1,3499,84,0.82 [0.54-1.26],0.3714014541305476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX15,Sorting nexin-15,3556,85,0.82 [0.56-1.21],0.3295715718858215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX18,Sorting nexin-18,3602,89,1.28 [0.86-1.92],0.2288213816510053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX2,Sorting nexin-2,3607,90,1.03 [0.81-1.30],0.8097149487263584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX5,Sorting nexin-5,3520,84,0.52 [0.24-1.14],0.1013492220233295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX9,Sorting nexin-9,4181,121,1.15 [0.91-1.45],0.2414829972886715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],4102,119,0.76 [0.53-1.07],0.1133429968333318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",4195,121,0.95 [0.67-1.35],0.7599902719859131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD3,Extracellular superoxide dismutase,3632,90,1.22 [0.97-1.53],0.0862261471106624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,3616,90,1.63 [1.25-2.12],0.0002890431908712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,4058,119,7.09 [5.30-9.48],6.822508887760185e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORD,Sorbitol dehydrogenase,4194,122,0.61 [0.50-0.74],4.650707888722759e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORT1,Sortilin,4181,121,1.21 [0.81-1.82],0.3500547057999108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOST,Sclerostin,4181,121,2.42 [1.65-3.55],6.848374044189423e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,3532,86,0.97 [0.64-1.46],0.8762833187343102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX2,Transcription factor SOX-2,3610,89,0.36 [0.14-0.89],0.0273535976899164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX9,Transcription factor SOX-9,3532,86,4.23 [1.95-9.19],0.0002604246417626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,3616,90,2.07 [1.50-2.85],1.0433754867712114e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPAG1,Sperm-associated antigen 1,3616,90,0.91 [0.62-1.32],0.6191528005727871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARC,SPARC,4185,121,1.06 [0.85-1.34],0.594385071397209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARCL1,SPARC-like protein 1,4173,121,4.72 [2.94-7.58],1.2569455617244568e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPART,Spartin,3556,85,1.00 [0.76-1.31],0.9909328348665972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPESP1,Sperm equatorial segment protein 1,3615,89,2.26 [1.33-3.86],0.0026361867067273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,4195,121,4.13 [3.37-5.06],1.2338690182547958e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,3556,85,4.30 [2.87-6.44],1.4483433437456365e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,4174,120,3.02 [2.53-3.59],2.5848325230694256e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,4195,121,6.18 [4.26-8.98],9.298142715583441e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,4215,123,2.62 [1.94-3.54],3.3952135940805176e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,3499,84,0.69 [0.35-1.38],0.2962848185954773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,4184,121,3.75 [2.45-5.73],1.1925379307857395e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,4198,120,4.03 [2.95-5.49],1.2721399575875622e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,3602,89,1.00 [0.87-1.14],0.9525812602170955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPOCK1,Testican-1,4145,120,0.35 [0.22-0.57],2.735510555185843e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON1,Spondin-1,4185,120,4.94 [3.67-6.64],4.372436333313154e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON2,Spondin-2,4167,121,10.26 [7.19-14.62],6.850961038465283e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPP1,Osteopontin,4225,123,3.53 [2.75-4.54],1.0014616619957849e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",3506,87,1.11 [0.68-1.79],0.6765172407805385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRING1,SREBP regulating gene protein,3482,86,1.38 [1.05-1.80],0.0200474467627823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR1B,Cornifin-B,3566,88,1.11 [0.90-1.37],0.3477550525366212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR3,Small proline-rich protein 3,3602,87,1.95 [1.58-2.41],4.737994656462678e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRY2,Protein sprouty homolog 2,4080,118,0.95 [0.79-1.13],0.5577888801109088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",3493,84,0.79 [0.40-1.58],0.5044499930173518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,3602,87,1.59 [1.12-2.26],0.0099889275421853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,4177,121,0.98 [0.86-1.12],0.7907235939023673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,4161,121,1.14 [0.88-1.49],0.3255050222756439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPK2,SRSF protein kinase 2,4174,120,1.04 [0.87-1.26],0.6509949174506864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,3615,89,1.81 [1.08-3.06],0.0251369021995932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSB,Lupus La protein,4054,117,0.96 [0.73-1.28],0.7967203594439543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",3506,87,1.09 [0.64-1.86],0.7450862939712803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,4181,121,0.79 [0.70-0.89],0.0001615113226959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4197,122,0.99 [0.68-1.43],0.9445785414773994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,3482,86,0.73 [0.33-1.59],0.4225367145571647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,3602,89,1.05 [0.71-1.55],0.800650877394929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST13,Hsc70-interacting protein,3556,85,0.62 [0.43-0.90],0.0115982787370725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4161,121,1.95 [1.55-2.46],1.1702604088175113e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",4232,123,4.19 [2.57-6.80],7.687906760298696e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",3506,87,1.02 [0.66-1.58],0.9264957845381064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAB2,Stabilin-2,3629,87,2.19 [1.04-4.59],0.0389927647061573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAM,Signal transducing adapter molecule 1,3607,90,1.54 [0.95-2.49],0.081417092760406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAMBP,STAM-binding protein,4137,120,0.87 [0.67-1.13],0.2963836883690793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT2,Signal transducer and activator of transcription 2,3506,87,1.12 [0.86-1.46],0.3944757275383853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,4161,121,0.95 [0.85-1.07],0.4400887437770042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,3482,86,0.97 [0.71-1.34],0.8646313167583943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC1,Stanniocalcin-1,4212,121,2.33 [1.76-3.08],3.3690347036410805e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC2,Stanniocalcin-2,4188,120,5.29 [2.78-10.08],3.905816449197425e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STEAP4,Metalloreductase STEAP4,3493,84,1.22 [0.96-1.56],0.1035820098809194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,4188,121,0.82 [0.64-1.06],0.1301921418587076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK11,Serine/threonine-protein kinase STK11,4107,122,0.96 [0.77-1.20],0.7201499090835362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK24,Serine/threonine-protein kinase 24,4054,117,0.93 [0.71-1.22],0.6019746847301555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK4,Serine/threonine-protein kinase 4,4181,121,0.89 [0.73-1.07],0.2140574481336556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",3482,86,1.00 [0.80-1.24],0.9687844746101608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX16,Syntaxin-16,4058,119,1.14 [0.87-1.49],0.3455356646743162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX1B,Syntaxin-1B,3532,86,1.44 [0.99-2.09],0.0532835873354341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX3,Syntaxin-3,3602,87,0.62 [0.31-1.24],0.1783484936140554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX4,Syntaxin-4,4161,121,1.43 [1.17-1.75],0.0005511613930383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX5,Syntaxin-5,3506,87,0.81 [0.46-1.43],0.4644428772079656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX6,Syntaxin-6,4058,119,1.09 [0.85-1.40],0.4827746265196276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX7,Syntaxin-7,3506,87,1.37 [0.89-2.11],0.148223505516573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX8,Syntaxin-8,4174,120,1.53 [1.13-2.08],0.006144723151316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP1,Syntaxin-binding protein 1,3616,90,0.89 [0.69-1.15],0.3781643439600327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP3,Syntaxin-binding protein 3,4058,119,1.03 [0.70-1.51],0.8763951507652118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,3602,89,1.11 [0.69-1.80],0.6660809046175966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGT1,Protein SGT1 homolog,4058,119,0.93 [0.76-1.14],0.5026887185202744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT1A1,Sulfotransferase 1A1,4212,121,0.95 [0.84-1.07],0.395876678038058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT2A1,Bile salt sulfotransferase,4174,120,1.24 [1.01-1.51],0.0367044605236934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF1,Formylglycine-generating enzyme,3506,87,1.00 [0.73-1.36],0.9918326630874598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,4212,121,1.36 [0.99-1.89],0.0604411854497863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",3616,90,1.11 [0.84-1.47],0.4558270249695352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD1,Sushi domain-containing protein 1,4107,122,0.88 [0.64-1.23],0.4632332210301887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD2,Sushi domain-containing protein 2,4195,121,1.98 [1.17-3.35],0.0105054751854007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD4,Sushi domain-containing protein 4,3607,90,1.81 [1.42-2.31],2.264307599645408e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,3540,84,8.89 [5.34-14.81],4.5833692555493836e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,3532,86,1.04 [0.75-1.44],0.8001671771700742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SWAP70,Switch-associated protein 70,3602,89,1.50 [0.92-2.44],0.1068419283837356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYAP1,Synapse-associated protein 1,3556,85,0.82 [0.56-1.19],0.2894163810827217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,3493,84,0.86 [0.57-1.29],0.4585950935916077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYT1,Synaptotagmin-1,3602,87,2.15 [1.63-2.85],7.946095174646756e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYTL4,Synaptotagmin-like protein 4,3615,89,0.92 [0.69-1.21],0.5371949232702273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,3566,88,1.01 [0.83-1.23],0.930043515416091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,4161,121,1.01 [0.88-1.16],0.8960225233575593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,3704,112,5.92 [3.80-9.23],4.078967979722413e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TADA3,Transcriptional adapter 3,3607,90,0.90 [0.54-1.49],0.6725699743099498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,4161,121,5.91 [4.64-7.52],3.007919735055416e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAGLN3,Transgelin-3,3482,86,1.22 [0.92-1.62],0.1766206416051189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TALDO1,Transaldolase,3622,87,0.97 [0.61-1.55],0.900523609673787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,4080,118,0.91 [0.72-1.16],0.4422821717620063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAP1,Antigen peptide transporter 1,3566,88,1.16 [0.91-1.49],0.229021521301568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,4054,117,1.09 [0.88-1.35],0.4225576159417571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",3532,86,1.12 [0.85-1.46],0.4177325066469735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",3607,90,0.63 [0.35-1.12],0.1133809184842686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAX1BP1,Tax1-binding protein 1,3602,87,1.31 [0.97-1.78],0.0772236983933736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D17,TBC1 domain family member 17,4054,117,0.70 [0.47-1.04],0.0792342467481697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D23,TBC1 domain family member 23,4161,121,1.05 [0.88-1.25],0.6136228260709247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D5,TBC1 domain family member 5,4174,120,1.11 [0.91-1.35],0.3011887184342267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCA,Tubulin-specific chaperone A,3556,85,0.88 [0.68-1.13],0.3244079367799156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCB,Tubulin-folding cofactor B,4145,120,0.95 [0.81-1.12],0.5664733944142565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCC,Tubulin-specific chaperone C,4145,120,0.96 [0.78-1.18],0.7013618198024901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,4058,119,0.97 [0.80-1.18],0.7968224407359642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBR1,T-box brain protein 1,3532,86,0.72 [0.42-1.21],0.2134094944557998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,4143,120,0.71 [0.61-0.82],6.9327820727525525e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,4107,122,0.96 [0.78-1.19],0.726548729620492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN1,Transcobalamin-1,3543,88,1.15 [0.65-2.04],0.6255112227149061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN2,Transcobalamin-2,4225,123,4.28 [3.24-5.66],1.6211761790814103e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCOF1,Treacle protein,3615,89,1.98 [1.23-3.20],0.0049884949166774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCP11,T-complex protein 11 homolog,3566,88,0.88 [0.59-1.31],0.5184940243377973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCTN3,Tectonic-3,3615,89,0.75 [0.40-1.41],0.371961377623451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,4054,117,1.06 [0.95-1.18],0.3001409022345174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",3532,86,1.02 [0.61-1.70],0.946328299128656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,3607,90,0.98 [0.73-1.30],0.8783266583829445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDRKH,Tudor and KH domain-containing protein,4054,117,1.12 [0.92-1.35],0.2660427572399582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEF,Thyrotroph embryonic factor,3499,84,0.94 [0.57-1.55],0.8180068412568027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEK,Angiopoietin-1 receptor,4185,121,1.53 [0.78-2.99],0.2173083181000709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TERF1,Telomeric repeat-binding factor 1,3506,87,1.21 [0.62-2.37],0.581332294817416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TET2,Methylcytosine dioxygenase TET2,3557,88,0.91 [0.72-1.14],0.4017890709761577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX101,Testis-expressed protein 101,3532,86,1.68 [1.19-2.37],0.0030103595161053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX33,Testis-expressed protein 33,3566,88,0.90 [0.51-1.60],0.7208940053304891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TF,Serotransferrin,3631,89,0.29 [0.14-0.63],0.0015432078036063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,3493,84,0.87 [0.59-1.28],0.4915366486103734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF1,Trefoil factor 1,4175,121,2.18 [1.92-2.47],2.174145177454092e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF2,Trefoil factor 2,4192,120,2.81 [2.36-3.35],9.683039102460856e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF3,Trefoil factor 3,4158,120,2.81 [2.42-3.27],1.2114092463523236e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI,Tissue factor pathway inhibitor,4182,122,1.28 [0.87-1.88],0.2128282554585012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,4177,121,1.81 [1.48-2.22],1.0945927537806742e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFRC,Transferrin receptor protein 1,4196,122,1.84 [1.27-2.67],0.0011563807907308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TG,Thyroglobulin,3607,90,1.24 [1.06-1.45],0.0084842292720015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFA,Protransforming growth factor alpha,4174,120,2.67 [2.07-3.45],6.054387947096935e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,4220,121,2.20 [1.61-3.00],6.645880269111874e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,3607,90,0.86 [0.58-1.28],0.4592770521913303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,4165,122,0.66 [0.38-1.14],0.1375089504799968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,3506,87,4.50 [2.43-8.33],1.699091827166842e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,4185,121,5.40 [4.44-6.56],1.0377032486594012e-64
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,4232,123,6.74 [4.82-9.43],8.06867903015006e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,4171,121,0.79 [0.64-0.98],0.0294630703553414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,3632,90,13.42 [8.92-20.21],1.49034772373866e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,3476,86,0.80 [0.60-1.07],0.1336743542593156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBD,Thrombomodulin,4181,121,6.96 [5.20-9.31],4.8594596802173095e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS2,Thrombospondin-2,4195,121,1.67 [1.26-2.22],0.0003272930067305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS4,Thrombospondin-4,4192,122,1.23 [0.89-1.69],0.2179273538825754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THOP1,Thimet oligopeptidase,4167,120,0.37 [0.24-0.56],2.3811040671166144e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THPO,Thrombopoietin,4107,122,1.63 [1.11-2.37],0.0116482570213838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,3499,84,1.04 [0.86-1.26],0.6728034818821496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,3482,86,1.06 [0.60-1.86],0.8395306132391098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THTPA,Thiamine-triphosphatase,3600,90,0.89 [0.70-1.12],0.3155254746873894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,4212,121,8.91 [6.18-12.84],9.156186797269248e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,4060,120,0.96 [0.84-1.10],0.5994152820946836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,4232,123,1.20 [0.80-1.79],0.3825386559646148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",4046,117,1.17 [0.83-1.66],0.3638372528142033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,3566,88,1.49 [1.19-1.85],0.0004190307278606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,4197,122,1.30 [0.93-1.83],0.1292940210927978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,3615,89,1.15 [0.70-1.89],0.586935608052344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,3602,87,0.83 [0.65-1.07],0.1477245020769037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,4128,120,5.80 [4.29-7.84],3.2899211855644575e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,3615,89,2.19 [1.63-2.94],1.9301309754295144e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,4198,120,1.06 [0.94-1.19],0.3521666780599103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,4195,121,2.58 [1.88-3.56],5.747619790749765e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,4175,121,15.51 [8.41-28.61],1.7292599219250597e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJAP1,Tight junction-associated protein 1,4185,121,1.00 [0.83-1.22],0.980206753827202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJP3,Tight junction protein ZO-3,3493,84,1.34 [0.91-1.96],0.1398187305008707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TK1,"Thymidine kinase, cytosolic",3566,88,1.10 [0.71-1.68],0.6752898572089636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR1,Toll-like receptor 1,3506,87,2.26 [1.15-4.46],0.0183216697336303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR2,Toll-like receptor 2,3566,88,2.43 [1.01-5.84],0.0478824881686776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR3,Toll-like receptor 3,4228,121,1.38 [1.06-1.80],0.0182373455013392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR4,Toll-like receptor 4,3506,87,0.87 [0.41-1.83],0.7130976870553393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,3532,86,0.90 [0.60-1.36],0.6224409227386889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,3566,88,1.16 [0.82-1.65],0.4104070887725062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,3499,84,0.91 [0.53-1.57],0.746484389087805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,3499,84,0.90 [0.60-1.35],0.6142309807640782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED8,Protein TMED8,3602,89,0.92 [0.76-1.12],0.3984199218799045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM106A,Transmembrane protein 106A,3607,90,0.95 [0.71-1.28],0.743876816766655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM132A,Transmembrane protein 132A,3520,84,1.27 [0.94-1.72],0.1181694853958682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM25,Transmembrane protein 25,3616,90,1.36 [0.91-2.04],0.1296250436282799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMOD4,Tropomodulin-4,3482,86,1.65 [1.08-2.54],0.0219626085740951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,3493,84,1.07 [0.83-1.40],0.5916398051311298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,3594,87,3.13 [2.36-4.15],2.258152186074024e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS15,Enteropeptidase,4161,121,1.39 [1.17-1.66],0.0002462459046782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS5,Transmembrane protease serine 5,4128,120,1.66 [1.08-2.55],0.0202631422512648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMSB10,Thymosin beta-10,4195,121,1.66 [1.34-2.05],2.7713969575303868e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNC,Tenascin,4197,122,2.00 [1.48-2.70],6.346505232734891e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNF,Tumor necrosis factor,4104,122,2.20 [1.85-2.61],3.1942333184737245e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,3602,89,1.32 [0.97-1.81],0.0790590082223229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,4080,118,0.90 [0.58-1.41],0.6506596477002625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,3556,85,0.78 [0.55-1.11],0.1671621199621457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,4145,120,3.90 [3.22-4.73],1.5968906505718229e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,4145,120,1.74 [1.57-1.93],4.156268299253097e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,4197,123,1.63 [1.16-2.29],0.0048766391847956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,4228,121,5.91 [4.74-7.36],1.6864922705199696e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,4176,120,3.53 [2.35-5.30],1.1886663371588979e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,4185,121,7.72 [5.87-10.17],4.4575939748160113e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,4185,120,3.52 [2.86-4.33],2.136693484771796e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,4080,118,2.27 [1.68-3.09],1.2890290508801445e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,4185,120,7.41 [5.76-9.54],1.4086778030991982e-54
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,3556,85,4.59 [2.91-7.26],6.622330368261809e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,4215,123,5.63 [4.54-6.98],4.9051165949013265e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,4195,121,13.50 [10.08-18.08],3.1344984633169168e-68
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,4195,121,2.09 [1.84-2.36],3.2118372890753993e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,4212,121,14.38 [9.65-21.43],3.287392322072269e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,4220,121,6.12 [4.73-7.91],2.9221666387742243e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,4145,120,2.40 [1.98-2.91],5.050905866279736e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,4212,121,2.69 [2.12-3.42],4.843795532824098e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,4145,120,3.36 [2.84-3.97],2.4992161262670848e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,4228,121,1.42 [0.78-2.59],0.2568403453284297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,4174,120,0.89 [0.68-1.16],0.3802957722356781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,4228,121,0.92 [0.53-1.59],0.7648791571588556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,4198,120,9.32 [5.91-14.68],6.5478448261103865e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,4228,123,2.42 [1.54-3.81],0.0001251485976516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,4145,120,1.22 [0.93-1.62],0.1545855801566012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,3629,87,1.94 [1.18-3.17],0.0084879427076168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,3602,87,0.92 [0.72-1.17],0.4862206012811566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNN,Tenascin-N,3629,87,1.41 [0.89-2.24],0.1427809524201366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNNI3,"Troponin I, cardiac muscle",4107,122,1.22 [1.00-1.48],0.0487918221547181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNPO1,Transportin-1,3566,88,1.17 [0.66-2.10],0.5873135272566117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNR,Tenascin-R,4145,120,1.97 [1.38-2.81],0.0001795711012041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNXB,Tenascin-X,4195,121,0.77 [0.43-1.38],0.3807476858520723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,3615,89,1.08 [0.83-1.40],0.5725567709058217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1,DNA topoisomerase 1,3602,89,1.10 [0.93-1.30],0.259524949931722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",3482,86,0.65 [0.39-1.10],0.1060986744190724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP2B,DNA topoisomerase 2-beta,3506,87,1.00 [0.77-1.30],0.9788121589167786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,3520,84,1.12 [0.79-1.60],0.5284874349473074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53,Cellular tumor antigen p53,4058,119,1.17 [0.81-1.69],0.4001506443876456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53BP1,TP53-binding protein 1,3506,87,1.28 [1.02-1.61],0.03377882965733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,3466,81,0.66 [0.43-1.00],0.0479213962107699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,4107,122,1.00 [0.59-1.71],0.9952130567696312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP73,Tumor protein p73,3532,86,0.68 [0.37-1.26],0.2234788811584576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPBGL,Trophoblast glycoprotein-like,3532,86,0.80 [0.46-1.41],0.4422219338757537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPD52L2,Tumor protein D54,3556,85,0.91 [0.75-1.11],0.3441251963723524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,3615,89,2.20 [1.10-4.40],0.0261427371512213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPM3,Tropomyosin alpha-3 chain,3499,84,1.41 [1.00-1.98],0.0474073303805783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPMT,Thiopurine S-methyltransferase,4058,119,0.59 [0.46-0.74],1.0191569189735322e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPP1,Tripeptidyl-peptidase 1,4150,120,1.52 [1.14-2.03],0.0043948308059814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,3566,88,1.24 [0.99-1.54],0.056502927356387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,4054,117,1.15 [0.76-1.75],0.5132626754430047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPR,Nucleoprotein TPR,3499,84,1.22 [0.88-1.68],0.2334234005614904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,3482,86,1.13 [0.85-1.50],0.3888641971791324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSAB1,Tryptase alpha/beta-1,4220,121,1.82 [1.31-2.54],0.0004054684119041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSD1,Tryptase delta,3616,90,2.05 [1.45-2.90],5.350810402649112e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSG1,Tryptase gamma,3506,87,0.77 [0.34-1.72],0.5243728704394122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPT1,Translationally-controlled tumor protein,4080,118,1.02 [0.78-1.33],0.8952842531962124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF2,TNF receptor-associated factor 2,4174,120,0.97 [0.77-1.22],0.789700248879909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",3506,87,0.98 [0.58-1.67],0.9519860186248604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,3499,84,0.85 [0.53-1.37],0.509849292578396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,3566,88,0.84 [0.64-1.08],0.1735355361725234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREH,Trehalase,3629,87,0.93 [0.71-1.21],0.5813626302494832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,4176,120,1.69 [1.31-2.18],4.815967321745077e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML1,Trem-like transcript 1 protein,3632,90,1.01 [0.69-1.48],0.9480239612480617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML2,Trem-like transcript 2 protein,4195,121,3.58 [2.45-5.23],4.3612309332872866e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,4215,123,1.72 [1.34-2.21],1.9563493344449672e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,4174,120,0.90 [0.73-1.11],0.3315203856847946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,3558,88,1.00 [0.73-1.37],0.9772615242038872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,3602,89,0.97 [0.80-1.17],0.7427582487059521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM26,Tripartite motif-containing protein 26,3482,86,0.87 [0.59-1.28],0.4823224228657272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,3532,86,0.94 [0.71-1.24],0.6644633535481268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM5,Tripartite motif-containing protein 5,4174,120,0.91 [0.75-1.10],0.3296889714428032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,3607,90,0.92 [0.73-1.15],0.4648012231089475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,3499,84,1.05 [0.71-1.54],0.8092435500483203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC1,Hamartin,3506,87,1.02 [0.77-1.36],0.8796263689593925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC22D1,TSC22 domain family protein 1,3616,90,0.88 [0.64-1.21],0.4321736613758422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSHB,Thyrotropin subunit beta,4181,121,0.75 [0.62-0.92],0.0060786637475068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSLP,Thymic stromal lymphopoietin,4107,122,0.95 [0.72-1.26],0.7242788115246539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSNAX,Translin-associated protein X,3499,84,0.54 [0.30-0.95],0.0327257727438851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN1,Tetraspanin-1,4107,122,0.99 [0.80-1.23],0.9327105089515269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN15,Tetraspanin-15,3499,84,1.24 [0.89-1.72],0.1976144164623494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN7,Tetraspanin-7,3493,84,0.80 [0.59-1.07],0.1365550943764157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN8,Tetraspanin-8,3602,89,1.08 [0.89-1.30],0.4549340149194099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,3506,87,1.26 [0.77-2.04],0.3558550460137988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TST,Thiosulfate sulfurtransferase,4052,117,1.11 [0.89-1.38],0.3627360046937511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTF2,Transcription termination factor 2,3532,86,0.89 [0.58-1.36],0.5834295050182854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTN,Titin,3499,84,1.21 [0.92-1.59],0.1832409092750726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTR,Transthyretin,3596,89,0.42 [0.20-0.86],0.0178908212181783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TUBB3,Tubulin beta-3 chain,3493,84,1.54 [0.70-3.39],0.278901546776686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TWF2,Twinfilin-2,3629,87,0.94 [0.73-1.20],0.6048553348613952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXK,Tyrosine-protein kinase TXK,3566,88,0.93 [0.69-1.24],0.6141632914866846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXLNA,Alpha-taxilin,4145,120,0.99 [0.82-1.20],0.9505580746799552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXN,Thioredoxin,3568,88,0.71 [0.42-1.20],0.201025071764385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,4185,121,1.13 [0.65-1.96],0.6726565493249224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,4212,121,1.77 [1.42-2.22],5.619714073141742e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,3602,87,0.94 [0.64-1.39],0.767868902304577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNL1,Thioredoxin-like protein 1,3489,84,0.91 [0.72-1.16],0.4595360170372706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",4195,121,0.82 [0.58-1.16],0.2669022188053951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYMP,Thymidine phosphorylase,4152,120,1.08 [0.84-1.39],0.5516614068411174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,4181,121,2.58 [1.48-4.49],0.0008102169136626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",3506,87,2.25 [1.60-3.16],3.1049185196468685e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,4161,121,0.51 [0.32-0.80],0.0032412034912357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,3607,90,0.79 [0.38-1.66],0.5336626661037887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,3615,89,1.37 [0.98-1.90],0.0662941461935978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,3506,87,1.11 [0.78-1.59],0.5587656950576643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBQLN3,Ubiquilin-3,3499,84,1.41 [1.14-1.75],0.0019013240020928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBXN1,UBX domain-containing protein 1,3556,85,0.90 [0.66-1.22],0.5004918487243304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,3602,89,0.95 [0.82-1.10],0.4989854214675999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,3499,84,1.04 [0.84-1.27],0.7412398538065988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,3499,84,0.85 [0.42-1.75],0.6642398402933011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ULBP2,UL16-binding protein 2,4145,120,7.73 [5.70-10.48],1.3516983602488864e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UMOD,Uromodulin,4218,121,0.34 [0.28-0.43],3.773872072619667e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC5D,Netrin receptor UNC5D,3506,87,2.65 [1.55-4.53],0.0003654586161594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC79,Protein unc-79 homolog,3482,86,1.07 [0.74-1.55],0.707211098280565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNG,Uracil-DNA glycosylase,3607,90,1.12 [0.62-2.03],0.7011513000799061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPB1,Beta-ureidopropionase,3615,89,0.84 [0.69-1.03],0.0987005218041258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3A,Uroplakin-3a,3493,84,0.83 [0.55-1.26],0.3808588802191474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,3560,87,1.25 [0.95-1.64],0.1126008438459093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROD,Uroporphyrinogen decarboxylase,3556,85,0.64 [0.46-0.88],0.0059456088623785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROS,Uroporphyrinogen-III synthase,3532,86,0.74 [0.52-1.06],0.1028426459144753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USO1,General vesicular transport factor p115,4161,121,0.99 [0.83-1.19],0.9558359504393262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,3607,90,1.03 [0.77-1.37],0.8383800587938195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,3602,87,2.25 [1.70-2.98],1.2652086195392825e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,3499,84,1.04 [0.82-1.32],0.7176994418120612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,4107,122,0.95 [0.80-1.13],0.5796749630548854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,4058,119,0.92 [0.67-1.26],0.5881101050653166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,4107,122,1.23 [0.96-1.57],0.1021168842504565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,3506,87,0.95 [0.75-1.21],0.6859537430860019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,4174,120,0.90 [0.74-1.10],0.289868449433122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASN,Vasorin,4121,120,6.69 [4.42-10.12],2.2882675126950843e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,3632,90,0.89 [0.68-1.18],0.4238690895490963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,4161,121,1.90 [0.88-4.10],0.1009087848812519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,3493,84,0.99 [0.80-1.23],0.9321948674524118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,4196,122,5.58 [3.66-8.51],1.4951908877897685e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAN,Versican core protein,4212,121,2.83 [1.70-4.70],6.142247998220053e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,3482,86,1.07 [0.85-1.34],0.5721929182890408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFA,Vascular endothelial growth factor A,4215,121,2.01 [1.57-2.56],2.047875584854298e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,3506,87,4.27 [2.31-7.92],3.912089686971347e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFC,Vascular endothelial growth factor C,4185,121,1.14 [0.86-1.51],0.3495607477666491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,4221,121,4.36 [3.11-6.12],1.2824136870549914e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VGF,Neurosecretory protein VGF,3616,90,3.24 [2.28-4.63],7.995343474867449e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIM,Vimentin,4107,122,0.94 [0.83-1.08],0.3859298940512856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,3520,84,0.82 [0.32-2.08],0.6720701477206328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIT,Vitrin,3615,89,2.92 [1.94-4.42],3.3637066476617165e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,4161,121,2.42 [1.86-3.14],3.049500781781283e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN1,Pantetheinase,3632,90,0.77 [0.60-0.99],0.0392424027758369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,4161,121,1.47 [1.02-2.10],0.0370868977103707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,3566,88,0.72 [0.51-1.01],0.0563541239394514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,4161,121,1.06 [0.86-1.30],0.5821982186409536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,3607,90,0.88 [0.70-1.09],0.2387999877022252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,4161,121,1.05 [0.86-1.28],0.6465716033587675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,3607,90,1.19 [0.72-1.97],0.4923256386768703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,3499,84,1.64 [1.00-2.68],0.0504182863006852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,3607,90,2.38 [1.94-2.94],3.329742498796911e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,4188,120,6.89 [5.41-8.77],1.836298443908909e-55
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,4174,121,1.25 [0.98-1.58],0.0675690647506345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSNL1,Visinin-like protein 1,3602,87,1.25 [0.78-2.00],0.3434004887993039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,4054,117,1.77 [1.32-2.39],0.0001482076539632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,3566,88,0.62 [0.33-1.17],0.1429295983146447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,4107,122,1.29 [1.02-1.62],0.0300145456446768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,4212,121,0.94 [0.75-1.19],0.6203643370589759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,4058,119,1.97 [1.35-2.89],0.0004946237571374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,3556,85,1.04 [0.72-1.48],0.8486703956728042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,4207,123,1.28 [0.87-1.88],0.2022221659299874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,3482,86,0.98 [0.75-1.27],0.8623572514913241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2,Brorin,4130,120,7.78 [5.73-10.57],2.1778736528550213e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,3616,90,1.35 [1.03-1.78],0.0305987760610158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWF,von Willebrand factor,4232,123,1.26 [1.02-1.56],0.0348621176709603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",4195,121,1.51 [1.00-2.29],0.0520621556113593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,4080,118,1.02 [0.79-1.30],0.904801458641356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,4107,122,0.97 [0.82-1.15],0.7403352022013283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,4054,117,1.09 [0.90-1.33],0.3730187824723966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASHC3,WASH complex subunit 3,3602,87,1.22 [0.95-1.57],0.1217129180866897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,3506,87,0.90 [0.62-1.31],0.5846119148938071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WDR46,WD repeat-containing protein 46,3607,90,0.93 [0.52-1.66],0.7943922213177129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,3538,89,1.43 [1.14-1.79],0.0018414928379554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,4209,123,2.03 [1.65-2.51],4.330058788952848e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,3974,111,5.43 [4.47-6.60],6.17649121577685e-65
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",4131,120,0.69 [0.48-1.00],0.0487591337900909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",4185,120,4.04 [2.61-6.25],3.487553918340829e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WIF1,Wnt inhibitory factor 1,4215,123,1.29 [0.83-2.02],0.2608889616421689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WNT9A,Protein Wnt-9a,4080,118,3.69 [2.92-4.68],2.177799597321937e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,4145,120,0.88 [0.65-1.20],0.4258863761189477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XCL1,Lymphotactin,4215,123,1.71 [1.43-2.04],4.346257090513604e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XG,Glycoprotein Xg,4208,123,6.60 [5.07-8.59],9.102511310511673e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,3506,87,1.32 [0.94-1.86],0.105008267220656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,4185,121,0.78 [0.68-0.90],0.0006306830423474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XRCC4,DNA repair protein XRCC4,4054,117,0.87 [0.55-1.38],0.5465943929742143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,3602,87,12.59 [8.44-18.76],1.6392592086720302e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",3602,89,0.96 [0.83-1.10],0.5492772858312944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YES1,Tyrosine-protein kinase Yes,4161,121,1.07 [0.93-1.23],0.3579603694790669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YJU2,Splicing factor YJU2,3607,90,0.94 [0.49-1.80],0.8562371142309134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,3499,84,0.62 [0.45-0.87],0.0049744331828657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YTHDF3,YTH domain-containing family protein 3,4080,118,0.92 [0.76-1.11],0.3775350537817663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YWHAQ,14-3-3 protein theta,3556,85,0.90 [0.68-1.20],0.484958602513334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YY1,Transcriptional repressor protein YY1,3506,87,0.92 [0.43-1.96],0.8224877731177656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBP1,Z-DNA-binding protein 1,3506,87,1.57 [1.05-2.34],0.0263493045794543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,4058,119,1.06 [0.84-1.32],0.6295023754364517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,4107,122,1.81 [1.43-2.31],1.224885081798701e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,3499,84,1.01 [0.72-1.41],0.9623278818649478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,3602,89,0.93 [0.74-1.18],0.5580865608391635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,3602,87,1.33 [0.85-2.08],0.2174403195490595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF174,Zinc finger protein 174,3506,87,1.28 [0.78-2.08],0.3251626088124453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF75D,Zinc finger protein 75D,3566,88,0.93 [0.66-1.32],0.6800056770007438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF830,Zinc finger protein 830,3607,90,1.12 [0.88-1.43],0.3694003615817883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRD2,Protein ZNRD2,3602,89,1.06 [0.80-1.39],0.6888332959687378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,3607,90,0.91 [0.61-1.34],0.6211449992652499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,3520,84,1.00 [0.92-1.08],0.934661222369226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,3482,86,0.76 [0.36-1.60],0.4705721199966887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZPR1,Zinc finger protein ZPR1,3493,84,0.67 [0.49-0.93],0.0151029564286718
